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Chapter 1
Introduction
As the abundance of molecular data in the life sciences increases, the use of mathe-
matical and computational tools to provide a deeper understanding of how gene reg-
ulatory networks (GRNs) function is becoming both necessary and possible. In the
last 10 years or so, the field known as ‘systems biology’ has emerged which seeks
to understand complex systems comprised of many connected elements with corre-
lated behaviours and non-linear interactions. Systems biology is an inherently multi-
disciplinary field, combining expertise and techniques from subjects such as mathe-
matical biology, bioinformatics, image processing, biophysics, wet-lab biology and
computer science. A large component of systems biology is concerned with the for-
mulation, study and analysis of theoretical models.
There are many good reasons to develop and use models. One of their main uses in
research is to predict how the system of interest will behave under conditions not yet
tested experimentally. There are many examples in the literature of computational
modelling successfully guiding biological experiments, for example see Locke et al.
(2005). Models may also be designed for communication of concepts, for sharing
with collaborators, for re-use as components of larger models, and even for training
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purposes (e.g. flight simulators, virtual surgery). We can also use models to try to
unearth the causes of an event that has already happened, for example, the Northeast
America blackouts in 2003 (Bolouri, 2008).
The sheer size and complexity of the data from global, high-throughput technologies is
such that unbiased and comprehensive data analysis can only be performed via compu-
tational methods. Moreover, GRNs, and indeed most biochemical networks, are highly
nonlinear systems, so that it is often very difficult to predict their behaviours without
extensive modelling. Computational mathematical models permit the use of sophisti-
cated analyses and visualisation methods that can reveal deeply hidden properties of
complex systems. Another very attractive feature of mathematical and computational
modelling is that the models can be unambiguously described and communicated. The
language of mathematics is universally understood, so dissemination of mathemati-
cal models can be trivial. Furthermore, computational models that conform to certain
standards can be automatically interpreted by a variety of software tools (e.g. SMBL
models), allowing greater scrutiny and re-use while avoiding mishandling.
Perhaps the strongest argument for using computational techniques to model and anal-
yse GRNs is that the low cost and high performance of computers allows us to perform
large numbers of in-silico experiments. In-silico experiments (i.e., theoretical experi-
ments facilitated by the power of computers) can explore scenarios too costly (in terms
of time or money) or too complicated to explore in a laboratory. They can help us
develop insights into the roles of different regulatory interactions within a system, and
guide experimental planning. In-silico experiments can also highlight inconsistencies
in our assumptions, such as when a GRN model is shown to be incapable of reproduc-
ing certain experimental observations (this is something that we will encounter in this
thesis, see section 8.5).
In addition to the above attractions, computational models of GRNs provide a number
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of serendipitous benefits. For example, in order to construct a computational model,
one often has to make all assumptions explicit. If there are any provisos, gaps, or ar-
bitrarily defined values or interactions, their formal definition within a computational
model should bring them to light. Of course, such explicit declarations can still be
buried in pages of code or equations, but good practice guidelines can help users iden-
tify such issues. Making assumptions explicit can also trigger new lines of investi-
gation. The models also facilitate automated consistency checking. Another benefit
of computational modelling is that such models can be stored in databases and pro-
grammatically interrogated, thus allowing researchers everywhere to quickly locate
and download a model. Indeed, the concept of ‘cloud biology’ is gaining momen-
tum and many authors recognise its importance for the future (Slaymaker et al., 2012).
As these technologies mature, one can envisage organ-, organism- or disease-specific
model repositories that allow users to share interim models and explore the behaviour
of their model in the context of models of related processes developed by other re-
searchers.
Computational models of GRNs can take a variety of forms. Until recently, modelling
studies have predominately used deterministic, temporal approaches. This includes
models comprised of directed and undirected graphs, boolean networks, generalised
logical networks, nonlinear ordinary differential equations, delay differential equa-
tions, stochastic differential equations and stochastic master equations (Jong, 2002).
Although these models have attempted to be quantitative, they have often only yielded
qualitative insights into the underlying biological system. This situation can be ex-
plained by two major difficulties facing the field of systems biology. First of all, the
biochemical reaction mechanisms underlying regulatory interactions are usually not
known or are incompletely known. This means that detailed kinetic models cannot
be built and more approximate models are required. In the second place, quantitative
information regarding kinetic parameters and molecular concentrations is only seldom
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available. Unsurprisingly, the best modelling efforts have used fine-grained, quantita-
tive and stochastic models which have been restricted to regulatory networks of small
size and modest complexity that have been already well-characterised through experi-
mental means. There has also been a marked lack of spatio-temporal models of GRNs
in the systems biology literature — such models form the focus of this thesis.
In comparison to temporal models there are few spatio-temporal models of intracellu-
lar signalling pathways in the literature, although the body of work is growing. Early
attempts at spatio-temporal modelling of intracellular pathways containing negative
feedback loops were carried out by Glass and co-workers, who recognised the in-
herent spatial heterogeneity of cells and observed oscillatory dynamics for activator-
inhibitor kinetics (Glass and Kauffman, 1970; Shymko and Glass, 1974). Mahaffy et
al. subsequently developed models to capture spatial features for such pathways, in-
troducing delays for transcription and translation and oscillatory dynamics were again
observed (Mahaffy and Pao, 1984; Busenberg and Mahaffy, 1985; Mahaffy, 1988).
More recently, Gordon et al. developed a partial differential equation (PDE) model
for the p53-Mdm2 pathway (Gordon et al., 2009) including delays and which pro-
duced sustained oscillations. The model was solved in two spatial dimensions, but
did not consider separate compartments for the nucleus and cytoplasm. Other PDE
models not containing delays have also appeared recently including those of Terry et
al. who studied the Notch and NF-κB pathways, finding oscillatory behaviour that
closely resembles experimental results (Terry et al., 2011; Terry and Chaplain, 2011).
Spatio-temporal models of intracellular processes have been investigated not only in
the context of negative feedback loops. For instance, Kholodenko and co-workers
have considered general reaction-diffusion models of protein kinase and phosphatase
activity within cells (Brown and Kholodenko, 1999; Kholodenko, 2006), Cangiani and
Natalini have examined active transport of proteins along microtubules (Cangiani and
Natalini, 2010), and Dinh et al. have studied intracellular trafficking of adenoviral
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vectors (Dinh et al., 2005). For a review of modelling intracellular spatio-temporal
interactions, see Rangamani and Iyengar (2007) and Kholodenko (2006). It is clear
from these early studies that the development of models which reflect spatial and tem-
poral aspects of intracellular pathways can be regarded as a first step towards an effec-
tive computational approach in investigating conditions under which pathways become
deregulated and in the optimising of targeted drug treatment.
The strength of models depends on the appropriateness of the modelling assumptions.
Hence, in the next chapter we present background biology for eukaryotic cells, specif-
ically focusing on gene regulatory networks, the spatial structure of the eukaryotic
cell and intracellular transport mechanisms. In this thesis, we will focus on two spe-
cific gene regulatory networks, the Hes1 GRN (which plays a role in developmental
processes) and the p53-Mdm2 GRN (which is critical for regulating the cell-cycle).
Both can become deregulated in human cancer (Sang et al., 2008; Lane, 1992), so
their study is interesting both from a biological and a clinical perspective. We present
background biology for the Hes1 GRN in chapter 3 as well as a literature review of
previous mathematical modelling efforts. Importantly, we demonstrate that neglecting
spatial information can have major consequences in terms of reproducing experimen-
tal data. In chapter 4 we formulate and explore numerically a reaction-diffusion model
of the Hes1 GRN which builds on and extends previous modelling efforts. Using our
PDE model we are able to reproduce the oscillatory dynamic observed in experimental
data, as well as mimicking well-documented biological experiments. We explore fur-
ther the importance of spatial considerations in chapter 5 by making model extensions
which are only possible under a spatial regime. Specifically, we study the influence
of the nuclear membrane, active transport and cell shape on the Hes1 GRN. We find
our extended model is more robust to changes in parameters as well as being robust to
geometrical changes in our computational domain. We suggest a possible biological
experiment that could distinguish which model (the one presented in chapter 4 or the
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one presented in chapter 5) is more accurate. We depart from the continuum PDE ap-
proach in chapter 6 and develop a spatial stochastic model which accounts for intrinsic
noise in the Hes1 GRN. We focus our modelling efforts on embryonic stem cells (due
to the abundance of expression data for this cell line) and make a prediction regarding
the source of heterogeneity in embryonic stem cell differentiation. In chapter 7 we
introduce the more complex p53-Mdm2 GRN. As we did for the Hes1 GRN in chap-
ter 3, we begin by introducing the background biology of the p53-Mdm2 GRN and
a literature review of previous mathematical modelling efforts. Again, we are able to
demonstrate that the use of strictly temporal approaches can have certain limitations.
In chapter 8, a reaction-diffusion model of the p53-Mdm2 GRN is formulated and a nu-
merical simulation study is presented. Interestingly, a proteasome inhibition numerical
experiment unearths an inconsistency between our simulations and a biological exper-
iment, implying something is a askew with our modelling assumptions. This problem
is rectified in chapter 9, where we consider the influence of active transport and the
nuclear membrane on the p53-Mdm2 GRN. By accounting for active transport we are
able to faithfully reproduce data produced by the proteasome inhibition biological ex-
periment. Finally, concluding remarks and directions for future research are given in
chapter 10. Some technical details are deferred to an Appendix.
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Chapter 2
Biological background
In this chapter we review the biology of intracellular signal transduction. We focus on
gene regulatory networks, negative feedback loops and the spatial structure of eukary-
otic cells. We also discuss how molecules are transported within the cell.
2.1 Intracellular signal transduction
Intracellular signal transduction can be described as the transmission of molecular sig-
nals from a cell’s exterior to its interior. Molecular signals are transmitted between
cells by the secretion of hormones and other chemical factors. The ability of an or-
ganism to function normally is dependent on all the cells of its different organs com-
municating effectively with their surrounding environment and with each other — a
phenomenon known as intercellular communication. Eukaryotic cells require stimula-
tion for cell division and survival, for example, it is known that in the absence of certain
growth factors, the cell will undergo apoptosis (Collins et al., 1994). These extracellu-
lar stimulation requirements are necessary for controlling cell behaviour in unicellular
and multicellular organisms. In fact, signal transduction pathways are perceived to be
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so central to biological processes that a large number of diseases are attributed to their
disregulation.
Once a cell picks up a hormonal or sensory signal, it must transmit this information
from the surface to the interior parts of the cell — for example, to the nucleus. This
occurs via signal transduction pathways that are very specific, both in their activation
and in their downstream actions. Thus, the various organs in the body respond in
an appropriate manner (only) to relevant signals. In eukaryotic cells, most intracel-
lular proteins are activated by a ligand/receptor interaction and possess an enzymatic
activity — examples include tyrosine kinases and phosphatases. Some of them cre-
ate second messengers such as cyclic AMP and IP3, the latter controlling the release
of intracellular calcium stores into the cytoplasm. In general, second messengers are
molecules that relay signals from receptors on the cell surface to target molecules in-
side the cell, in the cytoplasm or nucleus. These second messengers then bring into
play complex GRNs which control the levels of mRNA and protein copy numbers
through various feedback loops. The changes in protein and mRNA copy numbers
can result in changes in cell behaviour, structure and the environment. For example, a
yeast cell which is surrounded by sugar solution will switch on genes to make enzymes
that process the sugar and convert it to alcohol. This process, which we associate with
wine-making, is how the yeast cell survives, gaining energy to multiply, which under
normal circumstances would enhance its survival prospects. An overview of signal
transduction is given in the schematic diagram in Figure 2.1.
2.1.1 Genes
The traditional definition of a gene is a region of DNA that is transcribed as a single
unit and carries information for a discrete hereditary characteristic, usually correspond-
ing to a single protein or a single RNA (Alberts et al., 2008). This definition has been
8
Figure 2.1: A schematic diagram presenting an overview of the main components of intra-
cellular signal transduction. Signals from outside the cell are processed by gene regulatory
networks which cause changes in mRNA and protein levels. These changes can influence cell
behaviour and internal structure or initiate certain feedback loops. The components of signal
transduction which are studied in this thesis are highlighted by the blue rectangle.
challenged in recent years, and it appears that what constitutes a gene often depends
on its context, hence there no longer exists a universally accepted definition (Keller
and Harel, 2007). It has been discovered that a gene may encode multiple transcrip-
tion start sites, overlapping coding regions, alternative splicing sites, untranslated and
regulatory RNAs, and enhancer binding sites hundreds of kilo-bases away from the
basal promoter they act on. This new data has led to an updated definition of a gene
as “a union of genomic sequences encoding a coherent set of potentially overlapping
functional products” (Gerstein et al., 2007). This updated definition defines genes by
functional products, whether they are proteins or RNA, rather than specific DNA loci.
In this thesis, we are concerned with the functional products of genes and how they reg-
ulate the expression of other genes. Our focus is on the theoretical and computational
techniques that we can use to gain the deepest insights from the available expression
data. We are aided in this undertaking by the fact that models of GRNs ultimately
make predictions about features digitally encoded in DNA, which can be tested unam-
biguously using DNA-based technologies.
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2.1.2 Gene regulatory networks
A gene regulatory network or genetic regulatory network lies at the core of intracel-
lular signal transduction. In brief, a GRN is a collection of DNA segments in a cell
which interact with each other indirectly through their RNA and protein products (and
with other substances in the cell), thereby governing the rates at which genes in the
network are transcribed into mRNA. In Figure 2.2, a schematic diagram of a generic
gene regulatory network is presented.
cytoplasm
nucleus
extracellular signal
receptor
proteins
cascade of interacting
proteins
inactive transcription factor
active transcription factor
DNA
Figure 2.2: A schematic diagram presenting a generic GRN. This diagram illustrates the chain
of intracellular events that occur when a cell receives an extracellular signal.
The sequence of events illustrated in Figure 2.2 can be summarised as follows. The
cell receives an extracellular signal via specific receptor proteins at the cell membrane.
This signal is carried through the cytoplasm by a cascade of interacting proteins which
often results in the activation of transcription factors. Transcription factors are a class
of molecules involved in regulating gene expression. They are usually proteins, al-
though they can also consist of short, non-coding RNA. Transcription factors function
by recognising certain nucleotide sequences before or after the gene in the nucleus.
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Eukaryotes often have a promoter region upstream from the gene, with certain specific
motifs that are recognised by the various types of transcription factor. By binding to
this region at the start of other genes (or even their own gene), transcription factors can
switch the gene ‘on’ or ‘off’, or in other words, initiate or inhibit the binding of RNA
polymerase. Transcription factors are also usually found working in groups or com-
plexes, forming multiple configurations that allow for varying degrees of control over
rates of transcription. Once RNA polymerase is bound, the process of transcription can
begin which yields mRNA. The newly formed mRNA is transported across the nuclear
membrane and can then diffuse in the cytoplasm. In the cytoplasm, the process of
translation can take place, where mRNA molecules interact with ribosomes (the pro-
tein production factories of the cell) to produce protein. It is worth noting that a single
mRNA molecule can produce large quantities of protein. The protein molecules can
be involved in numerous different events, such as feedback loops (positive or negative)
or protein cascades which can result in changes in cellular function.
2.1.3 Negative feedback loops
Negative feedback loops controlling the concentrations of key intracellular proteins
are prevalent in a diverse range of important cellular processes. Examples include
inflammation, meiosis, apoptosis and the heat shock response (Alberts et al., 2008;
Lahav et al., 2004; Fall et al., 2002). Experimental data reveal that pathways con-
taining negative feedback loops can exhibit sustained oscillations (Hirata et al., 2002;
Geva-Zatorsky et al., 2006; Nelson et al., 2004; Shankaran et al., 2009). This is not
unexpected given the interactions involved in a negative feedback loop.
A generic example of a negative feedback loop with variables x and y is shown in
Figure 2.3. The interactions involved in this negative feedback loop can be described
as follows. An increase in x causes y to increase, which in turn results in the inhibition
11
yx
Figure 2.3: A schematic diagram of a generic negative feedback loop.
of x. After x begins to decrease, this will also cause y levels to diminish, eventually
allowing x to increase again. This process repeats and thus produces oscillations in
both x and y.
2.2 The spatial structure of the eukaryotic cell
Gene regulation is an inherently spatial process. In the eukaryotic cell, there are a
variety of internal compartments (see Figure 2.4) called organelles, each of which has
its own lipid membrane. Organelle function can be divided into three main categories:
information processing, energy processing, and packaging of chemical products. The
nucleus (the defining feature of the eukaryotic cell) is the organelle most associated
with information processing. It is surrounded by two membranes which are referred
to as the nuclear envelope. Nuclear pore complexes determine where species move in
and out of the nucleus and how quickly they do so. The nucleus contains long, sin-
gle strands of DNA called chromosomes, which become visible during cell division.
The key process of transcription occurs at specific sites — genes — in the nucleus,
and some genes are located closer to the nuclear membrane than others, increasing
their sensitivity to transcription factors (Cole and Scarcelli, 2006). Up to 25% of
the volume of the nucleus can be taken by structures called nucleoli. Nucleoli are
a non-membrane bound structure where ribosomal RNA is transcribed and ribosomal
subunits are assembled. Mitochondria (which break down sugars) are associated with
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energy processing and have their own internal structures and DNA. The set of packag-
ing organelles is collectively known as the endomembrane system. Its most prominent
organelle is the endoplasmic reticulum. This system as a whole is a collection of bio-
logical containers that can move, separate, package, and transport chemicals, similar to
a chemical manufacturing plant. Cell shape and size change over time and are known
to influence intracellular signal transduction (Meyers et al., 2006; Neves et al., 2008).
The cytoplasm is the gel-like substance that resides between the cell membrane and
nuclear membrane, holding all the cell’s internal organelles. The cytoplasm is given
structure and shape by the cytoskeleton. The cytoskeleton is comprised of three major
types of protein filaments: actin filaments, microtubules and intermediate filaments.
The centrosome, located a small distance outside the nuclear envelope, is the primary
microtubule-organising centre of eukaryotic cells (where microtubules originate). In
many organisms, the centrosome consists of a pair of centrioles, each one a hollow
tube formed by nine triplets of microtubules. Lysosomes and peroxisomes are small
membrane-bound organelles that contain digestive enzymes used to break down waste
materials and make use of molecular oxygen to oxidise organic molecules respectively.
Also within the cytoplasm, another key process — translation — occurs in the ribo-
somes. All of these observations regarding the spatial structure of the eukaryotic cell
serve to emphasise the fact the intracellular environment is extremely heterogeneous
and mathematical models of GRNs will be more faithful the more they seek to account
for spatial features inherent to the eukaryotic cell.
2.3 Intracellular transport mechanisms
To help establish and maintain uneven distributions of specific proteins, RNAs and or-
ganelles, eukaryotic cells employ several distinct mechanisms for molecular transport.
The appropriate subcellular localisation of molecular species is critical for a cell to
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Figure 1-30  Molecular Biology of the Cell, Fifth Edition (© Garland Science 2008) 
Figure 2.4: The spatial structure of the eukaryotic cell. Copyright 2008 from Molecular Bi-
ology of the Cell, Fifth Edition by Alberts et al. Reproduced by permission of Garland Sci-
ence/Taylor & Francis LLC.
remain healthy (Kim et al., 2000; Johansson et al., 2008; Norvell et al., 2005).
2.3.1 Diffusive transport
Diffusion is the main mechanism of transport for many important materials in the cell
(e.g. amino acids). It is sometimes described as ‘passive transport’ as it does not re-
quire any energy. Simply put, it is the movement of molecules from a region of high
concentration to a region of low concentration. Diffusive transport has a number of im-
portant implications for cellular processes because of its undirected nature. Molecules
which undergo diffusion can create a stable gradient between the site of synthesis and
utilisation. Such gradients can have important implications for certain biological pro-
cesses, for example, the localisation of bcd mRNA to the anterior of the oocyte is
essential for setting up an antero-posterior axis when it is translated in the embryo.
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This mRNA encodes a transcription factor that regulates the expression of a hierarchy
of segmentation genes that define the details of antero-posterior patterning (Wang and
Hazelrigg, 1994). Bcd proteins diffuse away from their anterior source, thus giving
rise to a gradient of nuclear protein with a high concentration near the anterior and low
concentration at the posterior (Tekotte and Davis, 2002).
2.3.2 Active transport
Unlike molecular diffusion, active transport is directed and requires energy. Active
transport is a broad term and can refer to two different transport processes: molecular
transport across a membrane or molecular transport facilitated by motor proteins along
microtubules.
Active transport across a membrane is directional and requires an input of energy to
move substances against their concentration gradients. This allows a cell to maintain
small molecules and ions at concentrations very different from those in the surround-
ing environment. There are two basic types of active transport across a membrane:
primary active transport and secondary active transport. Primary active transport in-
volves the direct hydrolysis of ATP, which provides the energy required for transport.
Secondary active transport does not use ATP directly. Instead, its energy is supplied
by an ion concentration and electrical gradient established by primary active transport.
This transport system uses the energy of ATP indirectly to set up the gradient. Cal-
cium pumps are one mechanism cells use to shuttle calcium across cell membranes.
Calcium ATPases in the plasma membrane mediate active transport of calcium out
of cells, serving to maintain the normal, low levels of free cytoplasmic calcium. An-
other well studied example of a calcium ATPase is found in the sarcoplasmic reticulum
of muscle cells, where it serves to pump calcium from the cytoplasm into those spe-
cialised forms of endoplasmic reticulum after a period of muscle contraction.
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In section 2.2, we noted that microtubules could provide structure for the eukaryotic
cytoplasm. This is not their only function, as they are also involved in the trafficking of
intracellular molecules towards the nuclear membrane and cell membrane. Two fam-
ilies of motor proteins associate with the microtubules: dynein and kinesin. Dynein
motors attach to proteins and transport them along microtubules towards the cell nu-
cleus whereas kinesin motors attach to proteins and transport them along microtubules
towards the cell membrane. Active transport along microtubules is involved in the
regulation of gene expression as it facilitates the (fast) translocation of transcription
factors into the nucleus, where they modulate gene activity (Lomakin and Nadezhdina,
2010). Also, active transport along microtubules aids in mRNA export within the cell
and helps localise mRNAs in particular zones of the cytoplasm — a good example
being bcd mRNA which we mentioned in section 2.3.1 (Schnee et al., 2005). We will
discuss active transport along microtubules in more detail in section 5.2.
2.3.3 Transport across the nuclear membrane
Transport across the nuclear membrane makes use of both passive and active transport.
The nuclear envelope consists of an inner and an outer nuclear membrane. The outer
membrane is continuous with the endoplasmic reticulum membrane, and the space be-
tween it and the inner membrane is continuous with the endoplasmic reticulum lumen.
RNA molecules, which are made in the nucleus, and ribosomal subunits, which are
assembled in the nucleolus, are exported to the cytoplasm. In contrast, all the proteins
that function in the nucleus are synthesised in the cytoplasm and are then imported.
The extensive traffic of materials between the nucleus and cytoplasm occurs through
nuclear pore complexes (NPCs), which provide a direct passageway across the nuclear
envelope. The NPC is freely permeable to small molecules, metabolites and ions, but
acts as a highly efficient molecular sieve for macromolecules — this being its main
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function. Proteins containing nuclear localisation signals are actively transported in-
ward through NPCs, while RNA molecules and newly made ribosomal subunits con-
tain nuclear export signals, which direct their outward active transport through NPCs.
Some proteins, including the nuclear import and export receptors, continually shuttle
between the cytoplasm and nucleus. Ran-GTPase provides both the free energy and the
directionality for nuclear transport. Cells regulate the transport of nuclear proteins and
RNA molecules through the NPCs by controlling the access of these molecules to the
transport machinery. Nuclear localisation signals are not removed, hence, nuclear pro-
teins can be imported repeatedly, as is required each time that the nucleus reassembles
after mitosis. We will return to the subject of transport across the nuclear membrane
in more detail in section 5.2.
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Chapter 3
The Hes1 gene regulatory network
3.1 Introduction
In this chapter, we review the biology and previous efforts to mathematically model the
Hes1 gene regulatory network. We pay special attention to experiments performed re-
cently and mathematical modelling efforts that the work presented in this thesis builds
on.
3.2 Biological background
Hes1 is a member of the family of basic helix-loop-helix (bHLH) transcription factors.
Hes1 is known to play a role in somitogenesis, the developmental process responsible
for segmentation of the vertebrate embryo. During somitogenesis, a “segmentation
clock” controls the timing of the assignment of mesodermal cells to discrete blocks.
The segmentation clock depends on the oscillatory expression of a complex network
of signalling pathways, including the Hes1 pathway which contains a simple negative
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feedback loop (see Figure. 3.1 for a schematic view of this). This feedback loop is
formed through interactions of the Hes1 protein with its own gene, where the Hes1
protein binds to N-box sequences on the hes1 promoter and represses the transcription
of hes1 mRNA. Specifically, Hes1 (in dimer form) binds to four binding sites upstream
of its transcriptional initiation site. Three of these binding sites are N-box sequences
and there is also a weak binding region around position –10 (Zeiser et al., 2007).
DNA
hes1 mRNA
Hes1 protein
Figure 3.1: A schematic diagram of the negative feedback loop in the Hes1 GRN. From hes1
mRNA, Hes1 protein is produced via the process of translation. Hes1 protein then inhibits
transcription of hes1 mRNA.
Experiments have measured the levels of hes1 mRNA and Hes1 protein in many differ-
ent cultured mouse cell lines (Hirata et al., 2002; Masamizu et al., 2006). In response
to a single serum treatment, it was found that levels of hes1 mRNA and Hes1 protein
exhibited oscillations with a regular period of approximately 2 to 3 hours. This coin-
cides with the period observed for the mouse segmentation clock. Shimojo et al. (2008)
showed that Hes1 oscillations are also observed in neural progenitor cells, again with
a period of about 2 to 3 hours. It was found that these oscillations were responsible
for the maintenance of neural progenitors and that sustained overexpression of Hes1
inhibits proliferation and differentiation of these cells. More recently, Kobayashi et al.
(2009) monitored Hes1 expression in embryonic stem (ES) cells. It was found that
Hes1 levels still oscillated in space and time, but with a period of 3 to 5 hours, longer
than that of other cell lines. This lengthened period is thought to be a result of the
increased stability of hes1 mRNA in ES cells (Kobayashi et al., 2009). Kobayashi and
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Kageyama continued to dissect the dynamics of the Hes1 GRN, finding that Hes1 os-
cillations contributed to heterogeneous differentiation responses of the ES cells, with
cells expressing low and high levels of Hes1 differentiating into neural and mesoder-
mal cells respectively (Kobayashi and Kageyama, 2010, 2011).
3.3 Mathematical modelling of the Hes1 gene regula-
tory network
3.3.1 Literature review
Mathematical models of oscillatory dynamics in the Hes1 GRN have taken a variety
of forms. The first attempt to model this pathway was presented in the experimen-
tal paper Hirata et al. (2002), where an ordinary differential equation (ODE) model
was used. However, in order to reproduce the observed oscillations, a third unknown
species was introduced. At about the same time, it was discovered that introducing
delays to ODE models of gene regulatory networks could produce sustained oscilla-
tory dynamics (Tiana et al., 2002). Jensen et al. found the invocation of an unknown
species could be avoided via the introduction of delay terms to a model of the Hes1
GRN (representing the processes of transcription and translation) (Jensen et al., 2003).
A delay differential equation (DDE) model of the Hes1 GRN was also studied in Monk
(2003). The effect of low particle numbers in Monk’s DDE model of the Hes1 GRN
was explored in Barrio et al. (2006). Here, the stochastic simulation algorithm (SSA)
was extended to allow for delays. Zeiser et al. found that there is not much evidence
for synergistic binding in the regulatory region of Hes1, and gave an estimate for the
Hill coefficient (Zeiser et al., 2007). The details of the Hes1 pathway were scrutinised
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in greater depth in Momiji and Monk (2008), again using a delay differential equa-
tion system. In particular, an investigation into the effects of dimerisation and com-
partmentalisation was presented. The role of Gro/TLE1 was considered in Bernard
et al. (2006). Other models have examined the role of the Hes1 GRN in somitogene-
sis (Agrawal et al., 2009). A spatio-temporal model of the Hes1 GRN (using a PDE
approach) was presented in Sturrock et al. (2011), the content of which forms the next
chapter. Extensions of this model were considered in Sturrock et al. (2012) and we
present these in chapter 5. A spatial stochastic model of the Hes1 GRN in embry-
onic stem cells was studied in Sturrock et al. (2013) and the material of this paper is
presented in chapter 6.
3.3.2 Ordinary differential equation model
Denoting by [m] and [p] the concentrations of hes1 mRNA and Hes1 protein respec-
tively, the basic reaction kinetics for this system can be modelled using ordinary dif-
ferential equations (ODEs) as follows:
d[m]
dt =
αhm
1+([p]/pˆ)h
−µm[m], (3.1)
d[p]
dt = αp[m]−µp[p]. (3.2)
The first term on the right hand side of equation (3.1) is a Hill function, which de-
creases as the protein concentration increases, modelling repression of hes1 mRNA
transcription by Hes1 protein. The parameter αm is the basal rate of transcription in
the absence of Hes1 protein. pˆ is the concentration of Hes1 that reduces the rate of
initiation of hes1 transcription to half of its basal value (the repression threshold). The
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second term represents the natural degradation of hes1 mRNA, at a rate µm. The first
term on the right hand side of equation (3.2) is the Hes1 protein production term from
translation of hes1 mRNA at a rate αp and the second term represents Hes1 protein
degradation at a rate µp.
Given that αm, p0, h, µm, αp, and µp are (strictly) positive constants, Dulac’s criterion
(stated in Appendix 11.2.1) can be used to prove that periodic solutions for this system
do not exist.
Proof. Let x =
 [m]
[p]
 and f(x) =
 αm1+([p]/ pˆ)h −µm[m]
αp[m]−µp[p]
 =
 M
P
. Hence we
can write equations (3.1), (3.2) more concisely as
dx
dt = f(x).
Let us suppose a nontrivial closed orbit, ∂A, exists with outward normal, n, and let ∂A
bound some nontrivial planar region A. It follows from the divergence theorem in the
plane that
∮
∂A
f(x) ·ndr =
∫∫
A
∇ · f(x)dA.
(3.3)
From the left hand side we have:
∮
∂A
f(x) ·ndr =
∮
∂A
(Md[p]−Pd[m])
=
∫ T
0
(M
d[p]
dt −P
d[m]
dt )dt
=
∫ T
0
(MP−PM)dt = 0. (3.4)
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However, from the right hand side we have
∫∫
A
∇ · f(x)dA =
∫∫
A
∂
∂ [m]
(
αm
1+([p]/pˆ)h
−µm[m]
)
+
∂
∂ [p]
(
αp[m]−µp[p]
)
dA
= −(µm +µp)
∫∫
A
dA< 0,
which produces a contradiction by the divergence theorem.
Hence, although the model seems to account for the important features of the nega-
tive feedback loop (mRNA production decreases as protein increases), it is unable to
reproduce the observed oscillatory dynamics. This implies that the model should be
reformulated and the modelling assumptions reconsidered.
3.3.3 Delay differential equation model
In an attempt to model the intracellular processes more accurately, Monk (2003) in-
troduced delays to equations (3.1), (3.2) to account for the processes of transcription,
translation and transport. This lead to a system of delay differential equations, which
can be written as:
d[m]
dt =
αhm
1+([p(t− τm)]/pˆ)h −µm[m], (3.5)
d[p]
dt = αp[m(t− τp)]−µp[p], (3.6)
where τm and τp represent delays. With the addition of these delay terms, Monk (2003)
showed that it was possible to obtain sustained oscillations without introducing extra
species. These results accurately reflect experimental data well but allow for few ques-
tions to be asked of the model. It was discovered recently (in a similar GRN) that
there is no substantial delay introduced by the process of transcription itself, but it
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was suggested that splicing or nuclear export may cause a delay in the negative feed-
back (Hanisch et al., 2013).
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Chapter 4
A reaction-diffusion model of the Hes1
gene regulatory network
4.1 Introduction
A spatio-temporal model of the Hes1 GRN is developed and studied in this chapter.
By simply accounting for the spatial structure of the cell and the diffusion of intracel-
lular molecules we are able to reproduce observed oscillatory behaviour without the
introduction of delays to the system.
4.2 Reaction-diffusion model formulation
We begin by introducing the PDE model developed in Sturrock et al. (2011) describ-
ing the intracellular interactions between hes1 mRNA and Hes1 protein. We adopt
the same notation as the previous chapter, i.e., [m] and [p] denote hes1 mRNA and
Hes1 protein concentrations respectively. Indeed, as will become apparent, the model
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builds directly on the ODE system presented by equations (3.1) and (3.2). The model
is considered on a two-dimensional spatial domain representing a cell, with a sepa-
rate nucleus and cytoplasm. In the equations below, a subscript n denotes a nuclear
concentration and a subscript c denotes a cytoplasmic concentration.
We assume both protein and mRNA are subject to diffusion (introduced in section 2.3.1).
Diffusion coefficients are denoted depending on the type of species (either a subscript
m for mRNA or p for protein) and location (a subsubscript n for nuclear or c for cyto-
plasmic). For example, the diffusion coefficient for hes1 mRNA in the nucleus is Dmn .
Both protein and mRNA are assumed to undergo linear decay, with parameter µm de-
noting mRNA decay and µp denoting protein decay. Production of mRNA takes place
by the process of transcription in the nucleus. Our production term for nuclear hes1
mRNA is a Hill-like function which decreases as protein levels in the nucleus increase.
In this function, the parameters pˆ, and h represent, respectively, the concentration of
Hes1 protein that reduces the transcription rate to half its basal value, and a Hill co-
efficient. αm defines the basal rate of mRNA production in the absence of nuclear
protein. It should be noted that this transcription rate implicitly accounts for post-
transcriptional modifications such as splicing, polyadenylation and editing, i.e., αm is
the rate by which fully formed messenger RNA is formed in the nucleus. Proteins are
translated from mRNA by ribosomes in the cytoplasm, a process that is likely to occur
at least some minimal distance from the nuclear membrane. Hence we assume protein
production occurs a small distance outside the nucleus with production rate propor-
tional to the amount of cytoplasmic hes1 mRNA, the constant of proportionality being
denoted αp. The full system of equations is therefore given by:
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∂ [mn]
∂ t = Dmn∇
2[mn]+
αm
1+([pn]/pˆ)h︸ ︷︷ ︸
transcription
−µm[mn], (4.1)
∂ [mc]
∂ t = Dmc∇
2[mc]−µm[mc], (4.2)
∂ [pc]
∂ t = Dpc∇
2[pc]+H(x,y) αp[mc]︸ ︷︷ ︸
translation
−µp[pc], (4.3)
∂ [pn]
∂ t = Dpn∇
2[pn]−µp[pn], (4.4)
where H(x,y) is a function accounting for the localisation of protein production in the
ribosomes a distance l from the centre of the nucleus (see Appendix 11.1 for details)
and is defined as follows:
H(x,y) =

0, if x2 + y2 ≤ l2,
1, if x2 + y2 > l2.
(4.5)
We apply continuity of flux boundary conditions across the (internal) nuclear mem-
brane and zero-flux boundary conditions at the outer cell membrane:
Dmn
∂ [mn]
∂n = Dmc
∂ [mc]
∂n and [mn] = [mc] at the nuclear membrane, (4.6)
Dpn
∂ [pn]
∂n = Dpc
∂ [pc]
∂n and [pn] = [pc] at the nuclear membrane, (4.7)
∂ [mc]
∂n = 0 at the cell membrane, (4.8)
∂ [pc]
∂n = 0 at the cell membrane, (4.9)
where n is a unit normal. We also apply zero-initial conditions, i.e.,
[mn] = [mc] = [pn] = [pc] = 0 at t = 0. (4.10)
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Figure 4.1: The domain used in numerical simulations of the Hes1 reaction-diffusion model.
Spatial units here are non-dimensional, with one non-dimensional spatial unit corresponding
to 10µm. The cell is an ellipse, centre (0,0), with major and minor axes of 3 and 2, respectively.
The nucleus is shown here as a blue circle, centre (0,0), radius 0.3. The cytoplasm (shown in
green) is the part of the cell that is outside the nucleus.
4.3 Numerical simulation results
To numerically solve equations (4.1) – (4.4) subject to conditions (4.6) – (4.10), we
used the following procedure. First we non-dimensionalised the model, details of
which are provided in Appendix 11.2.2. Then we chose non-dimensional parameter
values which yielded oscillatory dynamics and were guided by non-dimensional val-
ues used by Monk (2003). We solved the model numerically using the finite element
method as implemented in the software package COMSOL 3.5a, using triangular basis
elements and Lagrange quadratic basis functions along with a backward Euler time-
stepping method of integration. This numerical method of approximating the solution
of PDEs is used in all 2-dimensional and 3-dimensional simulations in this thesis. We
choose the finite element method due to its ability to handle complicated geometries
and boundaries with relative ease. The model equations were solved on the domain
shown in Figure 4.1, representing a cell with cytoplasmic and nuclear subdomains. A
typical simulation took approximately 55 seconds to run on an iMac with a 2.6 Ghz
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Intel core duo processor and 4gb of ram. Finally we calculated dimensional parame-
ter values — these are shown in the third column in Table 4.1. The calculations are
described in Appendix 11.2.2. For simplicity, all nuclear and cytoplasmic diffusion
coefficients were set equal to the same constant; we denote the dimensional diffusion
coefficient by Di j , which indicates diffusion of species i (mRNA or protein) in location
j (nucleus or cytoplasm).
We ran our simulations for a time corresponding to 720 minutes, which is consistent
with the longest time for which oscillatory dynamics were observed in the Hes1 GRN
following serum treatment (Hirata et al., 2002). We have found ranges of values for all
of the parameters such that the system exhibits sustained oscillatory dynamics, where
we define such dynamics as being able to observe at least five distinct peaks in the total
concentration of the transcription factor in the nucleus. This criteria is motivated by
the fact that 3 to 6 cycles of Hes1 protein were observed in response to serum treat-
ment (Hirata et al., 2002). These ranges are given in the fourth column in Table 4.1.
In order to find the range for any particular parameter, we varied this parameter whilst
holding all the other parameters fixed at their ‘default’ values, the dimensional versions
of which are stated in the third column of Table 4.1. For simplicity we investigated
only integer Hill coefficients. The meaning and use of non-integer Hill coefficients is
discussed in Zeiser et al. (2007) and Prinz (2010).
Figure 4.2a shows the dynamic evolution of the total concentrations of hes1 mRNA
and Hes1 protein over time in the nuclear compartment, while Figure 4.2b shows the
total concentrations in the cytoplasmic compartment. Both the nuclear and cytoplas-
mic compartments show that solutions of the Hes1 reaction-diffusion model exhibit
sustained oscillatory dynamics. Although the oscillations appear damped, the numeri-
cal solution still displays at least 6 cycles of Hes1 protein which is in keeping with our
biologically motivated criteria for ‘sustained oscillatory dynamics’. The model yields
results in qualitative agreement with biological experiments (Hirata et al., 2002).
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Figure 4.2: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model. The period of oscillation is approximately 100 minutes. Parameter values as per col-
umn 3, Table 4.1.
The plots presented in Figures 4.3a and 4.3b show how the hes1 mRNA and Hes1
protein distributions evolve spatially in the cell from t = 150 to 300 minutes. mRNA
is produced inside the nucleus and diffuses across the nuclear membrane to enter the
cytoplasm (Figure 4.3a). In the cytoplasm, mRNA is translated into protein, which is
then able to diffuse back into the nucleus, where it represses the production of its own
mRNA. The mRNA concentration has clearly depleted by t = 180 and 300 minutes, re-
flecting the period of the temporal oscillation seen in Figures 4.2a, and 4.2b. As can be
seen from Figure 4.3b, there is a delay in the rise of protein concentration after mRNA
peaks, for example see t = 240 for both mRNA and protein. There appears to be a low
to moderate concentration of protein at t = 240 minutes, whereas one can observe large
quantities of mRNA present in the nucleus and the region of the cytoplasm close to the
nucleus. It is not until t = 270 minutes that protein reaches high concentration levels
(as it did at t = 150 to 180 minutes). This is because it takes time for mRNA to be ex-
ported and accumulate in the cytoplasm. At t = 300 minutes the protein concentration
has decreased significantly once again, due to inhibition of mRNA transcription by the
protein. This process repeats, producing sustained oscillatory dynamics in space and
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Parameter Description Value in simulations Range over which oscillations are observed
Di j Diffusion coefficient of species i in
compartment j
3.13×10−11cm2s−1 2.67×10−11cm2s−1 to 1.25×10−9cm2s−1
αm Basal transcription rate of hes1
mRNA
6.25×10−11Ms−1 ≥ 3.87×10−12Ms−1
pˆ Critical concentration of Hes1 pro-
tein
1.00×10−9M 6.89×10−10M to 1.00×10−6M
h Hill coefficient 5 ≥ 4
µm Degradation rate of hes1 mRNA 1.25×10−3s−1 1.25×10−4s−1 to 1.50×10−3s−1
αp Translation rate of Hes1 protein 0.0555s−1 ≥ 0.0350s−1
µp Degradation rate of Hes1 protein 1.25×10−3s−1 1.25×10−4s−1 to 1.50×10−3s−1
l Minimum radial distance of transla-
tion from centre of nucleus
6.32µm nuclear membrane (3µm) to 6.63µm
Table 4.1: Description of parameters in the Hes1 reaction-diffusion model (defined in sec-
tion 4.2), values used in simulations, and ranges over which sustained oscillatory dynamics
are observed.
time.
4.4 Parameter values
Our range for the diffusion coefficient in Table 4.1 is consistent with two recent spatio-
temporal modelling studies of intracellular signalling pathways similar in scope to
the present study (Terry et al., 2011; Terry and Chaplain, 2011). Experimentalists
have found the diffusion coefficient of soluble proteins in the cytoplasm to be in the
range 10−9cm2s−1 to 10−8cm2s−1 (Matsuda et al., 2008; Seksek et al., 1997), which
is in agreement with the upper bound of our range. There is also a growing body of
evidence suggesting that proteins and mRNA molecules are subject to macromolecular
crowding, which generates an environment where diffusion is hindered by obstacles
and traps (Mendez et al., 2010). Taking this into account would likely increase our
lower bound to be consistent with experimental measurements.
The degradation rate µm for hes1 mRNA and the degradation rate µp for Hes1 protein
have both been estimated from experiments. Hirata et al. estimated µm to be 4.83×
10−4s−1 and µp to be 5.16×10−4s−1 (Hirata et al., 2002). Our parameter ranges for
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(a) hes1 mRNA
(b) Hes1 protein
Figure 4.3: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1 pro-
tein from times t = 150 to 300 minutes at 30 minute intervals for the Hes1 reaction-diffusion
model. The concentrations exhibit oscillatory dynamics in both time and space. Parameter
values as per column 3, Table 4.1.
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µm and µp in Table 4.1 contain these experimental estimates.
We mentioned previously in section 3.3.3 that a DDE model of the Hes1 GRN had
been explored in Monk (2003). Our range for the Hill coefficient, namely h ≥ 4,
is very similar to the range (h > 4) producing sustained oscillatory dynamics in the
DDE model in Monk (2003). Note that a larger Hill coefficient corresponds to greater
nonlinearity, or co-operativity, in the regulation of hes1 transcription by Hes1 protein.
As we mentioned in section 3.2, Hes1 acts as a dimer, which, according to Monk
(2003), is enough to suggest that h = 2. Hence, the requirement that h> 2 implies that
there may be interactions between the four binding sites for Hes1 at the hes1 promoter.
Our value for the critical concentration of Hes1, namely pˆ = 10−9M, is the same as the
critical concentration for the zebrafish Her1 protein mentioned in Lewis (2003). Her1
is similar to Hes1 in that both are believed to belong to simple negative feedback loops.
The DDE model of the Hes1 GRN in Monk (2003) contains a parameter (namely, p0)
analogous to pˆ but representing a number of molecules rather than a concentration.
A sensible range is suggested as 10 to 100. By an elementary calculation converting
concentration into number of molecules, we find that our value for pˆ corresponds to
approximately 68 molecules, which clearly lies within the postulated range in Monk
(2003).
Our estimate for the translation rate αp of 0.0555s−1 is similar to the rate mentioned
in Bernard et al. (2006) of 1min−1 or 0.0167s−1. The mRNA production rate αm has
not been measured experimentally, so we leave our estimate of 6.25×10−11Ms−1 as a
prediction. The distance l of translation from the centre of the nucleus has been studied
in Figures 9 - 11 in Sturrock et al. (2011) but a range of values such that sustained os-
cillatory dynamics occur was not stated. The range for l presented in Table 4.1 reveals
that oscillatory dynamics can be obtained when the minimum distance of protein trans-
lation coincides with where the cytoplasm meets the nucleus. However, increasing l
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too much results in a loss of oscillatory dynamics, implying that the precise spatial
location of the ribosome in the cytoplasm is important in our reaction-diffusion model
of the Hes1 GRN.
4.5 The influence of spatial dimension
In order to investigate whether the spatial dimension of our model influences its be-
haviour we must ensure that we vary only the spatial dimension. For this purpose, we
now consider a radially symmetric domain for our cell in 1, 2 and 3 spatial dimensions.
In 1 spatial dimension, this is simply a line for both nuclear and cytoplasmic compart-
ments. In 2 spatial dimensions, the nucleus is represented by a circle and the cytoplasm
is represented by an annulus. In 3 spatial dimensions, the nucleus is represented by a
sphere and the cytoplasm is represented by a spherical shell. Furthermore, we scale
the production parameters so that the size of the domain plays no role. Hence, the tran-
scription rate, αm is scaled by the length of the nucleus in 1D, the area of the nucleus in
2D and the volume of the nucleus in 3D. Similarly, the translation rate, αp is scaled by
the length of the cytoplasm in 1D, the area of the cytoplasm in 2D and the volume of
the cytoplasm in 3D. In addition, the spatial function localising translation of protein
(see equation 4.5) is adjusted appropriately depending on the spatial dimension. We
use the same initial and boundary conditions as defined in equations (4.6) – (4.10).
For 1-dimensional simulations we approximate the solution numerically using a back-
ward time centred space finite difference method. This numerical code was adapted
from work of Garvie (2007). Figures 4.4 and 4.5 reveal that our model still yields
oscillatory behaviour when solved in 1 spatial dimension. Figure 4.4 contains plots of
the total concentration of hes1 mRNA and Hes1 protein in both the nucleus and cyto-
plasm. This Figure reveals the period of oscillation to be approximately 90 minutes. In
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Figure 4.4: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model solved in 1 spatial dimension. The period of oscillation is approximately 90 minutes.
Parameter values as per column 3, Table 4.1 with αm and αp scaled appropriately.
Figure 4.5 we present a plot of the entire spatio-temporal evolution the model in 1D.
This spatial plot shows clearly shows sustained oscillatory behaviour for the duration
of the simulation. We now compare the 1-dimensional case with higher dimensional
simulations.
In Figures 4.6 and 4.7 we reveal that our model still yields oscillatory behaviour when
solved in 2 spatial dimensions on a radially symmetric domain. Figure 4.6 contains
plots of the total concentration of hes1 mRNA and Hes1 protein in both the nucleus
and cytoplasm. Unlike, Figure 4.2 we observe oscillations with consistent amplitude,
i.e., the solution tends to a limit cycle and does not reach a steady state. Hence changes
in geometry can lead to qualitative changes in the behaviour of our model (we will
return to this concept in section 5.7). In Figure 4.7 we present spatial snapshots of the
spatio-temporal evolution of the 2D radially symmetric model. The approximate 90
minute period can be seen by comparing t = 150 and t = 240 minutes for Hes1 protein
(Figure 4.7b). Qualitatively, there are no differences between the 1-dimensional and
2-dimensional cases. However, there are some minor quantitative differences. For
example, by comparing Figure 4.4a with Figure 4.6a, we discover that more protein
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(a) hes1 mRNA
(b) Hes1 protein
Figure 4.5: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1 pro-
tein for the Hes1 reaction-diffusion model solved in 1 spatial dimension. The x-axis represents
space (non-dimensional units) and y-axis represents time (in mins). The concentrations exhibit
oscillatory dynamics in both time and space. Parameter values as per column 3, Table 4.1 with
αm and αp scaled appropriately.
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Figure 4.6: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model solved in 2 spatial dimensions. The period of oscillation is approximately 90 minutes.
Parameter values as per column 3, Table 4.1 with αm and αp scaled appropriately.
accumulates in the nucleus in the 1-dimensional case. This is due to the fact that there
exist less directions for protein to move into in 1 dimension, and hence it is more likely
that protein will reach the nucleus.
Our model retains oscillatory dynamics when solved in 3 spatial dimensions, see Fig-
ures 4.8 and 4.9. Figure 4.8 contains plots of the total concentration of hes1 mRNA
and Hes1 protein in both the nucleus and cytoplasm. In Figure 4.9 we present spatial
snapshots of the spatio-temporal evolution of the 3D radially symmetric model. The
approximate 90 minute period can be seen by comparing t = 210 and t = 300 minutes
for hes1 mRNA (Figure 4.9a). Hence, the period of oscillation seems robust to changes
in spatial dimension. There are no qualitative differences between the 1-, 2- and 3-
dimensional cases. However, as we noted when comparing the 1- and 2-dimensional
cases, there exist some quantitative differences between the 1- and 3-dimensional cases
and the 2- and 3-dimensional cases. In general, we find that by increasing the spatial di-
mension, the amount of protein that accumulates in the nucleus lessens and the amount
that is retained in the cytoplasm increases. We offer the explanation that as the cyto-
plasm increases in dimension, there are more directions for protein to move into, and
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(a) hes1 mRNA
(b) Hes1 protein
Figure 4.7: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1 pro-
tein from times t = 150 to 300 minutes at 30 minute intervals for the Hes1 reaction-diffusion
model solved in 2 spatial dimensions. The concentrations exhibit oscillatory dynamics in both
time and space. Parameter values as per column 3, Table 4.1 with αm and αp scaled appropri-
ately.
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Figure 4.8: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model solved in 3 spatial dimensions. The period of oscillation is approximately 90 minutes.
Parameter values as per column 3, Table 4.1 with αm and αp scaled appropriately.
hence it is less likely that protein will accumulate in the nucleus.
In order to further investigate how the spatial dimension influences the Hes1 reaction-
diffusion model, we now present a study of the parameter ranges which are produced
by solving the model in different dimensions. In particular, we will study the range
of diffusion coefficients, Di j (see Table 4.1), which yield oscillatory dynamics (5 or
more peaks of Hes1 protein in the nucleus). These ranges are presented in Table 4.2.
We find that as the number of spatial dimensions is increased, the range of diffusion
coefficients yielding oscillatory dynamics becomes broader. Although, we note that
the range for 2- and 3-dimensional simulations is almost identical. Hence, for the rest
of the thesis we will use 2- or 3-dimensional simulations.
Given the small computational cost of solving a 1-dimensional parabolic PDE system,
we are able to produce a numerical ‘bifurcation diagram’ to illustrate how changing
the diffusion coefficient, Di j influences the behaviour of the system. We computed this
by plotting the maximum and minimum value of Hes1 protein recorded in the nuclear
compartment from t = 360 to 720 mins for 1000 different diffusion coefficients. The
40
(a) hes1 mRNA
(b) Hes1 protein
Figure 4.9: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1 pro-
tein from times t = 150 to 300 minutes at 30 minute intervals for the Hes1 reaction-diffusion
model solved in 3 spatial dimensions. The concentrations exhibit oscillatory dynamics in both
time and space. Parameter values as per column 3, Table 4.1 with αm and αp scaled appropri-
ately.
41
Spatial dimension Range of diffusion coefficient, Di j
1 1.25×10−11cm2s−1 to 8.33×10−10cm2s−1
2 2.08×10−11cm2s−1 to 1.96×10−9cm2s−1
3 2.08×10−11cm2s−1 to 2.00×10−9cm2s−1
Table 4.2: List of spatial dimensions for which the Hes1 reaction-diffusion GRN model is
solved, and ranges of diffusion coefficients which yield oscillatory dynamics.
time period was chosen to avoid any transient behaviour induced by the zero initial
conditions — this time period also reflects the timespan over which oscillations were
observed (i.e., 3 to 6 120 minute cycles). Note that the range of values may appear
inconsistent with those presented in row 1, Table 4.2 because the same criteria for os-
cillatory dynamics is not applied. As can be seen in Figure 4.10, if the diffusion coeffi-
cient is too small the maximum scaled concentration value is the same as the minimum
scaled concentration value, i.e., a steady state solution is obtained. By increasing the
diffusion coefficient a ‘Hopf’ bifurcation is produced and the system produces oscil-
latory dynamics (maximum and minimum concentration values are no longer equal).
If we increase the diffusion coefficient further, the oscillations cease, and once again
we find steady state values of Hes1 protein in the nucleus. Hence, if the diffusion
coefficient is too small or too large we no longer observe oscillatory behaviour. We
can understand this by considering the behaviour of the system in two extreme cases.
When Di j is very small (i.e., less than the lower bound presented in Table 4.2), protein
remains in the cytoplasm and mRNA remains in the nucleus, i.e., the species remain in
the compartment where they were originally synthesised. When Di j is very large (i.e.,
larger than the upper bound presented in Table 4.2), the system becomes ‘well-mixed’
and we know from section 3.3.2 that it is impossible for oscillatory dynamics to be
observed for a similar system.
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Figure 4.10: Plot showing how the maximum and minimum scaled concentration of Hes1
protein in the nuclear compartment change as the diffusion coefficient, Di j is varied.
4.6 Drug treatment
4.6.1 Inhibition of the proteasome
The proteasome is a large proteolytic protein complex found in all eukaryotic cells
that is the primary site for degradation of most intracellular proteins (Alberts et al.,
2008). The proteolytic activities of the proteasome can be inhibited by the class of
drugs known as proteasome inhibitors (Orlowski and Kuhn, 2008). Our previous sim-
ulation results have shown that oscillatory dynamics in the Hes1 system occur only
for a suitable protein degradation rate µp. Experiments have demonstrated that in the
presence of the proteasome inhibitor MG132, hes1 mRNA is transiently induced by a
serum treatment, but is then suppressed persistently thereafter (Hirata et al., 2002). We
now show the result of inhibiting the proteasome in the Hes1 reaction-diffusion model
by reducing the decay rate for Hes1 protein µp by a factor of 100. In order to make
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Figure 4.11: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model when the proteasome is inhibited. No oscillations are observed. Parameter values as
per column 3, Table 4.1 with µp reduced by a factor 100.
our simulation results more readily comparable with the experimental data, we run our
simulation for 240 minutes.
Our simulation results of the proteasome inhibition numerical experiment are presented
in Figures 4.11 and 4.12. Figure 4.11a shows a plot of the total concentrations of
hes1 mRNA and Hes1 protein in the nucleus over time, while Figure 4.11b shows
the corresponding total concentrations in the cytoplasm. In Figure 4.12 we reveal
the spatio-temporal evolution of the mRNA and protein concentrations (in response
to proteasome inhibition) respectively over the same time period. We make the local
concentration colour bars identical for mRNA and protein species so a more direct
comparison can be made. We can see large quantities of protein almost everywhere in
the cell and in contrast we can see almost no mRNA anywhere. Furthermore, as can
be seen from all these plots, no oscillations in the concentration levels are observed, in
line with the experimental results of Hirata et al. (2002).
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Figure 4.12: Plots showing the spatio-temporal evolution of hes1 mRNA (first row) and Hes1
protein (second row) from times t = 150 to 210 minutes at 30 minute intervals for the Hes1
reaction-diffusion model when the proteasome is inhibited. Hes1 protein is distributed almost
evenly throughout the cell (with slightly lower concentrations at the tips) for each time point.
hes1 mRNA concentration is so low it is not visible. Parameter values as per column 3, Ta-
ble 4.1 with µp reduced by a factor 100.
4.6.2 Translation inhibition
Treating cells with the drug cycloheximide inhibits the key process of translation in
cells. Cycloheximide functions by interfering with the translocation step in protein
synthesis (movement of two tRNA molecules and mRNA in relation to the ribosome)
thus blocking translational elongation. Cycloheximide is widely used in biomedical re-
search to inhibit protein synthesis in eukaryotic cells studied in vitro. It is inexpensive
and works quickly. Experiments have been performed in fibroblast cells to monitor
levels of hes1 mRNA in response to this treatment. In the experiments a sustained
increase of hes1 mRNA levels is reported (Hirata et al., 2002). We mimic this experi-
ment with our model by decreasing αp by a factor of 100 and running our simulation
for 300 minutes.
Our simulation results of the translation inhibition numerical experiment are presented
in Figures 4.13 and 4.14. Figure 4.13a shows a plot of the total concentrations of
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Figure 4.13: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model when translation is inhibited. No oscillations are observed. Parameter values as per
column 3, Table 4.1 with αp reduced by a factor 100.
hes1 mRNA and Hes1 protein in the nucleus over time, while Figure 4.11b shows the
corresponding total concentrations in the cytoplasm. Finally, Figure 4.14 shows the
spatio-temporal evolution of the mRNA and protein concentrations respectively over
the same time period. Again, we use the same local concentration colour bars for
easier comparison between the two species. In contrast to the proteasome inhibition
numerical experiment, we find large quantities of mRNA within the cell (particularly
in the nucleus and the part of the cytoplasm close to the nucleus). As can be observed
from all these plots, no oscillations in the concentration levels are observed, in line
with the experimental results of Hirata et al. (2002).
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Figure 4.14: Plots showing the spatio-temporal evolution of hes1 mRNA (first row) and Hes1
protein (second row) from times t = 150 to 210 minutes at 30 minute intervals for the Hes1
reaction-diffusion model when translation is inhibited. hes1 mRNA is found in high concentra-
tion in the nucleus. Hes1 protein concentration is so low it is not visible. Parameter values as
per column 3, Table 4.1 with αp reduced by a factor 100.
4.7 The influence of extrinsic noise: exploring model
dependence on initial conditions
Until now we have used zero initial conditions (ICs) for our numerical simulations of
the Hes1 reaction-diffusion model. This may be inappropriate given the highly het-
erogeneous nature of cells. To find two cells with the exact same amount and spatial
distribution of proteins and mRNAs at the same point in time is very unlikely. Hence,
in this section a study of the influence of random initial conditions is presented. Ini-
tial conditions are selected by the following procedure. First, from our simulations
with zero initial conditions (see Figure 4.2), the mean values for the total concentra-
tions of hes1 mRNA and Hes1 protein in the nucleus (meanmn , meanpn) and cytoplasm
(meanmc , meanpc) are obtained. Using these mean values, we define random initial
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condition vectors (mninit , mcinit , pninit , pcinit) as:
mninit ∼N (meanmn,meanmn/10), (4.11)
mcinit ∼N (meanmc,meanmc/10), (4.12)
pninit ∼N (meanpn,meanpn/10), (4.13)
pcinit ∼N (meanpc,meanpc/10). (4.14)
We then randomly generated initial conditions (using the randn function in MATLAB)
for each species, which are uniformly distributed throughout the appropriate compart-
ment. We performed 10 simulations of the Hes1 reaction-diffusion model with random
initial conditions sampled from equations (4.12) – (4.14). The result of integrating the
total protein concentration over the entire cell is presented in Figure 4.15a and the cor-
responding mRNA vs protein phase plane in Figure 4.15a. After an initial transient
period (which appears dependent on initial conditions), the total concentration level
settles into an oscillatory behaviour (or limit cycle). The amplitude, period and even
phase are largely unaffected by the change in initial condition. Although this study
of random initial conditions is far from exhaustive, we can say the model behaviour
appears to be robust to changes in initial conditions.
4.8 Discussion
Dissecting the mechanisms by which transcription factors are regulated within cells is
critical to understanding cellular function in health and disease and the opportunities
for therapeutic intervention. Results from previous mathematical models have reflected
simplified experimental findings but have not distinguished explicitly between spatial
compartments within the cell and have not considered (explicitly) spatial movement of
molecules. We showed in the previous chapter that an ODE model could not replicate
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Figure 4.15: Plots of the total concentrations Hes1 protein integrated over the entire cell for
the Hes1 reaction-diffusion model with different initial conditions. After an initial transient pe-
riod induced by the initial conditions, the model appears robust to changes in initial conditions.
Parameter values as per column 3, Table 4.1.
the experimentally observed oscillatory dynamics. We mentioned that previous mod-
ellers had worked around this problem by either introducing an unknown additional
species or adding delays into the system. Given that spatial localisation is particularly
important when modelling transcription factors, which, although produced in the cy-
toplasm, must be translocated to the nucleus to function. Using PDEs, we can model
these aspects of GRNs explicitly.
The simulation results of this chapter have demonstrated the existence of oscillatory
dynamics in the canonical negative feedback system (the Hes1 GRN) and have been
able to focus on reactions occurring both in the cell nucleus and in the cytoplasm.
Undoubtedly, the main advantage of using systems of PDEs to model intracellular
reactions is that the PDEs enable spatial effects to be examined explicitly (we will
exploit this fact more in the next chapter).
We varied the diffusion coefficients of the mRNAs and proteins and found a range of
values for these diffusion coefficients where the system exhibits oscillatory dynamics,
i.e., the results of the model have predicted a range of diffusion coefficients for the
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molecules involved so that oscillations can be observed. By varying the diffusion co-
efficients of the molecules, we can vary the flux rates across the nuclear membrane
(equivalent to varying nuclear import and export rates), thus granting greater control
and allowing a much more in depth analysis of the systems. We were also able to ma-
nipulate mathematically the location of the ribosomes (by varying the parameter l, thus
controlling where the proteins were synthesised within the cytoplasm. The simulation
results revealed an ‘optimum’ distance outside the nucleus for protein production for
which sustained (undamped) oscillations of large amplitude were observed. In other
words, if protein translation occurred too far from the centre of the nucleus then sus-
tained oscillatory dynamics were lost. Similar results were obtained by varying the
other model parameters, further demonstrating that the oscillations are robust to pa-
rameter changes.
We demonstrated that our model is robust to changes in spatial dimension and initial
conditions. Such features are desirable for any model — solving in lower dimensions
can reduce computational cost and it is unlikely that two cells will have the same
mRNA or protein distributions at any point in time. We also remarked that changes
in geometry can have important consequences (we will return to this notion in more
detail in the next chapter).
The spatial models presented here reflect (qualitatively) experimental findings both in
vitro (Hirata et al., 2002) and in vivo (Hamstra et al., 2006) and mark a conceptual ad-
vance in the modelling of intracellular processes. With the emergence of new imaging
technologies, validation of spatial models will be possible, with dynamic molecular
imaging of subcellular processes on the near horizon.
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Chapter 5
The influence of the nuclear
membrane, active transport and cell
shape on the Hes1 gene regulatory
network
5.1 Introduction
In this chapter we consider extensions to the Hes1 reaction-diffusion model presented
in chapter 4. Taking advatange of the inherently spatial nature of our modelling ap-
proach, we consider extensions that can only be explicitly modelled in a spatial setting.
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5.2 Extended model formulation
We begin to extend the Hes1 reaction-diffusion model by first accounting for the struc-
ture of the nuclear membrane. Encapsulating the nucleus, the nuclear membrane di-
vides the cell into two compartments, between which there is a constant exchange of
molecular material. This physical separation of the nucleus and cytoplasm provides a
level of spatial regulation in signal transduction. As mentioned in section 2.3.3, nucle-
ocytoplasmic transport occurs through the nuclear pore complex. The NPCs perforate
the two lipid bilayers which form the nuclear membrane and allow for bidirectional
transport of a large number of RNA and protein cargoes which vary in size from 1 kDa
to nearly 50 MDa (almost 40nm in diameter) (Weis, 2003). The number of functional
NPCs varies depending on the growth state of the cell, which in turn affects the overall
permeability of the nuclear membrane (Feldherr and Akin, 1991).
In order to model the nuclear membrane explicitly, we need to account for its thickness
d (which is also the depth of the NPC) and the diffusion of molecules across it. This
effectively allows us to model its permeability. The nuclear membrane thickness has
been estimated to be approximately 100nm (Beck et al., 2004). Regarding diffusion
across the nuclear membrane, note that since the NPCs are not located everywhere
within it, there exist some areas of it that cannot be traversed, and this slows down the
average rate at which particles diffuse across it. Molecular crowding may also slow
down this average rate. In the restricted space of an NPC, larger molecules, such as
proteins, will diffuse more slowly than smaller molecules, such as mRNA (Marfori
et al., 2010; Rodriguez et al., 2004). A second explicit step in modelling the nuclear
membrane is therefore to assume that diffusion across it is slower than in the cytoplasm
or nucleus, with protein diffusion slower than mRNA diffusion across the membrane.
Although diffusion coefficients for cytoplasmic, nuclear, and nuclear-embedded pro-
teins have been estimated experimentally (Klonis et al., 2002), we are not aware of
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experimental estimates for diffusion rates across the NPCs for hes1 mRNA and Hes1
protein. Therefore, still assuming (as we did at the end of section 6.2) that the nu-
clear and cytoplasmic diffusion coefficients are the same constant Di j , we shall simply
choose Dm = Di j /5 and Dp = Di j /15 for the nuclear membrane diffusion coefficients
for hes1 mRNA and Hes1 protein, respectively. In summary, we can take into account
nuclear membrane thickness and slower diffusion across it by replacing the boundary
conditions in (4.6) and (4.7) by those for a thin boundary layer of width d, defined by:
Dmn
∂ [mn]
∂n =
Dm([mn]− [mc])
d , (5.1)
Dmc
∂ [mc]
∂n =
Dm([mc]− [mn])
d , (5.2)
Dpc
∂ [pc]
∂n =
Dp([pc]− [pn])
d , (5.3)
Dpn
∂ [pn]
∂n =
Dp([pn]− [pc])
d . (5.4)
The boundary conditions, (5.1) – (5.4), describe the flux across the nuclear membrane.
This flux can be thought of as a permeability coefficient (defined as the diffusion co-
efficient of the species in the nuclear membrane divided by the membrane thickness)
multiplied by the concentration difference of the species across the nucleocytoplasmic
boundary.
Our second extension to the original reaction-diffusion model is to consider active
transport. As we mentioned in section 2.3.2, it is important for transcription factors
to be able to move quickly from the cytoplasm to the nucleus, which can be achieved
by active transport along microtubules. The microtubules are fibrous, hollow rods that
function primarily to help support and shape the cell. For the majority of the cell cy-
cle (i.e., the interphase period), the microtubules are arranged in the cytoplasm as an
aster originating from the microtubule-organising centre (MTOC) located close to the
nucleus (see Figure 2.4). The microtubules also play a major role in the intracellular
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trafficking of macromolecules and organelles (Cole and Lippincott-Schwartz, 1995;
Cangiani and Natalini, 2010). This trafficking of cargo molecules occurs as follows:
motor proteins bind to the cargoes and then actively transport them along microtubules.
Motor proteins can be split into two families – dyneins (which move molecules from
the cytoplasm towards the nuclear membrane) and kinesins (which move molecules to-
wards the cell membrane). Motor proteins interact with microtubules via their ATPase
domain, while their opposite terminus interacts with the cargo being transported. The
movement of proteins along microtubules towards the nucleus can be viewed as a bi-
ased random walk. For example, although cargoes bound to dynein mainly move in the
direction of the nucleus, there is evidence for detachment and reattachment of cargoes
to motor proteins, pauses, and simultaneous attachment to both dynein and kinesin
which can change the direction of movement through a “tug-of-war” (Muller et al.,
2008; Smith and Simmons, 2001). For simplicity, we shall model active transport of
the transcription factor Hes1 as always being directed towards the nucleus. We do this
by adding a convection term to the cytoplasmic Hes1 equation, namely equation (4.3),
which becomes:
∂ [pc]
∂ t = Dpc∇
2[pc]− ∇ · (a [pc])︸ ︷︷ ︸
active transport
+H(x,y)αp[mc]−µp[pc], (5.5)
where a is the convective velocity given by
a =
[
−ax√
x2 + y2
,
−ay√
x2 + y2
]
, (5.6)
and the parameter a is the convection speed. The vector field a is depicted in Figure 5.1.
Finally, in order to take into account the location of the MTOC, we modify the domain
on which our equations are solved. To be specific, we solve on the domain shown in
Figure 5.2. In this domain, the MTOC is located around the circumference of a circle
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Figure 5.1: Plot showing the vector field a (defined in equation (5.6)) modelling the convective
effect of the microtubules on protein transport.
a small distance away from the nucleus. Since microtubules originate from the MTOC
and not from the nucleus, we assume that active transport may occur only in the green
region outside the MTOC. Hence, in the outer green region, we assume cytoplasmic
Hes1 protein satisfies equation (5.5) but in the orange region between the MTOC and
the nuclear membrane we assume it satisfies equation (4.3).
5.3 Numerical simulation results
We explore here numerically the extended Hes1 model given by equations (4.1) – (4.4)
and (5.5), subject to conditions (4.8) – (4.9) and (5.1) – (5.4) and solved on the do-
main shown in Figure 5.2. We retained the parameter values used to simulate the
original Hes1 model in section 4.3. The diffusion coefficients across the nuclear mem-
brane have already been defined in terms of the diffusion coefficient in the nucleus
and cytoplasm, so did not need to be estimated. The nuclear membrane thickness was
chosen to be the same as the experimentally measured value of 100nm (Beck et al.,
2004). The rate of active transport was chosen to produce numerically stable sustained
oscillations. We summarise the dimensional parameter values used for the extended
Hes1 model in the second column of Table 5.1. As in the previous chapter, the pa-
rameter values we used in numerical simulations are in non-dimensional form. The
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Figure 5.2: The domain used in numerical simulations of the extended Hes1 model. Spatial
units here are non-dimensional, with one non-dimensional spatial unit corresponding to 10µm.
The cell is an ellipse, centre (0,0), with major and minor axes of 3 and 2, respectively. The
nucleus is shown as a blue circle, centre (0,0), radius 0.3. The microtubule-organising centre
(MTOC) is located around the circumference of the circle, centre (0,0), radius 0.35, which
surrounds the nucleus and is close to it. The cytoplasm is the part of the cell that is outside the
nucleus (the green and orange regions) and active transport occurs only in the green region.
It does not occur in the orange region because microtubules originate from the MTOC and not
from the nucleus.
non-dimensionalistion calculations are described in Appendix 11.2.2. Ranges of val-
ues such that the model exhibits sustained oscillatory dynamics were also found and
are stated in the third column of Table 5.1. We use precisely the same biologically mo-
tivated criteria for oscillatory dynamics that we used in the previous chapter (5 distinct
peaks of Hes1 protein in the nucleus). We run our simulations for 720 minutes which
corresponds to the maximum amount of time oscillatory dynamics were observed for.
By comparing Tables 4.1 and 5.1, we see that the parameter ranges yielding sustained
oscillatory dynamics are widened by the addition of an explicit nuclear membrane and
active transport. Our extended model is therefore both more faithful to the underlying
biology and a more robust oscillator. Note in particular that sustained oscillations may
occur in the extended model even when the Hill coefficient h is as low as two. As we
mentioned above in section 4.4, Hes1 acts as a dimer, which suggests that oscillations
should be possible with h = 2 (Monk, 2003). We have now found that this is indeed
possible, and so it may not be necessary to seek evidence for binding site interactions
or other nonlinearities to faithfully model the Hes1 GRN. Furthermore, by fixing h = 2
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we studied parameter sensitivity and found ranges of the nuclear membrane parameters
(i.e., permeability) and active transport speed which produce oscillatory dynamics.
As can be seen in Table 5.2, these ranges are quite broad and suggest that allowing
for a Hill coefficient of 2 could be a generic feature of systems including a nuclear
membrane and active transport. Oscillatory dynamics are observed over a wider range
of the parameter l. This is due to the fact that active transport moves proteins created
close to the cell membrane towards the nucleus, ensuring enough protein accumulates
in the nucleus to shut down hes1 mRNA production.
It has been estimated that motor proteins transport cargo along microtubules at a
speed of approximately 5.00× 10−5cms−1 (Smith and Simmons, 2001). Our value
for the rate of active transport in the second column of Table 5.1, namely a = 1.25×
10−6cms−1, is lower than this estimate, but it should be kept in mind that our value
incorporates not only transport but also implicitly incorporates reactions required for
active transport, such as binding to and dissociation from microtubules, as well as
competition between newly synthesised molecules of Hes1 protein to attach to micro-
tubules. It should also be kept in mind that molecules can become temporarily stuck
on microtubules, slowing down the average rate of active transport (Smith and Sim-
mons, 2001). A more advanced study of active transport would require consideration
of stochastic effects, in which context it might be fruitful to take a spatial stochastic
approach in a similar manner to Hellander and Lo¨tstedt (2010). In any case, our range
of values for the active transport rate such that sustained oscillatory dynamics occur
does include the estimate of 5.00×10−5cms−1. Moreover our range of values for the
nuclear membrane thickness indicate that the numerical solution is robust to variation
in this parameter, which is reassuring as this value is likely to vary between cells.
Figure 5.3a shows how the total nuclear concentrations of hes1 mRNA and Hes1 pro-
tein vary over time, and Figure 5.3b shows how the total cytoplasmic concentrations
of hes1 mRNA and Hes1 protein vary over time. By comparing Figures 5.3a and 5.3b
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Parameter Value in simulations Range over which oscillations are observed
Di j 3.13×10−11cm2s−1 6.67×10−12cm2s−1 to 1.13×10−9cm2s−1
αm 6.25×10−11Ms−1 ≥ 2.50×10−12Ms−1
pˆ 1.00×10−9M 3.17×10−11M to 7.69×10−7M
h 5 ≥ 2
µm 1.25×10−3s−1 2.08×10−4s−1 to 4.00×10−3s−1
αp 0.0555s−1 ≥ 2.50×10−3s−1
µp 1.25×10−3s−1 2.08×10−4s−1 to 3.79×10−3s−1
Dm 6.25×10−12cm2s−1 ≥ 2.50×10−14cm2s−1
Dp 2.08×10−12cm2s−1 ≥ 1.67×10−14cm2s−1
d 1×10−5cm ≤ 4.70×10−4cm
a 1.25×10−6cms−1 7.50×10−9cms−1 to 1.08×10−4cms−1
l 6.32µm nuclear membrane (3µm) to 10.7µm
Table 5.1: Parameter values used in simulations of the extended Hes1 model and ranges over
which sustained oscillatory dynamics are observed.
Parameter Value in simulations Range over which oscillations are observed
Dm 6.25×10−12cm2s−1 ≥ 1.38×10−13cm2s−1
Dp 2.08×10−12cm2s−1 ≥ 7.92×10−14cm2s−1
d 1.00×10−5cm ≤ 3.70×10−4cm
a 1.25×10−6cms−1 1.92×10−9cms−1 to 8.33×10−5cms−1
Table 5.2: Nuclear membrane (permeability) and active transport parameter values used in
simulations of the extended Hes1 model with fixed Hill coefficient h = 2 and ranges over which
sustained oscillatory dynamics are observed.
with, respectively, Figures 4.2a and 4.2b, we see that oscillatory dynamics are retained
in the model when a nuclear membrane and active transport are added to it. Yet there
are some quantitative differences between our new plots and those for the original
model. For example, a greater proportion of Hes1 enters the nucleus in our new plots,
for whereas in Figure 4.2 the height of the peaks in nuclear Hes1 were only approx-
imately 1.5% of those in the cytoplasm, Figure 5.3 shows that they are now approx-
imately 33% of those in the cytoplasm. Thus, although our new assumption of slow
diffusion across the nuclear membrane hinders the entry of Hes1 into the nucleus, our
other new assumption of cytoplasmic active transport of Hes1 is more than enough to
overcome this. The increased proportion of Hes1 protein in the nucleus influences the
production of hes1 mRNA. To be specific, since Hes1 is a transcription factor which
inhibits its own gene, hes1 mRNA production is reduced by the increased proportion
of nuclear Hes1 protein. In particular, hes1 mRNA levels in the nucleus drop to zero
between consecutive peaks in Figure 5.3a, a result not encountered in Figure 4.2a.
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Figure 5.3: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the extended Hes1 model.
The period of oscillation is approximately 120 minutes. Parameter values as per column 2,
Table 5.1.
We have examined the dependence of the nuclear to cytoplasmic ratio of Hes1 on the
speed of active transport. Figure 5.4 shows 100 different values of a, plotted in incre-
ments of 2.08× 10−7cms−1 (the sixth value, 1.25× 10−6cms−1 is the default value
used in simulations). All other parameter values are found in column 2, Table 5.1. The
nuclear to cytoplasmic ratio is obtained by taking the mean value of the total concen-
tration of Hes1 protein in the nucleus over a 1000 minute time period and dividing it
by the mean total value attained in the cytoplasm over the same time period. The plot
shows that the nuclear to cytoplasmic ratio of Hes1 protein increases monotonically as
a is increased and tends to a limiting value. We leave these observations as predictions
for experimentalists to corroborate.
Figures 5.5a and 5.5b show respectively how hes1 mRNA and Hes1 protein concen-
trations vary spatially within the cell from times t = 150 to 300 minutes. At time
t = 150 minutes, we see that nuclear hes1 mRNA levels are high and that there is
also hes1 mRNA concentrated outside the nucleus. The presence of hes1 mRNA in
the cytoplasm causes the production by translation of Hes1 protein, which is actively
transported towards the nucleus (see times 150 and 180 minutes). When Hes1 reaches
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Figure 5.4: Graph showing nuclear to cytoplasmic (N/C) ratio of Hes1 protein plotted against
a, the active transport speed. The plot shows that the nuclear to cytoplasmic ratio of Hes1
protein increases monotonically as a is increased and tends to a limiting value.
the MTOC directly outside the nucleus, it is no longer actively transported but moves
by diffusion alone. Hence Hes1 levels build up directly outside the nucleus. This build
up is exacerbated by the nuclear membrane, across which Hes1 moves by slow diffu-
sion. As levels of Hes1 rise in the nucleus, the transcription of hes1 mRNA is inhibited
(see times 180 and 210 minutes). Without mRNA transcription, no new Hes1 protein
can be created by translation. Hence levels of Hes1 fall throughout the cell by natural
degradation (see times 210 and 240 minutes). In the absence of Hes1, mRNA tran-
scription is no longer inhibited and this process resumes (at time 240 minutes). The
cycle just described now repeats, and indeed the oscillatory period of two hours (120
minutes) is clear from comparing times 150 and 180 minutes with times 270 and 300
minutes respectively.
When compared to the spatial profiles of the original Hes1 model (see Figures 4.3a
and 4.3b) the spatial profiles for hes1 mRNA are not changed qualitatively by our new
extensions to the model — the local concentration in the nucleus still reaches a much
higher peak than in the cytoplasm. However, the behaviour of Hes1 protein is changed.
Instead of building up outside the nucleus as in Figure 5.5b, it spreads out across the
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cytoplasm in the absence of active transport and an explicit nuclear membrane (see
Figure 4.3b).
5.4 Modelling spatial effects in the nucleus
Until now we have assumed that the diffusion coefficients for all species in each com-
partment are equal. While this assumption helps reduce the number of parameters in
the model, it may not be the most accurate approach. For example it is known that
proteins experience macromolecular crowding in the nucleus (Bancaud et al., 2009),
so a different nuclear protein diffusion coefficient may be more appropriate. To this
end, in Figure 5.6 we present the results of simulations exploring the effect of vary-
ing the diffusion coefficients of the molecules in the nucleus. As shown in the plots,
changing the diffusion coefficients causes a change in the amplitude and period of the
oscillations.
We have also assumed that transcription of hes1 mRNA occurs throughout the nucleus
(as if the gene is uniformly distributed). However, a more accurate way to model
transcription would be to localise mRNA production to a smaller sub-region of the
nucleus. This can be achieved in the model by modifying equation (4.1) as follows:
∂ [mn]
∂ t = Dmn∇
2[mn]+G(x,y)
(
αm
1+([pn]/pˆ)h
)
−µm[mn], (5.7)
where
G(x,y) =

1, if x2 + y2 ≤ r2,
0, if x2 + y2 > r2,
(5.8)
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(a) hes1 mRNA
(b) Hes1 protein
Figure 5.5: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1 pro-
tein from times t = 150 to t = 300 minutes at 30 minute intervals for the extended Hes1 model.
The concentrations exhibit oscillatory dynamics in both time and space. Parameter values as
per column 2, Table 5.1.
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and where r is the production zone radius. Simulation results from this modified model
are presented in Figure 5.7. The plots in Figure 5.7(a) show the mRNA concentration
in the nucleus over time as we reduce the production zone radius (r) and keep the
mRNA production rate (αm) constant. Oscillatory dynamics are maintained until a
critical value of the radius r is reached between 0.90µm and 0.49µm. The lower three
plots show that there is a loss of oscillatory dynamics when the production zone is too
small. The plots in Figure 5.7(b) show the mRNA concentration in the nucleus over
time as we decrease the production zone radius but increase the mRNA production rate
(dividing the default value of αm by the area of the production zone). It is revealed in
these plots that oscillatory dynamics can be maintained for smaller values of r.
5.5 Convection as the sole transport mechanism of cy-
toplasmic Hes1 protein
Our spatio-temporal modelling approach allows us to address questions which cannot
be answered using ODE or DDE models. For example, we can investigate different
ratios of active transport and diffusion such that sustained oscillatory dynamics occur
in the extended Hes1 model. We begin to explore this by decreasing the importance
of cytoplasmic protein diffusion relative to its active transport. Setting the diffusion
coefficient Dpc to zero we were still able to find sustained oscillatory dynamics for a
range of active transport rates a. Representative results are shown in Figure 5.8 for two
different values of a. Note that we run our simulations for 800 minutes here so that
we can ensure our predefined criteria for oscillatory dynamics are satisfied. Consistent
with intuition, the plots shown in Figure 5.8 show that a greater proportion of protein
accumulates in the nucleus as the active transport rate a is increased. Our results
suggest that sustained oscillatory dynamics will occur as long as sufficient quantities
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Figure 5.6: Plots showing the effect on the concentration profiles of varying the mRNA and
protein diffusion coefficients. In each row, the left plot shows the total concentrations in the
cytoplasm and the right plot shows the total concentrations in the nucleus (Hes1 protein in
blue, hes1 mRNA in red). Plots in the first row correspond to the case where all four diffusion
coefficients are different, i.e., Dpc = 3.13× 10−11cm2s−1, Dmc = 2Dpc , Dpn= 5Dpc , Dmn =
Dpc /10. Plots in the second row correspond to the case where the nuclear diffusion coefficients
are increased, i.e., Dpc = Dmc = 3.13× 10−11cm2s−1 and Dpn = Dmn = 10Dpc . Plots in the
third row show the result of increasing the diffusion coefficients of mRNA compared with protein
diffusion coefficients, i.e., Dpc = Dpn = 3.13×10−11cm2s−1 and Dmc = Dmn = 10Dpc . All other
parameter values are found in column 2, Table 5.1.
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Figure 5.7: Plots showing the effect on mRNA concentration in the nucleus of localising tran-
scription. In these simulations transcription (i.e., mRNA production) is localised to a region
in the nucleus defined by equation (5.8). (a) The radius r of the production zone is decreased
while the mRNA production rate αm is kept constant. As can be seen, oscillatory dynamics are
present until r becomes too small. (b) The radius r of the production zone is decreased but
the mRNA production rate αm is increased (dividing the baseline value of αm by the area of
the production zone). As can be observed, oscillatory dynamics are present for all values of r.
Parameter values as per column 2, Table 5.1.
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Figure 5.8: Plots of the total concentrations of hes1 mRNA (red) and Hes1 protein (blue) in (a)
the nucleus and (b) the cytoplasm for the extended Hes1 model in the absence of cytoplasmic
protein diffusion. Parameter values are as in the second column of Table 5.1, except that
Dpc = 0. The solid lines represent the case where a = 1.67×10−7cm s−1 and the dashed lines
represent the case where a = 2.50×10−7cm s−1.
of Hes1 protein reach the nucleus, regardless of the precise transport mechanism they
use to reach it. We leave this result as a prediction of the model since we are not aware
of any experiments which can demonstrate this. In the next section, we consider the
opposite situation to that considered here, decreasing the importance of active transport
relative to diffusion.
5.6 Microtubule disruption numerical experiment
Microtubules are important in a diverse array of cellular functions, ranging from cell
division to intracellular trafficking. Consequently microtubule-disrupting drugs are
used in cancer therapy and are studied experimentally (Jordan and Wilson, 2004;
Kavallaris, 2010; Carbonaro et al., 2011). Although we are not aware of microtubule-
disrupting drugs being used on the Hes1 pathway, we shall consider the effect of such
drugs in our extended Hes1 model and leave our observations as predictions. Clearly
microtubule-disrupting drugs will disrupt active transport along microtubules, so we
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Parameter Value in simulations Range over which oscillations are observed
Di j 3.13×10−11cm2s−1 3.33×10−11cm2s−1 to 1.46×10−9cm2s−1
αm 6.25×10−11Ms−1 ≥ 6.87×10−11Ms−1
pˆ 1.00×10−9M 1.05×10−9M to 1.00×10−5M
h 5 ≥ 6
µm 1.25×10−3s−1 1.25×10−4s−1 to 1.21×10−3s−1
αp 0.0555s−1 ≥ 0.0583s−1
µp 1.25×10−3s−1 1.25×10−4s−1 to 1.21×10−3s−1
Dm 6.25×10−12cm2s−1 ≥ 9.58×10−12cm2s−1
Dp 2.08×10−12cm2s−1 ≥ 6.25×10−12cm2s−1
d 1×10−5cm ≤ 8.00×10−6cm
a 0 -
l 6.32µm nuclear membrane (3µm) to 6.24µm
Table 5.3: Parameter values used in simulations of the extended Hes1 model in the case where
the active transport rate is set to zero, and ranges over which sustained oscillatory dynamics
are observed.
set the active transport rate a equal to zero in our extended model and otherwise retain
the parameter values in the second column of Table 5.1 (for convenience, the complete
set of parameters is stated also in the second column of Table 5.3). Figure 5.9 shows
the total concentrations for Hes1 protein and hes1 mRNA over time. The system no
longer satisfies the predefined criteria for sustained oscillatory dynamics (at least 5 dis-
tinct peaks in the total concentration of the transcription factor in the nucleus); rather
the oscillations are damped. This marks a qualitative change in the dynamics. In a
general sense, this is an encouraging result — a qualitative change in dynamics is the
type of response we might seek from drug therapy.
Figure 5.9 also shows quantitative changes in the dynamics. For example, a smaller
proportion of Hes1 now enters the nucleus (relative to Figure 5.3) — the total concen-
tration of Hes1 in the nucleus is only roughly 1% of that in the cytoplasm in Figure 5.9.
This reduction is to be expected since Hes1 is no longer actively transported towards
the nucleus.
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Figure 5.9: Plots of the total concentrations of hes1 mRNA (red) and Hes1 protein (blue) in
(a) the nucleus and (b) the cytoplasm for the extended Hes1 model in the absence of active
transport. The concentrations exhibit damped oscillations. Parameter values as per column 2,
Table 5.3.
The damped nature of the oscillations can be seen in Figure 5.10, which, like Fig-
ures 4.3 and 5.5 shows the spatio-temporal evolution of hes1 mRNA and Hes1 protein
from times t = 150 to 300 minutes at 30 minute intervals. For the entire 150 minute
time interval mRNA levels are high in the nucleus and protein levels are high in the
cytoplasm. The nuclear membrane effectively restricts the location of each species to
the compartment in which it is produced. Notice that some of the protein has reached
the cell membrane, something that was not observed in the model with active transport
(see Figure 5.5).
Although our set of parameter values (second column, Table 5.3) in the extended model
without active transport did not yield sustained oscillatory dynamics, we found that by
varying each parameter individually then such dynamics could occur. Ranges of values
for each parameter such that sustained oscillations occur are stated in the third column
of Table 5.3. Note that these ranges are narrower than those presented in Tables 4.1
and 5.1 and that, unlike in Tables 4.1 and 5.1, they do not contain the experimental
measurements for the parameters µm and µp. Furthermore, unlike in Table 5.1, the
experimental measurement for d is not contained in the range for d in Table 5.3.
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(a) hes1 mRNA
(b) Hes1 protein
Figure 5.10: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1
protein from times t = 150 to t = 300 minutes at 30 minute intervals for the extended Hes1
model in the absence of active transport. The concentrations exhibit damped oscillations in
time and space. Parameter values as per column 2, Table 5.3.
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5.7 The influence of cell shape
As mentioned in section 2.2, cell shape can influence intracellular signal transduc-
tion (Meyers et al., 2006; Neves et al., 2008). The influence of cell geometry on the
Notch-Delta and NF-κB pathways has recently been investigated by Terry and co-
workers, who found through spatio-temporal modelling that oscillatory behaviour in
these pathways is to some extent robust to changes in the shapes and relative sizes of
the nucleus and cytoplasm (Terry et al., 2011; Terry and Chaplain, 2011). We have
performed numerous simulations to study the influence of cell shape on the extended
Hes1 model, with parameters as in the second column of Table 5.1. We run our simula-
tions for long enough to check whether our predefined criteria for oscillatory dynamics
is satisfied. We present some of these results in Figures 5.11 and 5.12. It is clear from
these figures that sustained oscillatory dynamics are strongly robust to changes in cell
shape. Such robustness is reassuring since the shape of eukaryotic cells is highly vari-
able (Baserga, 2007; Pincus and Theriot, 2007).
Only one of the geometries in Figures 5.11 or 5.12 shows significant damping after the
initial peaks in Hes1 protein and hes1 mRNA total concentrations. This occurs in the
second row in Figure 5.12, where the MTOC surrounding the nucleus is significantly
increased in size. The increased size of the MTOC reduces the size of the region in
which active transport may occur. Hence the results in the second row in Figure 5.12
are similar to those presented in section 5.6 in which the active transport rate is set to
zero.
In general, we found that the qualitative behaviour of the extended Hes1 model is much
more robust to variety in cell shape than the quantitative behaviour — oscillatory dy-
namics can be retained when the domain is altered whilst, for example, the proportion
of Hes1 that enters the nucleus will change and also the period seems very sensitive
to cell shape. Hence, to obtain quantitatively accurate results, we should use a domain
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Figure 5.11: Plots showing the effect on the extended Hes1 model of varying the nuclear shape.
In each row, the left plot shows the shape on which we solve, and the middle and right plots
show the corresponding numerical results. Spatial units here are non-dimensional, with one
non-dimensional spatial unit corresponding to 10µm. Total concentrations for Hes1 protein
are displayed in blue and for hes1 mRNA in red. Parameter values as per column 2, Table 5.1.
that exactly matches a living cell.
We explore the effect of using a realistic cell shape in Figures 5.14 and 5.15. For
this, we have used an image of an osteosarcoma cell since the Hes1 pathway is known
to play a critical role in the development of osteosarcomas (Zhang et al., 2008). The
image of the osteosarcoma cell, taken from Davidson (2011), is shown in Figure 5.13a,
and the imported domain used for simulations is shown in Figure 5.13b. An additional
region was added to account for the MTOC.
The realistic cell domain does not change the solution qualitatively - oscillations are
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Figure 5.12: Plots showing the effect on the extended Hes1 model of varying the nucleus
position (first row), the MTOC position (second row), and the cell shape (third row). In each
row, the left plot shows the shape on which we solve, and the middle and right plots show
the corresponding numerical results. Spatial units here are non-dimensional, with one non-
dimensional spatial unit corresponding to 10µm. Total concentrations for Hes1 protein are
displayed in blue and for hes1 mRNA in red. Parameter values as per column 2, Table 5.1.
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(a) image of cell (b) imported cell domain
Figure 5.13: Images of (a) an osteosarcoma cell (U-2 OS) (reproduced with permission
from Davidson (2011)) and (b) an imported image of this cell with axes displayed in non-
dimensional spatial units (one non-dimensional spatial unit corresponds to 10µm), which is
used as a domain in numerical simulations. A third region directly outside the nucleus was
added to the imported domain (shown as orange), the outer boundary of which represents the
MTOC cf. Figure 5.2.
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Figure 5.14: Plots of the total concentrations of hes1 mRNA (red) and Hes1 protein (blue) in
(a) the nucleus and (b) the cytoplasm for the extended Hes1 model solved over an osteosar-
coma cell domain as shown in Figure 5.13b. The period of oscillation is approximately 112.5
minutes. Parameter values as per column 2, Table 5.1.
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(a) hes1 mRNA
(b) Hes1 protein
Figure 5.15: Plots showing the spatio-temporal evolution of (a) hes1 mRNA and (b) Hes1
protein within the cell from times t = 150 to 300 minutes at 30 minute intervals for the ex-
tended Hes1 model solved over an osteosarcoma cell domain as shown in Figure 5.13b. The
concentrations exhibit oscillatory dynamics in both time and space. Parameter values as per
column 2, Table 5.1.
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evident from the total concentration plots of Figure 5.14. However, there are quan-
titative differences between the total concentration plots in Figure 5.14 and those in
Figure 5.3 (where the only difference in the system being solved is the domain used).
For instance, the total concentration of Hes1 protein in both the nucleus and cytoplasm
is reduced in Figure 5.14 relative to Figure 5.3, and there is also a notable reduction in
Hes1 protein total concentration compared to hes1 mRNA total concentration in both
the nucleus and cytoplasm. Interestingly, the ratio of nuclear to cytoplasmic protein is
retained.
Spatial profiles with the osteosarcoma cell domain are presented in Figure 5.15. Com-
paring Figures 5.15 and 5.5 allows us to see why the total protein concentration in
Figure 5.14 is significantly less than that in Figure 5.3. Whilst protein is produced
uniformly around the nucleus in Figure 5.5, this is not the case in the osteosarcoma
cell in Figure 5.15 because the nucleus is much nearer to the cell membrane and we
have made the assumption that protein is produced a small distance from the nucleus.
Protein is mainly produced in the osteosarcoma cell in the areas above and to the left
of the nucleus, where there is space for this to occur.
5.8 Drug treatment
5.8.1 Inhibition of the proteasome
As in section 4.6.1 we consider here the impact of proteasome inhibition. We now show
the result of inhibiting the proteasome in the extended Hes1 model by reducing the
decay rate for Hes1 protein µp by a factor of 100. To aid comparison with experimental
data we run our simulations for 240 minutes.
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Figure 5.16: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 extended model
when the proteasome is inhibited. No oscillations are observed. Parameter values as per
column 2, Table 5.1 with µp reduced by a factor 100.
Our simulation results of the proteasome inhibition experiment are presented in Fig-
ures 5.16 and 5.17. Figure 5.16a shows a plot of the total concentrations of hes1 mRNA
and Hes1 protein in the nucleus over time, while Figure 5.16b shows the corresponding
total concentrations in the cytoplasm. Finally, Figure 5.17 shows the spatio-temporal
evolution of the mRNA and protein concentrations respectively over the same time
period. As in section 4.6.1 we do not find oscillations in the concentration levels,
which is in line with the experimental results of Hirata et al. (2002). However, unlike
in section 4.6.1 the protein accumulates mainly in the nucleus (compare Figure 4.12
with Figure 5.17). The spatial distribution of proteins is not commented on in Hirata
et al. (2002), hence we leave the results of our numerical experiment as a prediction
of the model. We hope these results will inspire experimentalists to conduct additional
experiments.
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Figure 5.17: Plots showing the spatio-temporal evolution of hes1 mRNA (first row) and Hes1
protein (second row) from times t = 150 to 210 minutes at 30 minute intervals for the Hes1
extended model when the proteasome is inhibited. Hes1 protein is distributed almost almost
exclusively in the nucleus and within the MTOC for each time point. hes1 mRNA concentration
is so low it is not visible. Parameter values as per column 2, Table 5.1 with µp reduced by a
factor 100.
5.8.2 Translation inhibition
Following section 4.6.2 we now consider the effect of inhibiting the key process of
translation for the extended Hes1 model. We mimic this experiment using model by
decreasing αp by a factor of 100 and running our simulation for 300 minutes.
Our simulation results of the translation inhibition experiment are presented in Fig-
ures 5.18 and 5.19. Figure 5.18a shows a plot of the total concentrations of hes1 mRNA
and Hes1 protein in the nucleus over time, while Figure 5.18b shows the corresponding
total concentrations in the cytoplasm. Finally, Figure 5.19 shows the spatio-temporal
evolution of the mRNA and protein concentrations respectively over the same time pe-
riod. As can be seen from all these plots, no oscillations in the concentration levels are
observed, in line with the experimental results of (Hirata et al., 2002). Furthermore,
unlike in the proteasome inhibition experiment, notice that there is good agreement
between the Hes1 reaction-diffusion model and the extended He1 model (compare
77
0 50 100 150 200 250 300
0
1
2
3
4
5
time (min)
sc
a
le
d 
co
nc
en
tra
tio
n
(a) nuclear compartment
0 50 100 150 200 250 300
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
time (min)
sc
a
le
d 
co
nc
en
tra
tio
n
(b) cytoplasmic compartment
Figure 5.18: Plots of the total concentrations (in non-dimensional units) of hes1 mRNA (red)
and Hes1 protein (blue) in (a) the nucleus and (b) the cytoplasm for the Hes1 reaction-diffusion
model when translation is inhibited. No oscillations are observed. Parameter values as per
column 2, Table 5.1 with αp reduced by a factor 100.
Figure 4.14 and Figure 5.19).
5.9 The influence of extrinsic noise: exploring model
dependence on initial conditions
We now exam the sensitivity of the extended Hes1 model to changes in initial con-
ditions. In order to vary the initial conditions, we adopt the same procedure that we
used for the Hes1 reaction-diffusion model (see section 4.7). Once again, Figure 5.20a
shows the total concentration of protein over the entire cell for 10 simulations with
different initial conditions. After an initial transient period (which appears dependent
on initial conditions), the total concentration level settles into an oscillatory behaviour
(or limit cycle). The corresponding hes1 mRNA versus Hes1 protein phase plane is
displayed in Figure 5.20b. The amplitude, period and phase are largely unaffected by
the changes in initial conditions. Hence, although the presented study of random ini-
tial conditions is not comprehensive, from the simulations presented it appears that the
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Figure 5.19: Plots showing the spatio-temporal evolution of hes1 mRNA (first row) and Hes1
protein (second row) from times t = 150 to 210 minutes at 30 minute intervals for the Hes1
reaction-diffusion model when translation is inhibited. hes1 mRNA is found in high concentra-
tion in the nucleus. Hes1 protein concentration is so low it is not visible. Parameter values as
per column 2, Table 5.1 with αp reduced by a factor 100.
model behaviour is robust to changes in initial conditions.
5.10 Discussion
In this chapter we have extended the Hes1 reaction-diffusion model presented in the
previous chapter. The model was extended by including a nuclear membrane and active
transport. We accounted for the permeability of the nuclear membrane by considering
its thickness and the fact that diffusion across it is slower than in the nucleus or cyto-
plasm, and we assumed that proteins were convected from the cytoplasm to the nucleus
in order to model translocation along microtubules.
Experiments have shown that stimulation of the Hes1 GRN can cause hes1 mRNA and
Hes1 protein levels to oscillate for up to 720 minutes. These oscillations are under-
stood to be driven by a negative feedback loop. Therefore (as in the previous chapter)
we explored numerically our extended model in the context of sustained oscillatory
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Figure 5.20: Plots of the total concentrations Hes1 protein (blue) integrated over the entire cell
for the extended Hes1 model with different initial conditions. After an initial transient period
induced by the initial conditions, the model appears robust to changes in initial conditions.
Parameter values as per column 2, Table 5.1.
dynamics. We found ranges of values for the model parameters such that sustained os-
cillatory dynamics occurred, noting that these parameters were consistent with avail-
able experimental measurements. We also found that our model extensions acted to
broaden the parameter ranges that yielded oscillations compared with the simple Hes1
reaction-diffusion model (see chapter 4). Hence oscillatory behaviour is made more
robust by the inclusion of both the nuclear membrane and active transport.
Given that cell shape can influence intracellular signalling (Meyers et al., 2006; Neves
et al., 2008), we investigated the effect on the dynamics of various cell geometries,
finding for our extended Hes1 model that oscillatory dynamics are strongly robust to
changes in the size and shape of the cell and its nucleus. Such results are consistent
with other recent spatio-temporal modelling studies of intracellular signalling path-
ways (Terry et al., 2011; Terry and Chaplain, 2011). In the interest of making accurate
quantitative statements, we explored more realistic domains, hence we imported our
domain from an image of an osteosarcoma cell — the Hes1 GRN is known to play a
critical role in the development of osteosarcomas (Zhang et al., 2008). We were able to
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make quantitative observations regarding, for example, the proportion of Hes1 that en-
ters the nucleus. Our quantitative data serve as predictions until accurate experimental
data become available.
We demonstrated that our extended model is robust to localising mRNA production to
a small (gene like) region of the nucleus if the transcription rate parameter is scaled
appropriately. It is unlikely that the diffusion coefficient for molecules in the nucleus
would be the same for molecules in the cytoplasm and it is also unlikely that the dif-
fusion coefficient for different molecular specifies would be the same. To this end, we
showed that our model still yields oscillatory dynamics using a number of differential
diffusion coefficient combinations. We also explored the scenario of protein trans-
port by pure convection in the cytoplasm (i.e., no diffusion) and found that our model
could also yield oscillatory dynamics under this extreme condition. This implies that
the precise transport mechanism is not important, what is important is that the protein
reaches the nucleus sufficiently fast. Furthermore, we showed that our model is robust
to changes in initial conditions.
Motivated by experiments involving microtubule-disrupting chemotherapeutic drugs
(Jordan and Wilson, 2004; Kavallaris, 2010; Carbonaro et al., 2011), we considered the
special case in our extended model where active transport rates were set to zero. We
found that this narrowed the ranges of values for model parameters such that sustained
oscillatory dynamics occurred. We also considered the effect of proteasome inhibitor
drugs and translation inhibition drugs. The model was able to reproduce known ex-
perimental data qualitatively (Hirata et al., 2002). Although the translation inhibition
experiment yielded similar results for both the reaction-diffusion model and extended
model of the Hes1 GRN, the proteasome inhibition experiment yielded some interest-
ing differences. In particular, the extended model showed Hes1 protein levels only in
the nucleus after the proteasome inhibition numerical experiment. In contrast, the orig-
inal reaction-diffusion model showed Hes1 protein levels spread uniformly throughout
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the entire cell. Given the lack of direct experimental data for active transport along
microtubules of Hes1, this numerical experiment proposes a method for checking the
existence of active transport of Hes1. By simply treating the cell with proteasome in-
hibitors, the subsequent spatial distribution of Hes1 protein could indicate whether or
not Hes1 is actively transported into the nucleus.
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Chapter 6
A spatial stochastic model of the Hes1
gene regulatory network
6.1 Introduction
It is clear from the previous two chapters that mathematical models of the Hes1 GRN
can benefit from the inclusion of cell structure and accounting for movement of in-
tracellular molecules. While these models were able to reproduce the qualitative be-
haviour of the Hes1 GRN, i.e., oscillatory dynamics, they were not able to account
for variability in period and amplitude that is found in the corresponding experimental
data.
In biological systems there are numerous sources of stochasticity and heterogene-
ity, and these can have important consequences for understanding the overall system
behaviour. Intrinsic noise is commonly found in many intracellular signalling path-
ways (Shahrezaei and Swain, 2008; Barik et al., 2008, 2010). This noise can arise due
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to low abundance of molecular species, randomness in certain key processes (e.g. bind-
ing and unbinding of transcription factors to promoter sites), stochasticity in produc-
tion processes (transcription, translation) and degradation events (Wilkinson, 2009).
Clearly, mathematical models of GRNs with low copy numbers will be more faithful
the more they seek to account for stochastic and spatial features of these networks.
Very few spatial stochastic models exist in the literature but this is beginning to change.
Some of the first models of this kind were of the Min System in an Escherichia coli
cell (Howard and Rutenberg, 2003; Fange and Elf, 2006). Howard & Rutenberg used a
stochastic analogue of a 1D system of reaction-diffusion equations and found that, for
some parameter values, the protein concentrations were low enough that fluctuations
were essential for the generation of patterns. In the model of Fange & Elf trajectories
were generated using the next subvolume method (NSM), and numerical simulations
were able to reproduce all documented Min phenotypes, where deterministic or non-
spatial models could not. A spatial stochastic model of the MAPK pathway was de-
veloped in Takahashi et al. (2010). This model was implemented numerically using a
Green’s function reaction dynamics scheme, which allows for individual particle level
simulation of molecular species. Using this technique, MAPK responses that could
not be observed using a mean-field approach were produced. Another recent spatial
stochastic model was developed to study in detail a generic transcription factor binding
and unbinding to DNA (van Zon et al., 2006). Here, the spatial stochastic model was
able to support the use of well-stirred, zero-dimensional models for describing noise
in gene expression. It is clear from these few examples that spatial stochastic mod-
elling can provide insight into intracellular signalling pathways that other approaches
can not. For a comprehensive review of spatial stochastic modelling of intracellular
processes, see Burrage et al. (2011).
The development of mathematical models which reflect both spatio-temporal and stochas-
tic aspects of GRNs can be regarded as an important computational tool in making
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Figure 6.1: The negative feedback loop in the Hes1 GRN (with explicit promoter states). When
the promoter site is free, hes1 mRNA is transcribed at its maximal rate. hes1 mRNA then
produces Hes1 protein via the process of translation. Hes1 protein occupies the promoter
and represses the transcription of its own mRNA. The occupied promoter site is still able to
produce hes1 mRNA, but at a significantly reduced rate (Takebayashi et al., 1994). Reaction
arrows displayed in red only occur at the promoter site, while those in green occur only in the
cytoplasm and those in black occur everywhere within the cell.
predictions about the behaviours of GRNs and in the optimising of targeted drug treat-
ment. In this chapter we propose a novel spatial stochastic model of the Hes1 GRN.
We focus our study on Hes1 oscillations observed in embryonic stem (ES) cells, as the
quality and abundance of Hes1 expression data for this cell line far exceeds all others.
6.2 Spatial stochastic model formulation
We present here the formulation of the stochastic reaction-diffusion model, detailing
the reactions and how diffusion events are handled.
The basic assumptions concerning the molecular reactions in the Hes1 feedback loop
follow previous modelling efforts (Monk, 2003) and the previous two chapters. Fig-
ure 6.1 shows a revised schematic description of the network. Our model explicitly
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considers the spatial distributions of the species so reactions are now localised to sepa-
rate compartments of the cell, as indicated by the colours of the arrows. A key feature
of all previous models of the Hes1 GRN is that they rely on a phenomenological Hill
function term, which approximates the reduction in hes1 mRNA production caused by
Hes1 protein occupying its promoter site. The model presented in this chapter now
assumes that the promoter site exists in two states — a free state or one occupied by
Hes1 protein, represented by Pf and Po respectively. This is a first approximation, be-
cause — as we mentioned previously — there are actually multiple promoter sites that
Hes1 dimers can bind to, see (Zeiser et al., 2007). Hence, all reactions are modelled
by elementary mass action kinetics. Since our model is explicitly spatial and discrete,
we can model the switching of gene states easily, so a Hill function approach is neither
necessary nor appropriate.
6.2.1 The reaction-diffusion master equation
To account for intrinsic stochasticity we model the reaction-diffusion kinetics as a
continuous-time, discrete-space Markov process. The state of the system is the discrete
number of molecules of each of the species as a function of time. The likelihood of
a transition is described by its reaction propensity, which defines the probability of
transition from the state x to x + Nr per unit time:
x
ωr(x)−−−→ x+Nr, (6.1)
where Nr ∈ ZS is the transition step and is defined as the rth column in the stoichio-
metric matrix N and ωr(x) is the reaction propensity function. When the system can be
considered well mixed, the stochastic simulation algorithm (SSA) (Gillespie, 1976) or
variants of it are typically used to generate statistically exact realisations of the process.
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To introduce molecular motion due to diffusion, the spatial domain is subdivided into
non-overlapping voxels in a mesh, cf. Figure 6.2. Diffusion is modelled as first order
events where a species Sl in voxel ψi moves to an adjacent voxel ψ j, i.e.,
Sli
qli jxli−−−→ Sl j, (6.2)
where xli is the number of molecules of species l in voxel i, and qli j is a diffusion
rate constant that depends on Dl , the diffusion coefficient of species l, and on the
size and shapes of voxels ψi and ψ j. The equation that governs the time evolution of
the probability density of the system is called the reaction-diffusion master equation
(RDME). We assume that both hes1 mRNA and Hes1 protein can diffuse as described
above, with diffusion coefficient D = 6.00× 10−13m2min−1 (Matsuda et al., 2008).
We do not allow promoter species to diffuse, rather we assume the promoter species
remain in the gene subdomain.
For fine discretisations, the classical SSA becomes inefficient. The NSM (Elf and
Ehrenberg, 2004) is an algorithm adapted for simulations of the RDME, and it inherits
good scaling properties from the Next Reaction Method (NRM) (Gibson and Bruck,
2000). For all following simulations, we have used NSM as implemented in the UR-
DME (Unstructured Reaction-Diffusion Master Equation) software framework (Draw-
ert et al., 2012). URDME uses unstructured tetrahedral and triangular meshes such as
shown in Figure 6.2, thus enabling simulations to be performed on complex geome-
tries. The diffusion rate constants qli j are automatically computed for the unstructured
mesh as described in more detail in earlier studies, see Engblom et al. (2009) and Draw-
ert et al. (2012).
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Figure 6.2: The 3D meshed domain used in numerical simulations of the spatial stochastic
Hes1 model. The domain is discretised such that 10,946 voxels make up the domain. Axes
units here are in µm. The cell is represented by a sphere, centre (0,0), with radius 7.5µm. The
nucleus is shown here as a blue sphere, centre (0,0), radius 3µm. The cytoplasm (shown in
green) is the part of the cell that is outside the nucleus. The gene subdomain is chosen to be
the voxel closest to the centre of the cell (0,0), a distance r from the nuclear membrane (shown
in red).
6.2.2 Domain, initial and boundary conditions
The computational domain is shown in Figure 6.2. The cell is represented by two
concentric spheres with centre (0,0) and radius 7.5µm and 3µm respectively. The inner
sphere models the nucleus. These values are chosen to be consistent with experimental
measurements of ES cells (Zhou et al., 2001). The promoter site, or gene subdomain,
is taken to be a single voxel at a radial distance r from the nuclear membrane. Unless
otherwise stated we choose the promoter site to be at r = 3µm, i.e., the voxel closest to
the centre of the cell (0,0). We arbitrarily choose initial conditions such that 60 Hes1
proteins are uniformly distributed in the cytoplasmic subdomain, 10 mRNA molecules
in the nuclear subdomain and a single free promoter is found in the gene subdomain
(our model does not appear to be sensitive to initial conditions — see section 6.6).
Zero-flux boundary conditions are applied at the cell membrane and continuity of flux
boundary conditions are applied at the nuclear membrane as a means of modelling the
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Reaction Description Localisation Parameter values
Pf + protein
k1−⇀↽−
k2
Po Binding/unbinding of Hes1 protein to promoter Promoter site k1 = 1.00×109M−1min−1, k2 = 0.1min−1
Pf
αm−−→ mRNA Basal transcription of hes1 mRNA Promoter site αm = 3.00min−1
Po
αm/γ−−−→ mRNA Repressed transcription of hes1 mRNA Promoter site αm = 3.00min−1,γ = 30.00
mRNA
αp−→ mRNA+ protein Translation of Hes1 protein Cytoplasm αp = 1.00min−1
mRNA µm−→ φ Degradation of hes1 mRNA Entire cell µm = 0.015min−1
protein
µp−→ φ Degradation of Hes1 protein Entire cell µp = 0.043min−1
Sli
qli jxli−−−→ Sl j Molecular diffusion Entire cell D = 6.00×10−13m2min−1
Radial distance of gene from nuclear membrane Nucleus r = 3µm
Table 6.1: Description of reactions in the stochastic spatial Hes1 model, their localisation,
and initial parameter values used.
transport in and out of the nucleus. A summary of the reactions, their sub-cellular
localisation, and the initial parameters used in the simulations are found in Table 6.1.
6.3 Numerical simulation results
6.3.1 The model reproduces quantitative and qualitative behaviour
of wild-type ES cells
We performed simulations of the Hes1 GRN model using the parameter values in Ta-
ble 6.1 and in order to be consistent with biological experiments, we ran our simula-
tions for 1200 minutes (Kobayashi et al., 2009). Five representative trajectories are
displayed in Figure 6.3 (first row), along with corresponding periods (second row).
The instantaneous period presented in the second row is estimated using a Morlet con-
tinuous time wavelet transform (CWT) as implemented in a MATLAB toolbox called
WAVOS, see Harang et al. (2012) for details. Given the highly oscillatory and noisy
nature of our trajectories, the use of standard Fourier techniques can lead to inaccurate
estimates of the period, as Fourier analysis assumes stationarity of the signal and its
basis functions are unbounded in time (Mallat, 1999). Wavelets, in contrast, are lo-
calised in both time and frequency. This localises the analysis, allowing the changes in
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signal properties to be tracked over time (Torrence and Compo, 1998). Furthermore,
we make use of gaussian edge elimination to minimise artefacts in the approximation
of the period.
The evolution of the total number of proteins is in close agreement with recent experi-
mental studies, in terms of qualitative behaviour and quantitative values for the period.
Although there have been many experiments performed to analyse the oscillatory na-
ture of the Hes1 protein, it is not clear what units are used to measure protein expres-
sion levels, hence it is difficult to compare the numbers of Hes1 protein predicted from
our model with real experimental values. However, we have received estimates of the
copy number of hes1 mRNA in ES cells from experimentalists (see Table S3 of the
electronic supplementary material of Sturrock et al. (2013), which fall in the range 0
to 465, and our mRNA values also fall in this range as shown in Figure 6.4(a). Notice
that although there are large amplitude oscillations or variations in the protein copy
number levels, the hes1 mRNA copy numbers are relatively stable. This phenomenon
of small variations in mRNA copy number leading to large variations in protein copy
number is consistent with other studies, for example, see Hasty et al. (2000). It is
reasonable to assume that protein levels will be higher than mRNA levels (see Kar
et al. (2009) and Fusco et al. (2003)), hence the values predicted by our model (see
Figure 6.3) may be consistent with experimental values. In 6.4(a) we illustrate how
the signal is amplified from a single promoter site switching from a free or occupied
state to a large drop or increase in protein copy number. Consistent with intuition,
as the protein levels increase the likelihood of the promoter site becoming occupied
also increases and so it is not surprising that peaks in protein levels are followed by
occupation of the promoter site. Unlike the copy number of Hes1 protein, values for
its period can be found in the literature. Experimentalists estimated that the period for
Hes1 protein in ES cells lies in the range of 180 to 300 minutes. The periods from 100
different trajectories of our model are displayed in Figure 6.5, and many of these lie in
90
0 500 1000
0
200
400
600
800
1000
1200
1400
1600
c
o
py
 n
um
be
r
mean copy number = 779
 
 
623cell 1
0 500 1000
0
20
40
60
80
100
120
140
160
pe
rio
d 
(m
in)
mean period = 146.79
0 500 1000
0
200
400
600
800
1000
1200
c
o
py
 n
um
be
r
mean copy number = 659
 
 
891cell 2
0 500 1000
0
50
100
150
200
250
300
350
pe
rio
d 
(m
in)
mean period = 354.28
0 500 1000
0
500
1000
1500
c
o
py
 n
um
be
r
mean copy number = 890
 
 
600cell 3
0 500 1000
0
50
100
150
200
250
300
350
pe
rio
d 
(m
in)
mean period = 248.56
time (min)
0 500 1000
0
200
400
600
800
1000
1200
c
o
py
 n
um
be
r
mean copy number = 681
 
 
957cell 4
0 500 1000
0
50
100
150
200
pe
rio
d 
(m
in)
mean period = 204.46
0 500 1000
0
200
400
600
800
1000
1200
c
o
py
 n
um
be
r
mean copy number = 772
 
 
994cell 5
0 500 1000
0
50
100
150
200
250
300
350
pe
rio
d 
(m
in)
mean period = 268.75
Figure 6.3: In the first row, plots of the total numbers of Hes1 protein (found by summing
the number of proteins over the entire cell domain) are presented against time for 5 different
trajectories of the Hes1 model. The mean copy numbers are displayed in the titles of row 1. The
green vertical line represents the transference of cells to a neural differentiation medium. The
number highlighted in green is the copy number of Hes1 at this time. The second row shows
the corresponding time varying period as approximated by a Morlet continuous time wavelet
transform with gaussian edge elimination. The mean periods are displayed in the titles of row
2. Baseline parameter values are used, see column 4, Table 6.1.
the same range reported by biologists (compare Figure 6.5 with supplemental Figure
S1 of Kobayashi et al. (2009)). Since our model accounts for intrinsic noise, it is able
to reproduce the highly variable period and amplitude found in the expression of Hes1
protein in ES cells. This is a feature that the reaction-diffusion model and extended
model were not able to reproduce.
Furthermore, we include a plot of spatial snapshots of the spatio-temporal evolution
of Hes1 protein in Figure 6.6. Such spatial plots can be compared with experimental
movie clips of bioluminescence imaging of Hes1 protein in ES cells (see supplemental
movie file of Kobayashi et al. (2009) for example).
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Figure 6.4: (a) Plots showing the total copy number of all species over time for 5 different
trajectories of the Hes1 model (see Table 6.1 for parameter values). It can be seen from these
plots that the time in which the promoter site is occupied (free) corresponds to troughs (peaks)
in the copy number of hes1 mRNA and consequently troughs (peaks) in the copy number of
Hes1 protein. (b) Plots showing the total copy number of Hes1 protein and the corresponding
value of the free promoter, Pf , over time. It can be seen from this plot that if the promoter is
free for a long enough period of time, then this produces a peak in Hes1 expression. This is
particularly evident at approximately 600 minutes.
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6.3.2 Intrinsic noise can explain variability in ES cell differentia-
tion
Our model produces some trajectories that either have a period that is unrealistically
long (> 400 minutes) or simply do not oscillate with non-negligible amplitude. We
shall label these trajectories as cells exhibiting ‘persistent expression’ (PE) of Hes1.
For example, in Figure 6.5 we can observe 15 trajectories falling into this category.
In ES cells, as stated earlier, persistent high levels of Hes1 was indicative of cells that
would differentiate into mesodermal cells. Hence, our model can yield predictions con-
cerning the differentiation response of ES cells. In particular, given a batch of ES cells,
it is possible to predict how many would differentiate into neural and mesodermal cells
at a specific time. We have illustrated this idea in the top row of Figure 6.3. The green
vertical line indicates the time at which cells are transferred to a neural differentiation
medium (900 minutes) with the copy number of Hes1 at this time given beside the
line. Cells with high expression of Hes1 protein at this time would differentiate into
mesodermal cells while those displaying low expression levels would differentiate into
neurons. If we define high and low expression as the copy number being greater than
or less than the mean respectively, then we suggest that of the trajectories displayed
in Figure 6.3, cells 2, 4 and 5 would differentiate into mesodermal cells and cells 1
and 3 would differentiate into neurons. Hence, by accounting for intrinsic noise, our
simple model is able to reproduce the variability encountered experimentally in ES cell
differentiation.
6.4 Parameter sweeps
Here we explore the parameter space of our model in a bid to find the main sources
of stochasticity and variability exhibited in its trajectories. We achieve this mainly
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Figure 6.5: Plot showing the period of 100 different trajectories. The periods were calcu-
lated using a Morlet continuous wavelet transform with gaussian edge elimination. Baseline
parameter values are used, see column 4, Table 6.1.
through parameter sweeps. A parameter sweep is performed by holding all param-
eter values at their baseline values (see column 4, Table 6.1), then varying a single
parameter over some finite range and recording one hundred trajectories for each new
parameter set produced. For each trajectory recorded, we compute its mean period (as
in Figure 6.5) and visualise the output in a histogram. We perform parameter sweeps
for all parameters in the model and those figures that are not explicitly discussed here
are deferred to section 11.2.3 of the Appendix. We discuss here the two parameters
for which we do not have experimental measurements, namely, k1 and k2 as well as
two spatial parameters, D and r. Note that by only varying one parameter at a time,
we are neglecting most of the parameter space. A future study will investigate the full
parameter space of our model using data clustering techniques.
In general we found from the parameter sweeps that the model produces broad dis-
tributions of periods whenever oscillatory dynamics are found. Provided the sweep
does not yield trajectories entirely exhibiting persistent expression of Hes1 then we
find great variety in the mean periods computed.
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Figure 6.6: (a) Plot showing the total Hes1 protein copy number over a period of 600 minutes
from a single trajectory of the Hes1 model, and (b) Plots showing the corresponding spatial
distributions of Hes1 protein. Baseline parameter values are used, see column 4, Table 6.1.
The times for these spatial snapshots were chosen to correspond to the peaks and troughs of
oscillations in Hes1 protein copy number shown in (a) above. These times are highlighted
by the red asterisks in (a). In (b) blue voxels indicate regions of the cell which contain Hes1
protein.
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6.4.1 Hes1 must bind to the promoter sufficiently fast for oscilla-
tions to be observed
The rate at which Hes1 protein binds to the promoter region of the hes1 gene is an
important parameter in our model. It is responsible for the negative feedback Hes1
protein exhibits on its own mRNA production. We vary k1 over the range (1.00×107−
1.00×1010)M−1min−1, which is in line with experimental measurements of protein-
DNA binding rates (Tafvizi et al., 2011). The histogram displaying the mean periods
from the parameter sweep of k1 is displayed in Figure 6.7. The results are consistent
with intuition — if k1 is too small, Hes1 protein is unlikely to bind to the promoter
site and so the majority of trajectories display PE. Experimentalists have compared the
expression levels of wild-type Hes1 and a functionally defective Hes1 mutant, which
is unable to bind to the N or E box DNA sequence, in hematopoietic progenitor cells.
The authors reported no repression of Hes1 when the mutant levels were monitored,
in contrast to the wild-type case (Yu et al., 2006). This is comparable to low values of
k1 in our model, which produce trajectories which mainly exhibit persistent expression
(i.e., no repression of Hes1 levels). Hence, using our model we can investigate both
mutant and wild-type Hes1 genes. If we set k1 = 0 then all trajectories are found to
display PE, with high values of protein. As k1 is increased, we obtain a broad range of
periods, which appear to be quite robust to change provided k1 is above approximately
2.50×108 M−1min−1.
The parameter value for which we have the least information in our model is k2, the
rate at which protein unbinds from the promoter site, making the promoter free again.
We vary k2 in the interval 0.1− 1min−1 and the histogram containing this parameter
sweep is displayed in Figure 6.8. For lower values of k2 (0.01min−1 to 0.34min−1) we
can observe a broad range of periods, but as k2 is increased, we find more and more
trajectories displaying PE of Hes1. This can be interpreted biologically as the promoter
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Figure 6.7: Histogram plot showing the effect on the period of oscillations of changing the
parameter k1, the rate of Hes1 protein binding to the promoter site. 10 values of k1 from the
range 1.00× 107 M−1min−1 to 1.00× 1010 M−1min−1 were chosen, and 100 trajectories for
each different value were recorded. All other parameters in the model (see column 4, Table 6.1)
were held constant. The mean periods were computed and divided into ‘bins’ varying from 100
mins to persistent expression (PE), i.e., greater than 400 mins. For lower values of k1, most of
the computed mean periods fall into the PE bin. As k1 is increased, less and less mean periods
are found in the PE bin. Provided k1 is greater than approximately 2.50× 108 M−1min−1, it
appears to be relatively robust to change, with broad ranges of periods found.
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Figure 6.8: Histogram plot showing the effect on the period of oscillations of changing the
parameter k2, the rate of Hes1 protein unbinding from the promoter site. 10 values of k2
from the range (0− 1)min−1 were chosen, and 100 trajectories for each different value were
recorded. All other parameters in the model (see column 4, Table 6.1) were held constant.
The mean periods were computed and divided into ‘bins’ varying from 100 mins to persistent
expression (PE), i.e., greater than 400 mins. Consistent with intuition and in contrast to the
case of k1, for larger values of k2, most of the computed mean periods fall into the PE bin.
As k2 is decreased, less and less mean periods are found in the PE bin. Provided k2 is less
than approximately 0.56min−1, it appears to be robust to change, with broad ranges of periods
recorded.
site becoming free too quickly, which would prevent the negative feedback from taking
effect. As in the case of parameter k1, if we set k2 = 0 we find no oscillations in the
trajectories of our model. However, in contrast to k1, we find low protein levels.
6.4.2 Oscillatory dynamics are only found for sufficiently large dif-
fusion coefficients
We found in chapters 4 and 5 that PDE models of Hes1 oscillations exhibited oscil-
latory dynamics for a finite range of values of the diffusion coefficient, i.e., if the
diffusion coefficient was too large or too small then oscillations ceased. We investigate
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a range of values for the diffusion coefficient in our model, in order to see if the same
properties are retained in our stochastic model (see Figure 6.9 for the corresponding
parameter sweep). Interestingly, in the context of observing oscillatory dynamics, it
appears that D is bounded below, but not above. No matter how large the diffusion
coefficient is made, the model still yields oscillations. This is likely to be a result of
the stochastic nature of our model. Even if the diffusion coefficient is very large, it is
still not a certainty that the protein will find the gene site almost instantly, which is the
case in the corresponding continuum model. However, if the diffusion coefficient is too
small, then mRNA and protein will stay in the subdomain where they originated, which
is reflective of the continuum case. Overall, our spatial stochastic model is more robust
to changes in the diffusion coefficient than a continuum model of the same GRN. In
particular. oscillatory dynamics are observed for any diffusion coefficient greater than
or equal to D = 5.00×10−14m2min−1.
6.4.3 Oscillatory behaviour is robust to changes in the position of
the promoter site if the diffusion coefficient is large enough
It is known that some genes are located closer to the nuclear membrane than oth-
ers, which increases their sensitivity to transcription factors (Cole and Lippincott-
Schwartz, 1995). Evidence of precisely where the Hes1 gene is located within the
nucleus is lacking, and in any case this is likely to change from cell to cell. Hence,
given the symmetry of our domain, we investigate the influence of varying the distance
r of the promoter site from the nuclear membrane for 3 different diffusion coefficients
(see Figure 6.10 for the parameter sweeps). For a low value of the diffusion coefficient
(D = 1.00×10−14m2min−1), we find that the location of the promoter site strongly in-
fluences the oscillatory behaviour observed. Persistent expression of Hes1 is observed
when the promoter site is placed further away from the nuclear membrane, and as the
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Figure 6.9: Histogram plot showing the effect on the period of oscillations of changing the pa-
rameter D, the diffusion coefficient. 10 values of D from the range 7.50× 10−15 m2min−1
to 1.00× 10−10 m2min−1 were chosen, and 100 trajectories for each different value were
recorded. All other parameters in the model (see column 4, Table 6.1) were held constant.
The mean periods were computed and divided into ‘bins’ varying from 100 mins to persistent
expression (PE), i.e., greater than 400 mins. For lower values of D, most of the computed mean
periods fall into the PE bin. As D is increased, less mean periods are found in the PE bin.
Provided D is greater than approximately 5.00× 10−14 m2min−1, D appears to be robust to
change, with broad ranges of periods recorded.
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promoter site is moved closer to the nuclear membrane, we find a broader distribution
of periods. A slight dependence on promoter site location is observed for the default
value of the diffusion coefficient, D = 6.00× 10−13m2min−1. Here, if the promoter
site is too close to the nuclear membrane, more trajectories exhibiting PE are found.
Finally, for larger diffusion coefficients, specifically D = 1.00× 10−11m2min−1, we
find a broad range of oscillatory dynamics which are robust to promoter site location.
6.5 Controlling differentiation responses via drug treat-
ment
We explore here the influence of inhibiting the proteasome in the context of our spatial
stochastic model in a similar manner to the previous two chapters. The proteasome
is a large proteolytic protein complex found in all eukaryotic cells that is the primary
site for degradation of most intracellular proteins. The proteolytic activities of the pro-
teasome can be inhibited by the class of drugs known as proteasome inhibitors. It is
known that exposing fibroblast cells to proteasome inhibitors (specifically 100 µM of
ALLN) results in increased levels of Hes1 protein and decreased levels of hes1 mRNA.
In particular, it was shown that hes1 mRNA levels peak 1 hour after proteasome inhi-
bition treatment (Hirata et al., 2002). We reproduce this experiment using our model
by decreasing µp by a factor of 100 and running our simulation for 240 minutes (see
Figure 6.11). The model is able to reproduce the experiment qualitatively, i.e., mRNA
levels peak quickly then stabilise at a low number while protein levels saturate at high
levels. We performed 100 simulations with µp decreased by a factor 100 and found
that the average time for hes1 mRNA levels to peak was 29.36 minutes (shorter than
that of fibroblast cells and similar to the peak times we found for the PDE models, see
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(b) D = 6.00× 10−13m2min−1
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(c) D = 1.00× 10−14m2min−1
Figure 6.10: Histogram plots showing the effect on the period of oscillations of changing
the parameter r, the distance of the promoter site from the nuclear membrane for 3 different
values of D, the diffusion coefficient. The second histogram, (b), corresponds to the default
value for D, so in this case we only varied r, all other parameters were held constant (see
column 4, Table 6.1). In the case of (a), we chose a faster diffusion coefficient (D = 1.00×
10−11 m2min−1) and in (c) we chose a slower diffusion coefficient (D= 1.00×10−14 m2min−1).
For all 3 histograms displayed, 10 values of r from the range (0−3)µm were chosen, and 100
trajectories for each different value were recorded. The mean periods were computed and
divided into ‘bins’ varying from 150 mins to persistent expression (PE), i.e., greater than 400
mins. In (a) and (b) we see little variation in the mean periods recorded, suggesting r is robust
to change and not a sensitive parameter. However, in (c), when the diffusion coefficient is
slower, we find the position of the promoter site is important for determining the mean period
distribution. We find that with a slower diffusion coefficient, it is possible to observe oscillatory
dynamics if the promoter site is located closer to the nuclear membrane.
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Figure 6.11: A single trajectory from a proteasome inhibition numerical experiment. The
total numbers of hes1 mRNA (red) and Hes1 protein (blue) are plotted against time. Baseline
parameter values are used, with the exception of µp which is reduced by a factor 100.
Figures 4.11 and 5.16). We are not aware of proteasome inhibition experiments per-
formed in ES cells, and so leave this result as a quantitative prediction of the model.
Using our model, we can also make the prediction that ES cells treated with protea-
some inhibitors are more likely to differentiate into mesodermal cells.
Treating cells with cycloheximide inhibits the key process of translation in cells. Ex-
periments have been performed in fibroblast cells to monitor levels of hes1 mRNA
in response to this treatment. In the experiments a sustained increase of hes1 mRNA
levels is reported (Hirata et al., 2002). We mimic this experiment with our spatial
stochastic model by decreasing αp by a factor of 100 and running our simulation for
300 minutes. The results of this numerical experiment are shown in Figure 6.12 (and
can be compared with Figures 4.13 and 5.18). Our model is able to reproduce qualita-
tive behaviour, i.e., an increase in hes1 mRNA numbers. In terms of exact numbers, we
recorded the mean copy number of hes1 mRNA produced by our model under trans-
lation inhibition conditions and compared it with the wild-type case (recording 100
means for each case then taking the average of the means). The translation inhibition
experiment caused mean mRNA levels to increase from 50 to 183 (more than threefold
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Figure 6.12: A single trajectory from a translation inhibition numerical experiment. The to-
tal numbers of hes1 mRNA (red) and Hes1 protein (blue) are plotted against time. Baseline
parameter values are used with the exception of αp which is reduced by a factor 100.
increase). We leave this result as a quantitative prediction of the model. Furthermore,
we observe that protein levels are persistently low, so using our model we can make
the prediction that ES cells undergoing translation inhibition would be more likely to
differentiate into neuronal cells.
6.6 The influence of extrinsic noise: exploring model
dependence on initial conditions
In this section we present the results of an initial condition sensitivity analysis. We
choose ten different arbitrary initial conditions as stated in Table 6.2. In Figure 6.13
the mean periods of 100 realisations for each different initial condition is plotted in a
histogram. There are only small differences in the mean period distributions. Hence,
we conclude that our spatial stochastic model of the Hes1 GRN appears to be robust to
changes in initial condition.
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Pf Po protein mRNA
IC1 0, -, - 1, -, - 0, 600, 0 0, 0, 0
IC2 1, -, - 0, -, - 0, 0, 0 0, 0, 60
IC3 0, -, - 1, -, - 0, 0, 0 0, 0, 0
IC4 1, -, - 0, -, - 0, 600, 0 0, 0, 60
IC5 0, -, - 1, -, - 0, 600, 600 0, 60, 60
IC6 0, -, - 1, -, - 0, 60, 0 1, 0, 0
IC7 1, -, - 0, -, - 0, 0, 0 0, 0, 120
IC8 0, -, - 1, -, - 1, 0, 0 1, 0, 0
IC9 1, -, - 0, -, - 10, 0, 0 0, 0, 120
IC10 0, -, - 1, -, - 0, 60, 60 0, 120, 120
Table 6.2: Table showing the 10 different initial conditions used to test the model sensitiv-
ity/robustness to different initial conditions. The values are the initial number of free promoter,
occupied promoter and the copy number of proteins and mRNA in the promoter, nucleus or
cytoplasm respectively.
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Figure 6.13: Histogram plot showing the effect on the mean period of oscillation of using the
10 different initial conditions defined in column 4, Table 6.1. The initial conditions were chosen
arbitrarily. The results of the plot show that the model is robust to changes in initial condition.
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6.7 Discussion
ES cells are pluripotent stem cells with the ability to differentiate into various cell types
belonging to all three germ layers: ectoderm, mesoderm and endoderm. Application of
these differentiated cells is highly anticipated for regenerative medicine, but ES cells
respond heterogeneously to different cues, resulting in a mixture of various types of
differentiated cells. The basic mechanism governing such heterogeneity in the differ-
entiation of ES cells is not well understood but recent studies have suggested the cyclic
expression of Hes1 plays a role.
In this chapter, we have presented a spatial stochastic model of the Hes1 GRN that
yields results in close agreement with experimental studies. Transcriptional feedback
systems in eukaryotic cells are inherently stochastic and spatial and the work presented
here emphasises the need for mathematical models to account for this. With these
modelling assumptions, we were able to propose intrinsic noise as the main driving
force for the heterogeneity observed in ES cell differentiation responses.
In contrast to the PDE models of the Hes1 oscillator presented in the previous two
chapters, our spatial stochastic model is able to reproduce the variability in period and
amplitude of Hes1 oscillations observed in experiments. We were able to ask more
questions of our model than recent stochastic DDE models (Barrio et al., 2006), as
well as being able to directly compare our numerical simulations with bioluminescence
movies of in vivo Hes1 expression. Additionally, our model does not rely on a Hill-
function approximation to the negative feedback that Hes1 protein exerts on its own
mRNA, the validity of which has been cast into doubt in recent years (Weiss, 2009).
Our model was able to produce the observed highly variable expression levels of Hes1
under a wide range of conditions. To this end, we presented extensive parameter
sweeps in which we varied a single parameter at a time and presented (in histogram
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format) the mean period distributions. We focussed on parameters for which we had
the least information and also spatial parameters such as the location of the gene site
within the nucleus. We were also able to demonstrate that our model is robust to
changes in initial conditions.
Given the potential application for regenerative medicine, we have also proposed meth-
ods of controlling differentiation responses via drug treatment. Our model has pre-
dicted that applying proteasome inhibitors to an ES cell could yield a mesodermal cell
while applying translation inhibitors could yield a neuronal cell. Our model was also
able to reproduce experimental results in which hes1 transgenes were introduced to
hematopoietic progenitor cell which encoded a mutant Hes1 protein lacking the DNA-
binding domain (Yu et al., 2006).
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The p53-Mdm2 gene regulatory
network
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Chapter 7
The p53-Mdm2 gene regulatory
network
7.1 Introduction
We begin this chapter by reviewing the background biology of the p53-Mdm2 GRN.
We go on to discuss some recent experimental data that has emerged in this area as
well as reviewing mathematical modelling efforts. As in the case of the Hes1 GRN,
we are able to demonstrate that using a strictly temporal approach can have limitations
in modelling the p53-Mdm2 GRN.
7.2 Biological background
The pleiotropic p53 tumour suppressor protein is a well-established regulator of the
cell cycle (Levine, 1997). In response to a variety of cellular stresses, such as DNA
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damage, ribosome biogenesis defects, oncogene activation, hypoxia and chemothera-
peutic drugs, p53 is activated and induces a range of responses including cell cycle
arrest, senescence or apoptosis (programmed cell death) (Vousden and Prives, 2009;
Vogelstein et al., 2000). The central role of p53 as a cell cycle regulator is highlighted
in human cancers. Mutations that inactivate p53 function have been detected in more
than 50% of human cancers (Bennet et al., 1999). Importantly, even tumours with wild
type p53 have defects in upstream regulators or downstream effectors of p53. There-
fore, inactivation of the p53 GRN is a common event in cancer development (Zilfou
and Lowe, 2009; Toledo and Wahl, 2006).
In normal unstressed conditions, the levels and activity of p53 remain low, but in re-
sponse to cellular stress, p53 levels are increased and the p53 pathway is activated. A
vital negative regulator of p53 function in cells is the Mdm2 oncogene product. Mdm2
suppresses p53 function by at least two mechanisms. Firstly, Mdm2 interacts with the
transactivation domain of p53 in the N-terminus inhibiting p53 transcriptional activity
and secondly, Mdm2 acts as a ubiquitin E3-ligase, promoting p53 ubiquitination and
proteasomal degradation. Mdm2 is also a target gene for p53. This creates a negative
feedback loop which provides tight regulation of p53 function in cells (Coutts et al.,
2009; Carter and Vousden, 2009). This negative feedback loop is depicted schemati-
cally in Figure 7.1.
Mdm2
Mdm2mp53
Figure 7.1: Schematic diagram of the p53-Mdm2 gene regulatory network. p53 mRNA pro-
duces p53 protein, which then upregulates Mdm2 mRNA (stated as “Mdm2m” in the schematic)
expression. Mdm2 then enhances degradation of p53 (through the process of ubiquitination).
The importance of the p53-Mdm2 negative feedback loop was first demonstrated in
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mouse animal model systems where deletion of Mdm2 caused embryonic lethality
that was rescued by concomitant p53 deletion (Jones et al., 1995; de Oca Luna et al.,
1995). Mdm2 is overexpressed in tumours with wild type p53 function, which could
account for suppression of p53 function (Toledo and Wahl, 2006; Marine and Jochem-
sen, 2003). It has also been observed that Mdm2 protein levels dramatically decrease
within the first 5 minutes after DNA damage, which allows for the accumulation of
p53 (Stommel and Wahl, 2004). Therefore, a key activity of Mdm2 in cells is to sup-
press p53 function. Given the importance of p53 in controlling cell cycle and tumour
development, it is not surprising that the p53-Mdm2 feedback loop is very tightly con-
trolled in cells. The spatial localisation of p53 is also critical to maintaining cellular
homeostasis. It is known that mislocalisation of p53, specifically cytoplasmic seques-
tration, is found in various tumour types, such as colorectal carcinoma, undifferentiated
neuroblastoma and breast carcinoma (O’Brate and Giannakakou, 2003).
Experimental data have revealed that in response to gamma irradiation, p53 and Mdm2
concentrations exhibit oscillatory dynamics, both spatially and temporally (Geva-Zatorsky
et al., 2006, 2010). It was found that isogenic cells in the same environment behaved in
highly variable ways following DNA damaging gamma irradiation. In some cells more
than 10 peaks in p53 and Mdm2 levels were observed, while in others low-frequency
fluctuations that did not resemble oscillations were found (Geva-Zatorsky et al., 2006).
These results have been confirmed by in vivo experiments (Hamstra et al., 2006) but
the precise function of these oscillations is still under investigation (Zhang et al., 2007;
Batchelor et al., 2009).
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7.3 Mathematical modelling of the p53-Mdm2 gene reg-
ulatory network
7.3.1 Literature review
Mathematical models of the p53-Mdm2 system have taken a variety of forms. One of
the earliest models was that of Bar-Or et al. (2000), which included an unknown inter-
mediary component to the system representing the delayed synthesis of Mdm2 by p53
(despite extensive research into p53-Mdm2 interactions, no such intermediary has been
identified to date). In the experimental paper of Geva-Zatorsky et al. (2006), six tem-
poral models were presented which could explain the oscillatory dynamic observed.
The first of these models contained the basic structure of the p53-Mdm2 negative feed-
back loop and failed to reproduce the oscillatory dynamic. The rest relied on delays or
the introduction of nonlinearities to produce the observed oscillatory dynamic. Other
authors have chosen different approaches, such as combining positive feedback loops
with negative feedback loops in ODE metapopulation-like models (Ciliberto et al.,
2005; Zhang et al., 2007). These models were the first to make the important dis-
tinction between nuclear and cytoplasmic concentrations. Some models have taken
stochastic effects into account (Puszyn´ski et al., 2008; Proctor and Gray, 2008; Ouat-
tara et al., 2010) while others have used time delays (Tiana et al., 2002; Monk, 2003;
Mihalas et al., 2006; Ma et al., 2005; Batchelor et al., 2008), in a manner similar to that
discussed for the Hes1 GRN previously. A stochastic boolean network approach was
formulated and applied to the p53-Mdm2 GRN in Liang and Han (2012). The main
advantage of this approach is the cheap computational cost but it may lack the predic-
tive power of other approaches. An attempt was made to model the spatial aspect of
the system in Gordon et al. (2009), where an extra species was added to account for
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a time delay. A spatio-temporal model of the p53-Mdm2 GRN was recently devel-
oped in Sturrock et al. (2011) and extensions were presented in Sturrock et al. (2012)
(from which the contents of the next two chapters are taken). Even more recently, an-
other spatio-temporal model of the p53-Mdm2 GRN appeared in the literature which
took into account more biology (specifically, post-translational modifications and uni-
directional nuclear transport) and yielded oscillatory dynamics for larger ranges of
spatial parameters (Dimitrio et al., 2013).
7.3.2 Ordinary differential equation model
Let us denote concentrations of p53, Mdm2 mRNA and Mdm2 by [p53], [Mdm2m] and
[Mdm2] respectively. One possible way of translating the reaction schematic presented
in Figure 7.1 into an ODE model is as follows:
d[p53]
dt = β −
µ +ν
 [Mdm2]h1
M̂dm2
h1
+[Mdm2]h1

 [p53], (7.1)
d[Mdm2m]
dt = α +η
 [p53]h2
p̂53
h2
+[p53]h2
 −φ [Mdm2m], (7.2)
d[Mdm2]
dt = γ[Mdm2m]−ρ [Mdm2], (7.3)
where β , µ , ν , h1, M̂dm2, α , h2, p̂53, φ , γ , and ρ are (strictly) positive constants.
The ODE describing p53 is composed of a production term β , followed by a natural
degradation term of rate µ , and finally a degradation term which is a bounded mono-
tonically increasing function of Mdm2, with parameter ν , Hill coefficient h1 and acti-
vation threshold M̂dm2. The second ODE, modelling Mdm2 mRNA, has a production
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term with basal rate α , followed by an enhanced production term dependent on the
amount of p53 (taking the form of a Hill-like function), with rate η , Hill coefficient h2,
and critical concentration p̂53, modelling the activity of p53 as a transcription factor,
and finally a natural degradation term of rate φ . The final ODE is for Mdm2 protein,
which simply has a production term dependent on the amount of Mdm2 mRNA, rate γ ,
and a natural degradation term, rate ρ . After performing a large number of numerical
simulations under a wide range of parameter sets we were not able to find sustained
oscillatory dynamics for equations (7.1) – (7.3). For this system, we are not able to
apply the classical Dulac’s criterion to prove the non-existence of periodic solutions.
Instead we adopt the approach outlined in Busenberg and Driessche (1993), which
was first demonstrated in Busenberg and Driessche (1990). This approach extends
Dulac’s criterion to systems in R3. For a full account of Busenberg’s criterion, see
Appendix 11.3.1. We now apply this criterion to the system of equations (7.1) – (7.3)
in order to prove that oscillatory dynamics can not exist.
Proof. Let D be an invariant region of the phase space and let g(p53,Mdm2m,Mdm2)=
[g1(p53,Mdm2m,Mdm2),g2(p53,Mdm2m,Mdm2),g3(p53,Mdm2m,Mdm2)] be a vec-
tor field which is piecewise smooth on D which satisfies the conditions
g · f = 0 and (∇×g) · (1,1,1)< 0 on D0 = D−∂D ,
where ∂D is the boundary of D , and where f = ( f1, f2, f3) is a Lipschitz continuous
field on D0. Then the differential equation system d[p53]dt = f1, d[Mdm2m]dt = f2, and
d[Mdm2]
dt = f3, has no periodic solutions in D0.
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Let f1, f2, f3 denote the right hand side of (7.1), (7.2), and (7.3) respectively, i.e.,
f1 = β −
µ +ν
 [Mdm2]h1
M̂dm2
h1
+[Mdm2]h1

 [p53],
f2 = α +η
 [p53]h2
p̂53
h2
+[p53]h2
 −φ [Mdm2m],
f3 = γ[Mdm2m]−ρ [Mdm2].
Let g take the following form:
g1 =
−1
f1 ,
g2 =
1
2 f2 ,
g3 =
1
2 f3 .
Clearly, g · f = 0 on D0, and some symbolic calculations yield the expression:
(∇×g) · (1,1,1) = − γ
2
(
γ [Mdm2m]−ρ [Mdm2])2
− ν [Mdm2]
h1 h1M̂dm2
h1
[p53]
[Mdm2]
((−β +[p53]ν +[p53]µ) [Mdm2]h1 + M̂dm2h1 (−β +[p53]µ))2
− η [p53]
h2h2 p̂53
h2
2[p53]
((−α +φ [Mdm2m]−η)[p53]h2 + p̂53h2 (−α +φ [Mdm2m]))2
< 0,
which is negative on D0. Therefore by Corollary 1 (shown in Appendix 11.3.1), there
are no periodic solutions in D0. The invariance of the region D is easily obtain by
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noting that the field f given by the right hand side of (7.1) – (7.3), when evaluated on
the boundary ∂D of D , never points towards the exterior of D .
Hence, although the ODE model seems to account for the important features of the
negative feedback loop (Mdm2 enhances degradation of p53), it is unable to reproduce
the observed oscillatory dynamics.
7.3.3 Delay differential equation model
As in the case of the Hes1 ordinary differential equation system, Monk (2003) added
a delay (represented by τ) to equations (7.1) – (7.3) in order to account for transport,
transcription and translation, yielding the following system of DDEs:
d[p53]
dt = β −
µ +ν
 [Mdm2]h1
M̂dm2
h1
+[Mdm2]h1

 [p53], (7.4)
d[Mdm2m]
dt = α +η
 [p53(t− τ)]h2
p̂53
h2
+[p53(t− τ)]h2
 −φ [Mdm2m], (7.5)
d[Mdm2]
dt = γ [Mdm2m]−ρ [Mdm2]. (7.6)
Numerical simulations of system (7.4) – (7.6) produce oscillations (Monk, 2003), but
do not distinguish between events taking place in the nucleus and cytoplasm. The
grouping of many processes into one delay term also limits the number of questions
that can be asked of the model. Given the success we had with modelling the relatively
simple Hes1 GRN, we now adopt a partial differential equation approach to modelling
the more complex p53-Mdm2 GRN.
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Chapter 8
A reaction-diffusion model of the
p53-Mdm2 gene regulatory network
8.1 Introduction
In this chapter, we develop and study a novel spatio-temporal model of the p53-Mdm2
GRN. In a similar manner to chapter 4 we advance previous models by accounting
for space, the basic structure of the eukaryotic cell (a nucleus and cytoplasm) and
diffusion of intracellular molecules. By accounting for these fundamental features
of the eukaryotic cell, we are able to reproduce the oscillatory dynamics observed in
experiments without the introduction of delays or additional unknown species.
8.2 Reaction-diffusion model formulation
In our formulation of a PDE model of the p53-Mdm2 GRN, we first modify the sys-
tem of equations presented in equations (7.1) – (7.3) to include an additional species,
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DNA
p53 φ
Mdm2
Mdm2 mRNA
p53 mRNA
Figure 8.1: Detailed schematic diagram of the p53-Mdm2 GRN. p53 mRNA produces p53
protein, which then upregulates Mdm2 mRNA expression. Mdm2 then enhances degradation of
p53 (through ubiquitination) and inhibits the transcription of Mdm2 mRNA.
namely, p53 mRNA. This allows for the accurate modelling of p53 translation in the
cytoplasm. We also account for inhibition of p53 transcriptional activity by Mdm2;
which means our model now accounts for the two main mechanisms of p53 repression
by Mdm2 (Thut et al., 1997). However, we wish to stress that this is not necessary to
produce oscillatory dynamics. Indeed, by simply adding diffusion and appropriately
compartmentalising the ODE system defined by equations (7.1) – (7.3) we can repro-
duce the oscillatory dynamics observed in the p53-Mdm2 experimental data. In fact,
this model was presented and explored in Sturrock et al. (2011). Here we present the
model developed in Sturrock et al. (2012) which is displayed schematically in Fig-
ure 8.1.
We use the variables [p53m], [p53], [Mdm2m], and [Mdm2] to represent the concen-
trations of, respectively, p53 mRNA, p53 protein, Mdm2 mRNA, and Mdm2 protein.
In keeping with the notation used for the Hes1 GRN models, a subscript n denotes a
nuclear concentration and a subscript c denotes a cytoplasmic concentration.
As we did for the Hes1 model, we assume all species are subject to diffusion, mRNA
is produced only in the nucleus, and protein is produced only in the cytoplasm. Dif-
fusion coefficients are denoted in a similar manner to the Hes1 system: a subscript
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indicates the localisation of the species, with n or c denoting a nuclear or cytoplas-
mic concentration and a subsubscript 1, 2, 3 or 4 referring to p53 mRNA, p53, Mdm2
mRNA, or Mdm2 respectively. We assume all species are subject to linear decay, with
parameters φ , µ and ρ denoting mRNA decay, p53 protein decay, and Mdm2 protein
decay respectively. In addition, we assume p53 undergoes Mdm2 dependent degra-
dation in both the nucleus and cytoplasm. This is consistent with experimental data
which shows that co-compartmentalisation of p53 and Mdm2 results in Mdm2 depen-
dent degradation of p53 (Xirodimas et al., 2001). We assume that this degradation
term is equal to a linear decay term with parameter ν , scaled by a bounded monoton-
ically increasing function of Mdm2 protein concentration with Hill coefficient h1 and
activation threshold M̂dm2. We make the assumption that p53 mRNA is produced at a
constant rate ζ and Mdm2 mRNA is produced at a constant rate α . Furthermore, we
assume Mdm2 mRNA undergoes nuclear p53 dependent production (taking the form
of a Hill-like function), with rate η , Hill coefficient h2, and critical concentration p̂53.
This enhanced production term is also assumed to decrease as nuclear Mdm2 protein
levels increase, with parameter θ . This assumption takes into account the fact that
Mdm2 protein inhibits the transcriptional activity of p53 (Thut et al., 1997). Finally,
we assume protein production occurs a small distance outside the nucleus (as in the
case of the Hes1 model) and is dependent on the relevant concentration of mRNA,
occurring at rate β for p53 protein and γ for Mdm2 protein.
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The complete system of equations is given by:
∂ [p53mn]
∂ t = Dn1∇
2[p53mn]+ζ −φ [p53mn], (8.1)
∂ [p53mc]
∂ t = Dc1∇
2[p53mc]−φ [p53mc], (8.2)
∂ [p53c]
∂ t = Dc2∇
2[p53c]+H(x,y)β [p53mc]
−
µ +ν
 [Mdm2c]h1
M̂dm2
h1
+[Mdm2c]h1

 [p53c], (8.3)
∂ [p53n]
∂ t = Dn2∇
2[p53n]−
µ +ν
 [Mdm2n]h1
M̂dm2
h1
+[Mdm2n]h1

 [p53n], (8.4)
∂ [Mdm2mn]
∂ t = Dn3∇
2[Mdm2mn]+α +η
(
[p53n]h2
(p̂53+[Mdm2n]/θ)h2 +[p53n]h2
)
−φ [Mdm2mn], (8.5)
∂ [Mdm2mc]
∂ t = Dc3∇
2[Mdm2mc]−φ [Mdm2mc], (8.6)
∂ [Mdm2c]
∂ t = Dc4∇
2[Mdm2c]+H(x,y)γ[Mdm2mc]−ρ [Mdm2c], (8.7)
∂ [Mdm2n]
∂ t = Dn4∇
2[Mdm2n]−ρ [Mdm2n], (8.8)
where H(x,y) is the function controlling cytoplasmic protein production in ribosomes
defined in equation 4.5.
We apply zero initial conditions, zero-flux boundary conditions at the cell membrane,
and continuity of flux boundary conditions across the nuclear membrane:
[p53mn] = [p53mc] = [p53n] = [p53c] = [Mdm2mn] = [Mdm2mc] = [Mdm2n] = [Mdm2c] = 0 at t = 0,
(8.9)
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Dn1
∂ [p53mn]
∂n = Dc1
∂ [p53mc]
∂n and [p53mn] = [p53mc] at nuclear membrane, (8.10)
Dn2
∂ [p53n]
∂n = Dc2
∂ [p53c]
∂n and [p53n] = [p53c] at nuclear membrane, (8.11)
Dn3
∂ [Mdm2mn]
∂n = Dc3
∂ [Mdm2mc]
∂n and [Mdm2mn] = [Mdm2mc] at nuclear membrane,
(8.12)
Dn4
∂ [Mdm2n]
∂n = Dc4
∂ [Mdm2c]
∂n and [Mdm2n] = [Mdm2c] at nuclear membrane, (8.13)
∂ [p53mc]
∂n = 0 at cell membrane, (8.14)
∂ [p53c]
∂n = 0 at cell membrane, (8.15)
∂ [Mdm2mc]
∂n = 0 at cell membrane, (8.16)
∂ [Mdm2c]
∂n = 0 at cell membrane. (8.17)
As the p53 pathway is known to play a role in the development of osteosarcomas (Diller
et al., 1990), we choose the imported shape of an osteosarcoma cell shown in Fig-
ure 5.13 as our domain. Our objective is to study sustained oscillatory dynamics,
so we must find non-dimensional parameter values such that our model yields such
dynamics. Nearly all of the parameters in our new modified model are contained
in the original p53-Mdm2 model in Sturrock et al. (2011), which has already been
studied in the context of oscillations. Hence, for these parameters, we choose the
non-dimensional values used for the original model, which are stated in equation (60)
in Sturrock et al. (2011). The remaining parameters are ζ and θ , for which we have
found appropriate values by a simulation study. From our non-dimensional parameter
values, we have calculated dimensional values and these are stated in the third column
of Table 8.1. Details regarding non-dimensionalisation and the calculation of dimen-
sional parameter values can be found in Appendix 11.3.2. As in section 4.3, all nuclear
and cytoplasmic diffusion coefficients are made equal to each other, and we retain the
notation Di j to indicate diffusion of species i (mRNA or protein) in location j (nucleus
or cytoplasm).
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Figure 8.2: Plots of the total concentrations of p53 mRNA (black), p53 (blue), Mdm2 mRNA
(green), and Mdm2 (red) in (a) the nucleus and (b) the cytoplasm, for the p53-Mdm2 reaction-
diffusion model. The period of oscillation is approximately 215 minutes. Parameter values as
per column 2, Table 8.1.
8.3 Numerical simulation results
We present here the numerical solutions of the PDE system defined by equations (8.1) –
(8.8) subject to conditions (8.9) – (8.17) and parameters from the third column of
Table 8.1. Figure 8.2 shows the total concentrations of p53 and Mdm2 in the nucleus
and cytoplasm.
As in the case of numerical simulations of our Hes1 GRN reaction-diffusion model,
we find that our spatio-temporal model of the p53-Mdm2 GRN yields sustained oscil-
latory dynamics. In addition, the period of oscillation lies in the 3 to 7 hour range of
experimentally measured periods (Bar-Or et al., 2000; Geva-Zatorsky et al., 2006). We
note that p53 mRNA levels reach a steady state because they are not involved directly
in a negative feedback loop. These total concentration plots reveal that the mRNA con-
centration (for both p53 and Mdm2) is higher in the nucleus compared to the protein
concentrations and vice versa for the cytoplasmic compartment. For the particular pa-
rameter set we chose (see column 3, Table 8.1) we find larger amplitude oscillations for
p53 protein rather than Mdm2 protein — this is a phenomenon not inconsistent with
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time course data for some cells presented in Geva-Zatorsky et al. (2010). We present
plots in Figure 8.3 of how the dynamics of the p53-Mdm2 system evolve in space as
well as time.
The spatial snapshots of Figure 8.3 can readily be compared with time-lapse mi-
croscopy images of individual cells with p53 and Mdm2 proteins fluorescently tagged
(for example, a comparison can be made with Figure 1 of Geva-Zatorsky et al. (2010).
In Figure 8.3a, we see that p53 has accumulated in the cytoplasm at t = 300 minutes.
p53 then begins to diffuse across the nuclear boundary and enter the nucleus at t = 360
minutes. The presence of p53 in the nucleus upregulates the expression of Mdm2 (via
Mdm2 mRNA) which results in enhanced decay of p53 (see t = 420 minutes). By
t = 540 minutes, the p53 concentration begins to increase again, giving a period of
oscillation of approximately 3 hours.
Figure 8.3b shows the plots of Mdm2 protein concentration over time. Notice that
Mdm2 appears in abundance at t = 420 minutes, 60 minutes after p53 appears in abun-
dance, reflecting the time for Mdm2 mRNA production, export from the nucleus and
translation in the cytoplasm. The presence of Mdm2 in the cell causes the enhance-
ment of p53 degradation which in turn causes the down-regulation of Mdm2 expres-
sion. This is shown at t = 540 minutes where Mdm2 levels have depleted considerably.
The negative feedback Mdm2 exerts on p53 is made clear in these spatial plots by the
fact that wherever Mdm2 levels are high in the cell, p53 levels are low and vice versa.
8.4 Parameter values
We have found ranges of values for all of the parameters in our reaction-diffusion
model of the p53-Mdm2 GRN such that it exhibits sustained oscillatory dynamics,
where (as in section 4.3) we define such dynamics as at least 5 distinct peaks in the total
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(a) p53
(b) Mdm2
Figure 8.3: Plots showing the spatio-temporal evolution of (a) p53 and (b) Mdm2 within the
osteosarcoma cell domain from times t = 240 to t = 540 minutes at 60 minute intervals for the
reaction-diffusion p53-Mdm2 model. The concentrations exhibit oscillatory dynamics in both
time and space. Parameter values as per column 3, Table 8.1.
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concentration of the transcription factor (in this case, p53) in the nucleus. Choosing
this criteria rules out any heavily damped oscillatory solutions of our model but does
not ignore solutions exhibiting sustained oscillatory dynamics. These ranges are given
in the fourth column in Table 8.1. To find the range for each parameter, we varied it
whilst holding all the other parameters fixed at their ‘default’ values, the dimensional
versions of which are stated in the third column of Table 8.1.
Parameter Description Value in simulations Range over which oscillations are observed
Di j Diffusion coefficient of species i in
compartment j
3.00×10−11cm2s−1 1.00×10−11cm2s−1 to 1.67×10−8cm2s−1
ζ Basal rate of p53 mRNA transcrip-
tion
2.92×10−10Ms−1 ≥ 5.83×10−11Ms−1
φ Degradation rate of mRNA 5.83×10−4s−1 1.00×10−4s−1 to 1.10×10−3s−1
β Translation rate of p53 0.33s−1 ≥ 5.13×10−2s−1
µ Degradation rate of p53 1.00×10−4s−1 ≤ 4.33×10−4s−1
ν Mdm2 dependent degradation of
p53
3.33×10−2s−1 1.67×10−3s−1 to 3.33s−1
h1 Hill coefficient for Mdm2 depen-
dent degradation of p53
2 ≥ 1
M̂dm2 Activation threshold for Mdm2 de-
pendent degradation of p53
3.20×10−5M 3.20×10−6s−1 to 2.10×10−4s−1
α Basal rate of Mdm2 mRNA tran-
scription
2.92×10−11Ms−1 ≤ 2.25×10−10Ms−1
η Maximal p53 dependent transcrip-
tion of Mdm2 mRNA
1.67×10−9Ms−1 ≥ 2.08×10−10Ms−1
h2 Hill coefficient for p53 dependent
transcription
4 ≥ 1
p̂53 Threshold parameter of p53 2.50×10−6M ≤ 1.65×10−5M
θ Mdm2 inhibition of p53 transcrip-
tion
4.00 ≥ 15.60×10−3
γ Translation rate of Mdm2 0.67s−1 ≥ 0.10s−1
ρ Degradation rate of Mdm2 8.33×10−4s−1 1.33×10−4s−1 to 7.00×10−3s−1
l Minimum radial distance of transla-
tion from centre of nucleus
6.32µm 3.46µm to 9.27µm
Table 8.1: Description of parameters in the p53-Mdm2 reaction-diffusion model defined in
section 8.1, values used in simulations, and ranges over which sustained oscillatory dynamics
are observed.
The p53-Mdm2 model permits oscillatory dynamics for a wide range of diffusion co-
efficients, which include the experimentally measured values of Matsuda et al. (2008)
and Seksek et al. (1997). Only two of the parameters in Table 8.1 have been measured
experimentally, namely the degradation rate µ of p53 protein and the degradation rate
ρ of Mdm2 protein. According to Finlay (1993), these degradation rates are approx-
imately 3.85× 10−4s−1 for both p53 and Mdm2. This value lies within the ranges
calculated which produce oscillatory dynamics (see Table 8.1 entries for µ and ρ).
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Assuming that the decay rates of p53 mRNA and Mdm2 mRNA are of roughly the
same order as the decay rate of hes1 mRNA, which has been estimated experimentally
at 4.83× 10−4s−1 (Hirata et al., 2002), then the range presented for φ is in agree-
ment with experimentally measured values. To calculate the value and range for the
parameter l, defined in Table 8.1 as the minimum radial distance of translation from
the centre of the nucleus, we took the centre of the nucleus to be the origin in the
non-dimensional domain in Figure 5.13. Interestingly, we find that protein translation
must begin a small distance from the nuclear membrane for this case. Our ranges of
values for the remaining parameters in Table 8.1 are consistent with the values found
in the modelling literature, where analogous parameters exist (Proctor and Gray, 2008;
Ciliberto et al., 2005; Puszyn´ski et al., 2008; Geva-Zatorsky et al., 2006).
8.5 Proteasome inhibition numerical experiment
In this section, we consider the implications of treating the p53-Mdm2 GRN with pro-
teasome inhibitors. It is known that exposing cells to proteasome inhibitors results in
increased levels of p53 and Mdm2. In particular, it was shown in Maki et al. (1996)
that gamma-irradiated cells treated with the proteasome inhibitor MG115 caused in-
creased expression of p53. More recently, experiments conducted by Xirodimas et al.
(2001) revealed that by treating cells with proteasome inhibitor MG132, both p53 and
Mdm2 levels increased. Furthermore, both proteins localised in the nucleus. To model
this effect, we decrease the protein degradation parameters, µ , ν , and ρ by a factor
λ , which we will refer to as the inhibition factor. All other parameter values used for
the simulations are as detailed in column 3, Table 8.1, but we divide µ , ν , and ρ by
λ = 300 so that their values become:
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µ = 3.33×10−7s−1, ν = 1.11×10−4s−1, ρ = 2.78×10−6s−1. (8.18)
In Figure 8.4 we can see how the decrease in protein degradation parameters has af-
fected the total concentrations of the variables in our p53-Mdm2 GRN model. The
numerical solutions no longer display oscillatory dynamics, but instead Mdm2 levels
increase monotonically and p53 levels appear to saturate and reach a steady state. The
total concentrations quickly exceed the levels in Figure 8.2 where the proteasome was
not inhibited. Both p53 and Mdm2 appear in larger quantities in the cytoplasm as
opposed to the nucleus. Mdm2 mRNA levels remain low in spite of increased lev-
els of p53 as a result of Mdm2 protein directly inhibiting p53 transcriptional activity.
Unsurprisingly, p53 mRNA levels are unaffected by this numerical experiment.
The spatial plots presented in Figure 8.5 show the spatial distributions of p53 and
Mdm2 concentrations at t = 1500 minutes. Mdm2 concentrations are distributed evenly
throughout the cell by this time and p53 concentrations are located mainly in the cyto-
plasm (where they are originally created). Although Mdm2 dependent degradation of
p53 is decreased, it is not zero, so p53 is more likely to be found where it is initially
made (i.e., the cytoplasm). Hence, our model was not able to reproduce the observed
experimental phenomenon of p53 and Mdm2 localising in the nucleus. This implies
our modelling assumptions are in some way flawed or not faithful to the underlying
biology.
8.6 Discussion
The p53-Mdm2 GRN is known to have a central role in the response of the cell to
cytotoxic or radiotoxic insults resulting in DNA damage. The localisation of p53 is
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Figure 8.4: Plots of the total concentrations of p53 mRNA (black), p53 (blue), Mdm2 mRNA
(green) and Mdm2 (red) in (a) the nucleus and (b) the cytoplasm, for the p53-Mdm2 reaction-
diffusion model. Parameter values as per column 3, Table 8.1, with the exception of parameters
µ , ν , and ρ which are specified in equation (8.18). The total concentrations of Mdm2 con-
tinue to increase over the 1500 minute time interval and accumulate mainly in the cytoplasmic
compartment, whereas p53 levels saturate after t = 250 minutes, accumulating mainly in the
cytoplasmic compartment.
(a) p53 concentration (b) Mdm2 concentration
Figure 8.5: Plots showing the spatial distribution of (a) p53 and (b) Mdm2 within the osteosar-
coma cell domain of Figure 5.13 at time t = 1500 minutes, for the p53-Mdm2 reaction-diffusion
model. The concentrations of p53 are localised mainly in the cytoplasm whereas Mdm2 is
almost homogeneously distributed throughout the cell. Parameter values as per column 3,
Table 8.1, with the exception of parameters µ , ν , and ρ which are specified in equation (8.18).
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very important for maintaining cellular homeostasis and it is known to be mislocalised
in many forms of human cancer (for a complete list, see Table 4 in O’Brate and Gi-
annakakou (2003) and references therein). Furthermore hindering p53 translocation to
the nucleus alters the transcriptome of the cell and contributes to carcinogenesis (Vous-
den and Prives, 2009). Hence a spatio-temporal model of the p53-Mdm2 GRN could
shed light on processes that have clinical significance.
In this chapter, we have presented a reaction-diffusion model of the p53-Mdm2 GRN.
It is known that p53 and Mdm2 concentrations can exhibit a dynamical, oscillatory re-
sponse to gamma irradiation at the single cell level. Our numerical simulations reflect
experimental findings both in vitro (Hirata et al., 2002; Geva-Zatorsky et al., 2006) and
in vivo (Hamstra et al., 2006) and mark a conceptual advance in the modelling of in-
tracellular processes. Furthermore, our period of oscillation (3.6 hours) fell within the
3 to 7 hour range measured in experiments (Bar-Or et al., 2000; Geva-Zatorsky et al.,
2006). Additional complexities of post-transcriptional mRNA and post-translational
protein modifications, while not explicitly incorporated into the model, occur within
the timescales modelled and do not fundamentally change the sequence or timing of
events.
Where possible, parameter values were taken from experimental measurements, oth-
erwise they were chosen to be in agreement with other recent modelling efforts. As
in the case of the Hes1 GRN, we demonstrated that the model is robust to changes in
parameter values (when varying one parameter at a time).
Our proteasome inhibition numerical experiment highlighted an inconsistency between
our numerical simulations and real biological data. In a biological experiment, treat-
ment of a cell with proteasome inhibitor MG132 resulted in both p53 and Mdm2 pro-
teins localising in the nucleus Xirodimas et al. (2001). However, our numerical exper-
iment predicted p53 to localise mainly in the cytoplasm and Mdm2 to distribute itself
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almost evenly throughout the cell. This led us to rethink our modelling assumptions
and the next chapter contains a modified model of the p53-Mdm2 GRN that extends the
one presented in this chapter and rectifies the inconsistency found in the proteasome
inhibition experiment.
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Chapter 9
The influence of the nuclear
membrane and active transport on the
p53-Mdm2 gene regulatory network
9.1 Introduction
In this chapter we consider extensions to the p53-Mdm2 reaction-diffusion model pre-
sented in chapter 8. The extensions we consider can only be made in an explicitly
spatial setting and provide insight into the way p53 is transported into the nucleus.
9.2 Extended p53-Mdm2 model formulation
We now extend the p53-Mdm2 model defined in section 8.1 to include a nuclear mem-
brane and active transport. The importance of modelling the nuclear membrane explic-
itly has been made clear in section 5.2 but, in terms of the p53-Mdm2 GRN specifically,
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it is worth noting that p53 nucleocytoplasmic transport is known to be tightly regulated
and that disruption to this transport can play a role in tumorigenesis (Ryan et al., 2001).
We define the explicit nuclear membrane boundary conditions in a similar manner to
the Hes1 model in section 5.2. Thus, recalling our notation from section 8.1 that Di j
indicates diffusion of species i (mRNA or protein) in location j (nucleus or cytoplasm),
and still assuming that Di j is constant (independent of i and j), we define mRNA and
protein diffusion coefficients in the nuclear membrane as, respectively, Dm = Di j/5
and Dp = Di j/15 to reflect slow mRNA diffusion across the nuclear membrane and
even slower protein diffusion, and we replace boundary conditions (8.10) – (8.13) with
boundary conditions appropriate for a permeable thin boundary layer of thickness d
defined by:
Dn1
∂ [p53mn]
∂n =
Dm([p53mn]− [p53mc])
d , (9.1)
Dc1
∂ [p53mc]
∂n =
Dm([p53mc]− [p53mn])
d , (9.2)
Dn2
∂ [p53n]
∂n =
Dp([p53n]− [p53c])
d , (9.3)
Dc2
∂ [p53c]
∂n =
Dp([p53c]− [p53n])
d , (9.4)
Dn3
∂ [Mdm2mn]
∂n =
Dm([Mdm2mn]− [Mdm2mc])
d , (9.5)
Dc3
∂ [Mdm2mc]
∂n =
Dm([Mdm2mc]− [Mdm2mn])
d , (9.6)
Dn4
∂ [Mdm2n]
∂n =
Dp([Mdm2n]− [Mdm2c])
d , (9.7)
Dc4
∂ [Mdm2c]
∂n =
Dp([Mdm2c]− [Mdm2n])
d . (9.8)
In terms of active transport, it is known that p53 is shuttled towards the nucleus along
microtubules (O’Brate and Giannakakou, 2003; Lomakin and Nadezhdina, 2010). Al-
though there is no direct evidence for Mdm2 transport along microtubules, there is
evidence to suggest that Mdm2 can be actively transported to the nucleus (Mayo and
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Donner, 2001). Therefore, as we did in section 5.2 for the Hes1 model, we shall include
convection terms in the cytoplasmic protein equations to account for active transport,
which changes equations (8.3) and (8.7) to the following:
∂ [p53c]
∂ t = Dc1∇
2[p53c]−∇ · (a [p53c])+H(x,y)β [p53mc]
−
µ +ν
 [Mdm2c]h1
M̂dm2
h1
+[Mdm2c]h1

 [p53c], (9.9)
∂ [Mdm2c]
∂ t = Dc3∇
2[Mdm2c]−∇ · (a [Mdm2c])+H(x,y)γ[Mdm2mc]
−ρ [Mdm2c], (9.10)
where the convective velocity a is defined as in equation (5.6) and is plotted in Fig-
ure 5.1. As we did for the extended Hes1 model, we assume that convection does not
occur in the region between the MTOC and the nuclear membrane (the orange region
in Figure 5.2). Hence, in this region, equations (8.3) and (8.7) apply.
9.3 Numerical simulation results
We performed simulations of the extended p53-Mdm2 model given by equations (8.1) –
(8.8) and (9.9) – (9.10) subject to conditions (8.9), (8.14) – (8.17) and (9.1) – (9.6).
We retained the parameter values used to simulate the p53-Mdm2 reaction-diffusion
model stated in section 8.4 and for the additional parameters introduced by extending
the model we chose values to give numerically stable sustained oscillations. Our pa-
rameter values are summarised in the second column of Table 9.1. As in the previous
chapter, details regarding non-dimensionalisation and the calculation of dimensional
parameter values can be found in Appendix 11.3.2. Parameter ranges such that the
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extended model exhibits sustained oscillatory dynamics (defined as at least 5 peaks of
p53 in the nucleus) were found and are stated in the third column of Table 9.1.
Notice that most of the ranges in Table 9.1 are wider than those in Table 8.1, and in
particular this is true for the diffusion coefficient. Hence, as we found for the Hes1
model, extending the p53-Mdm2 model to include a nuclear membrane and active
transport makes it a more robust oscillator. Our rate of active transport in the second
column of Table 9.1 is similar to the rate of active transport used in the Hes1 model
in Table 5.1. However, notice that, unlike in Table 5.1, our range of values for the
active transport rate in Table 9.1 includes zero. Hence active transport is not needed
for sustained oscillatory dynamics in the extended p53-Mdm2 model (see section 9.4
below). The parameter l permits oscillations over a larger range than in Table 5.1 but
still does not permit sustained oscillations when translation occurs too close to the
nucleus.
Parameter Value in simulations Range over which oscillations are observed
Di j 3.00×10−11cm2s−1 3.67×10−12cm2s−1 to 5.33×10−8cm2s−1ζ 2.92×10−10Ms−1 ≥ 9.12×10−12Ms−1
φ 5.83×10−4s−1 2.00×10−4s−1 to 1.87×10−4s−1
β 0.33s−1 ≥ 9.33×10−3s−1
µ 1.00×10−4s−1 ≤ 1.67×10−3s−1
ν 3.33×10−2s−1 6.67×10−4s−1 to 1.17s−1
h1 2 ≥ 1
M̂dm2 3.2×10−5M 5.60×10−6M to 8.00×10−4M
α 2.92×10−11Ms−1 ≤ 1.50×10−10Ms−1
η 1.67×10−9Ms−1 ≥ 1.04×10−10Ms−1
h2 4 ≥ 1
p̂53 2.50×10−6M ≤ 1.13×10−4M
θ 4.00 ≥ 1.56×10−2
γ 0.67s−1 ≥ 0.05s−1
ρ 8.33×10−4s−1 2.33×10−4s−1 to 3.67×10−3s−1
Dm 6.00×10−12cm2s−1 ≥ 2.22×10−14cm2s−1
Dp 2.00×10−12cm2s−1 ≥ 7.43×10−15cm2s−1
d 1.00×10−5cm ≤ 1.00×10−3cm
a 1.00×10−6cms−1 ≤ 5.83×10−5cms−1
l 6.32µm 3.87µm to 11.8µm
Table 9.1: Parameter values used in the extended p53-Mdm2 model and ranges over which
sustained oscillatory dynamics are observed.
Figure 9.1 shows how the total concentrations of the variables in the extended p53-
Mdm2 model vary over time in both the nucleus and cytoplasm. The model has
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changed significantly from that which was presented in the previous chapter but the
solution still exhibits oscillatory dynamics (compare Figures 9.1a and 9.1b with Fig-
ures 8.2a and 8.2b). However, there are numerous quantitative differences in the nu-
merical solution. For instance, a far larger proportion of the p53 and Mdm2 proteins
now enters the nucleus, on account of being actively transported towards it and despite
the barrier of slower diffusion across the nuclear membrane. To be more specific, Fig-
ure 8.2 show that peaks in nuclear p53 total concentration are approximately 8% the
height of peaks in cytoplasmic p53 total concentration, whereas in Figure 9.1 in our
new results this has changed to 33%. For Mdm2, the change is from approximately
2.5% to 33%. The peaks in p53 total nuclear concentration are taller and narrower in
our new results, exhibiting pulsatile-like dynamics and dropping to zero between con-
secutive peaks. Such dynamics are consistent with recent experimental data showing
that, in response to DNA damage, p53 exhibits sharp pulses (Batchelor et al., 2009;
Loewer et al., 2010). The period of oscillation is now shorter than the period observed
for the reaction-diffusion model of the previous chapter. The observed period for the
extended model is 3 hours, which is consistent with experimental data (Bar-Or et al.,
2000; Geva-Zatorsky et al., 2006). As we mentioned in the previous chapter, p53
mRNA does not exhibit oscillations since it is not involved in a negative feedback loop
and is not coupled to any other equations — this is why we can see steady state levels
of p53 mRNA in Figure 9.1.
In Figure 9.2 we show spatial profiles for p53 and Mdm2 from times t = 240 minutes
to t = 540 minutes at 60 minute intervals. At t = 240 minutes, it can be observed
that p53 has accumulated in the cytoplasm and nucleus. In the nucleus it upregulates
Mdm2 mRNA transcription, which leads to increased production of Mdm2 in the cy-
toplasm (t = 300 minutes). Mdm2 enhances degradation of p53, both in the cytoplasm
and in the nucleus. In particular, since Mdm2 is actively transported to the nucleus,
then Mdm2 dependent degradation of p53 is sufficiently strong to eradicate p53 there
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(t = 360 minutes). Mdm2 levels fall through natural degradation, which frees p53 from
Mdm2 dependent degradation and allows levels of p53 to rise in the cytoplasm. Levels
of p53 quickly then rise in the nucleus through active transport (t = 420 minutes). The
process just described now repeats, producing oscillatory dynamics. The 180 minute
period of oscillations is clear from Figure 9.2. It is also clear that the nuclear mem-
brane retards the nuclear entry of p53 and Mdm2 — the local concentrations reach
their highest levels in or next to the nuclear membrane. This result reinforces the idea,
discussed in Gasiorowski and Dean (2003) and Chahine and Pierce (2009), that the
nuclear pore complex is an attractive site for delivering chemotherapeutic drugs to dis-
rupt or enhance intracellular signalling. Exploiting the spatial nature of our approach,
we created ‘computational animations’ of the numerical solution of the extended p53-
Mdm2 model. These animations can be readily compared with the experimental results
obtained by Lahav et al. (2004) (supporting online material) where fluorescent fusion
proteins were employed to visualise the protein concentration levels inside single cells.
Upon doing this we find good qualitative agreement between the numerical solution
and the experimental data.
As was the case with the extended Hes1 model in section 5.5, we found in the extended
p53-Mdm2 model that oscillatory dynamics could occur even when the cytoplasmic
protein diffusion coefficients were all set to zero (results not shown). In other words,
it is possible to observe sustained oscillatory dynamics when proteins are transported
to the nucleus by convection alone.
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Figure 9.1: Plots of the total concentrations of p53 mRNA (black), p53 (blue), Mdm2 mRNA
(green), and Mdm2 (red) in (a) the nucleus and (b) the cytoplasm, for the extended p53-Mdm2
model. The period of oscillation is approximately 180 minutes. Parameter values as per col-
umn 2, Table 9.1.
9.4 Microtubule disruption numerical experiment
In section 5.6 we mentioned that microtubules are seen as an attractive target for
chemotherapeutic drugs. Hence we now consider the effect of such drugs in our ex-
tended p53-Mdm2 model. The effect of such drugs will be to disrupt active transport
and therefore we set the active transport rate a equal to zero in our extended model.
All other parameter values are as per the second column of Table 9.1 (for convenience,
the complete set of parameters is also stated in the second column of Table 9.2 below).
Figure 9.3 shows the total concentrations for all model species over time. Sustained
oscillatory dynamics can be seen but the oscillations are now smoother than when ac-
tive transport was permitted, levels of nuclear p53 no longer drop to zero between
successive peaks, the amplitude of p53 oscillations has grown enormously relative to
Mdm2 oscillations in both the nucleus and the cytoplasm, and the oscillatory period has
significantly increased (compare Figure 9.3 with Figure 9.1). The period is still in the
range of experimental measurements (Bar-Or et al., 2000). There are also reductions in
the overall amounts of nuclear p53 and nuclear Mdm2. For p53, peaks in total nuclear
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(a) p53
(b) Mdm2
Figure 9.2: Plots showing the spatio-temporal evolution of (a) p53 and (b) Mdm2 within the
osteosarcoma cell domain from times t = 240 to t = 540 minutes at 60 minute intervals for the
extended p53-Mdm2 model. The concentrations exhibit oscillatory dynamics in both time and
space. Parameter values as per column 2, Table 9.1.
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concentration are approximately 6% of the height of peaks in total cytoplasmic concen-
tration in Figure 9.3, reduced from 33% in Figure 9.1, while for Mdm2 the reduction
is from 33% in Figure 9.1 to 2.5% in Figure 9.3. These latter findings are consistent
with in vivo experiments showing that the microtubule-depolymerizing agent nocoda-
zole causes levels of nuclear p53 to fall (Roth et al., 2007), and is also consistent with
experiments showing that the treatment of cells with microtubule-disrupting agents be-
fore subjecting these cells to DNA damage causes both nuclear p53 and nuclear Mdm2
levels to fall (Giannakakou et al., 2000).
Figure 9.4 shows spatial profiles for p53 and Mdm2 from times t = 240 minutes to
t = 540 minutes at 60 minute intervals. These proteins are produced in the cytoplasm
by the process of translation, a process which we earlier assumed to occur at least some
minimal distance from the nuclear membrane. This assumption has a clear impact on
the local concentrations of p53 and Mdm2 in Figure 9.4. New production of p53 and
Mdm2 is maximal at this minimal distance where, by our assumptions, p53 mRNA
and Mdm2 mRNA molecules diffusing outwards from the nucleus will first encounter
ribosomes. Newly synthesised p53 and Mdm2 diffuse outwards into the cytoplasm,
reaching the cell membrane in many places.
The spatial profiles in Figure 9.4 are quite different to those in Figure 9.2 where ac-
tive transport was permitted and forced newly synthesised p53 and Mdm2 to rapidly
translocate towards the nucleus. In the absence of directed transport towards the nu-
cleus, the local concentrations of p53 and Mdm2 within or next to the nuclear mem-
brane are hugely reduced. There is a chemotherapeutic implication. Chemotherapeutic
drugs are often used in combination, a practice known as combination chemother-
apy (Ferrari and Palmerini, 2007; Robati et al., 2008). The biggest advantage to this
practice is that it minimises the chances of resistance developing to any one agent.
Drugs which target proteins at the nuclear membrane will be ineffective if little of
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Figure 9.3: Plots of the total concentrations of p53 mRNA (black), p53 (blue), Mdm2 mRNA
(green) and Mdm2 (red) in (a) the nucleus and (b) the cytoplasm, for the extended p53-Mdm2
model in the absence of active transport. The period of oscillation is approximately 242.5
minutes. Parameter values as per column 2, Table 9.2.
the protein reaches the nuclear membrane, but Figure 9.2 shows that microtubule-
disrupting drugs may cause comparatively little of the protein to reach the nuclear
membrane. Hence the effectiveness of drugs designed to act at nuclear pore complexes
may be compromised by microtubule-disrupting drugs, and the combination of these
two types of drug may not always represent an optimal treatment strategy.
Table 9.2 contains ranges of parameter values which permit oscillatory dynamics in
the extended p53-Mdm2 model with no active transport. These ranges are narrower
than those in Table 8.1 where there was no active transport and no explicit nuclear
membrane, and are also narrower than the ranges in Table 9.1 where there was both
active transport and an explicit nuclear membrane. These results are consistent with
our findings for the Hes1 model in section 5.6. The parameter range for l now allows
for protein translation to occur directly outside the nucleus. This is a result of the
nuclear membrane slowing the entry of p53 to the nucleus, preventing Mdm2 levels
from spiking too quickly.
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(a) p53
(b) Mdm2
Figure 9.4: Plots showing the spatio-temporal evolution of (a) p53 and (b) Mdm2 within the
osteosarcoma cell domain from times t = 240 to t = 540 minutes at 60 minute intervals, for
the extended p53-Mdm2 model in the absence of active transport. The concentrations exhibit
oscillatory dynamics in both time and space. Parameter values as per column 2, Table 9.2.
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Parameter Value in simulations Range over which oscillations are observed
Di j 3.00×10−11cm2s−1 1.16×10−11cm2s−1 to 5.00×10−8cm2s−1ζ 2.92×10−10Ms−1 ≥ 5.83×10−11Ms−1
φ 5.83×10−4s−1 1.00×10−4s−1 to 1.03×10−3s−1
β 0.33s−1 ≥ 0.06s−1
µ 1.00×10−4s−1 ≤ 3.67×10−4s−1
ν 3.33×10−2s−1 1.33×10−3s−1 to 3.67s−1
h1 2 ≥ 1
M̂dm2 3.2×10−5M 3.00×10−6M to 2.40×10−4M
α 2.92×10−11Ms−1 ≤ 2.33×10−11Ms−1
η 1.67×10−9Ms−1 ≥ 2.17×10−10Ms−1
h2 4 ≥ 1
p̂53 2.50×10−6M ≤ 1.35×10−5M
θ 4.00 ≥ 1.60×10−3
γ 0.67s−1 ≥ 0.09s−1
ρ 8.33×10−4s−1 1.33×10−4s−1 to 6.67×10−3s−1
Dm 6.00×10−12cm2s−1 ≥ 1.50×10−13cm2s−1
Dp 2.00×10−12cm2s−1 ≥ 2.50×10−14cm2s−1
d 1.00×10−5cm ≤ 2.00×10−4cm
a 0 −
l 6.32µm nuclear membrane (approx. 2 to 3µm) to 8.94µm
Table 9.2: Parameter values used in the extended p53-Mdm2 model in the case where ac-
tive transport rates are set to zero, and ranges over which sustained oscillatory dynamics are
observed.
9.5 Proteasome inhibition numerical experiment
We repeat here the proteasome inhibition numerical experiment which we performed
on the reaction-diffusion model of the p53 GRN in section 8.5 for our extended p53-
Mdm2 GRN model. In section 8.5, we noted that we were not able to reproduce
the experiments conducted by Xirodimas et al. (2001), in which large levels of p53
and Mdm2 were recorded in the nucleus after treatment with proteasome inhibitor
MG132. Following the same approach in section 8.5, we divide the protein degradation
parameters, µ , ν , and ρ byλ , the inhibition factor. All other parameter values used for
the simulations are as detailed in Table 9.1, but we divide µ , ν , and ρ by λ = 300
so that their values become those shown in equation (8.18). We do not reduce these
protein degradation parameters to zero because proteasome inhibitors are not 100%
efficient (Lightcap et al., 2000).
In Figure 9.5 we can see how the decrease in protein degradation parameters has af-
fected the total concentrations of the variables in the p53-Mdm2 model including a
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nuclear membrane and active transport. The system no longer exhibits oscillatory dy-
namics, but instead p53 and Mdm2 levels increase monotonically, quickly exceeding
the levels in Figure 9.1 where there was no proteasome inhibition. We can now see
the level of protein in the nucleus exceeds that of the cytoplasm. Furthermore, the pro-
tein levels in the cytoplasm are actually largely concentrated in the region between the
nucleus and the MTOC, i.e., very close to the nucleus. This is reflected in the spatial
plots presented in Figure 9.6, where we can see high local concentrations of p53 and
Mdm2 in the nucleus at time t = 1500 minutes which accurately reflects the experi-
mental findings of Xirodimas et al. (2001) and Maki et al. (1996). The reason p53
and Mdm2 accumulate in the nucleus is due to active transport directing both species
towards the nucleus. Mdm2 levels rapidly increase because the degradation rate of
Mdm2 protein is decreased. Notice that p53 levels also increase, but not as rapidly
as Mdm2. As there is a higher concentration of Mdm2 in the cell, this increases the
likelihood of p53 being degraded via Mdm2 (although ν has been decreased, it is not
zero). Mdm2 mRNA levels remain low in spite of increased levels of p53 as a result
of Mdm2 protein directly inhibiting p53 transcriptional activity. p53 mRNA levels are
unaffected by this numerical experiment.
Combination chemotherapy was mentioned in section 9.4, and we noted that the com-
bination of microtubule-disrupting drugs and drugs designed to act at nuclear pore
complexes may not always represent an optimal treatment strategy. We can now add
to this discussion. Figure 9.6 suggests that when proteins that are actively transported
towards the nucleus are influenced by proteasome inhibitor drugs, their local concen-
tration will rise significantly at the nuclear membrane. Hence the combination of drugs
designed to act at nuclear pore complexes with proteasome inhibitor drugs may repre-
sent a potentially fruitful avenue for new chemotherapeutic experimental studies.
In Figure 9.7 we explore the relationship between the nuclear to cytoplasmic ratio of
protein and the inhibition factor, λ . We achieved this by first calculating the total
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Figure 9.5: Plots of the total concentrations of p53 mRNA (black), p53 (blue), Mdm2 mRNA
(green) and Mdm2 (red) in (a) the nucleus and (b) the cytoplasm, for the extended p53-Mdm2
model. We also note that the proteins in the cytoplasm are largely concentrated in the region
between the nucleus and the MTOC, i.e., very close to the nucleus, as can be seen in Fig-
ure 5.9. Parameter values as per column 2, Table 9.1, with the exception of parameters µ ,
ν , and ρ which are specified in equation (8.18). The total concentrations of p53 and Mdm2
continue to increase over the 1500 minute time interval and accumulate mainly in the nuclear
compartment.
concentrations of nuclear and cytoplasmic protein over a 1500 minute time period for
different values of λ . We then calculated the mean of these total concentrations and di-
vided the nuclear mean by the cytoplasmic mean. Finally, we plotted this ratio against
the value of λ . As can be seen from the plots, the nuclear to cytoplasmic ratio of p53
monotonically increases as λ is increased, whereas the nuclear to cytoplasmic ratio of
Mdm2 saturates once λ reaches a value of approximately 150. From Figure 9.7, we can
make the quantitative prediction that the proteasome inhibitor must effectively reduce
the degradation rates by a factor of 200 before more p53 and Mdm2 will accumulate
in the nucleus than in the cytoplasm.
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(a) p53 concentration (b) Mdm2 concentration
Figure 9.6: Plots showing the spatial distribution of (a) p53 and (b) Mdm2 within the os-
teosarcoma cell domain at time t = 1500 minutes, for the extended p53-Mdm2 model. The
concentrations of p53 and Mdm2 are localised mainly in the nucleus and between the nuclear
membrane and the MTOC. Parameter values as per column 2, Table 9.1, with the exception of
parameters µ , ν , and ρ which are specified in equation (8.18).
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Figure 9.7: Plots of the nuclear to cytoplasmic (N/C) ratio against the inhibition factor λ for
(a) p53 and (b) Mdm2. Values of λ are plotted in increments of 50, starting with 1 and ending
with 1001. Parameter values are found in column 2, Table 9.1, with the exception of parameters
µ , ν , and ρ which are reduced by a factor λ .
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9.6 Discussion
In this chapter we have extended the spatio-temporal model of the p53-Mdm2 GRN
presented in chapter 8. Our extensions consisted of introducing an explicit nuclear
membrane and allowing active transport of proteins. We accounted for the permeability
of the nuclear membrane by considering its thickness and the fact that diffusion across
it is slower than in the nucleus or cytoplasm, and assumed that proteins were convected
from the cytoplasm to the nucleus in order to model translocation along microtubules.
Experiments have shown that stimulation of the p53-Mdm2 GRN can cause p53 and
Mdm2 concentrations to exhibit oscillatory dynamics, driven by a negative feedback
loop. The concentrations oscillate with a period ranging from 3 to 7 hours (Bar-Or
et al., 2000; Geva-Zatorsky et al., 2006), which our extended model was able to re-
produce. Furthermore, we found ranges of values for the model parameters such that
sustained oscillatory dynamics occurred, noting that these ranges were consistent with
available experimental measurements. We also found that our model extensions acted
to broaden the parameter ranges that yielded oscillations compared with the previous
results of chapter 8. Hence oscillatory behaviour is made more robust by the inclusion
of both the nuclear membrane and active transport.
In the interests of making accurate quantitative statements, we explored our extended
p53-Mdm2 model on a domain that was imported from an image of an osteosarcoma
cell — the p53 pathway is known to be deregulated in osteosarcomas. We were able
to make quantitative observations regarding, for example, the proportion of p53 that
enters the nucleus. In particular, we saw that peaks in total nuclear concentration were
33% the height of peaks in total cytoplasmic concentration, whereas this proportion
was only 8% in the reaction-diffusion model. Hence, although the nuclear membrane
acts as a barrier to p53 nuclear localisation, active transport nevertheless increases
this localisation. Our quantitative data serve as predictions until accurate experimental
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data become available. We made qualitative observations too, noting that our new p53-
Mdm2 model exhibited pulsatile-like dynamics in keeping with several experimental
studies (Batchelor et al., 2009; Loewer et al., 2010).
Motivated by experiments involving microtubule-disrupting chemotherapeutic drugs
(Jordan and Wilson, 2004; Kavallaris, 2010; Carbonaro et al., 2011), we considered
the special case in our new models where active transport rates were set to zero. We
found that this narrowed the ranges of values for model parameters such that sustained
oscillatory dynamics occurred. For our p53-Mdm2 model, we found reductions in the
levels of nuclear p53 and nuclear Mdm2, in qualitative agreement with experimental
data in Roth et al. (2007) and Giannakakou et al. (2000). We also considered the effect
of proteasome inhibitor drugs in our p53-Mdm2 model by reducing protein degrada-
tion rates. This increased levels of p53 and Mdm2, especially in the nucleus, and
again these results matched experimental data (Maki et al., 1996; Xirodimas et al.,
2001). Hence, we were able to overcome the shortcomings of our reaction-diffusion
model presented in chapter 8. The active transport modelling assumption is critical
for our proteasome inhibition numerical experiment to reproduce real biological data.
Ignoring our nuclear membrane assumption results in even larger quantities of p53 and
Mdm2 accumulating in the nucleus (plots not shown).
From the spatial profiles for the p53-Mdm2 model, we observed that the nuclear mem-
brane retards the nuclear entry of p53 and Mdm2, with the local concentrations of these
species reaching their highest levels in or next to the nuclear membrane. Such results
indicate that the nuclear pore complex is an attractive site for delivering chemothera-
peutic drugs to disrupt or enhance intracellular signalling, as discussed in Gasiorowski
and Dean (2003) and Chahine and Pierce (2009). Our spatial profiles also suggested
that microtubule-disrupting drugs may cause comparatively little protein to reach the
nuclear membrane whereas proteasome inhibitor drugs may increase protein levels
both at the nuclear membrane and in the nucleus. We drew conclusions in terms of
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combination chemotherapy, suggesting that the effectiveness of drugs designed to act at
nuclear pore complexes may be limited by microtubule-disrupting drugs but enhanced
by proteasome inhibitor drugs. Computational animations of our spatio-temporal sim-
ulations closely matched the experimental results of Lahav et al. (2004) where con-
centration profiles of proteins in single cells were imaged utilising fluorescent fusion
proteins. With the continuing advance of imaging techniques in individual cells (Kher-
lopian et al., 2008; Michalet et al., 2005), it will become increasingly important to
model intracellular dynamics using a spatio-temporal framework.
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Chapter 10
Discussion and future directions
We conclude this thesis with a brief summary of the major points and some possible
avenues of future exploration. Of course, this is by no means exhaustive, and we refer
the reader to the appropriate chapters for a more detailed account.
10.1 Discussion
The primary message arising from the work presented in this thesis is that spatio-
temporal modelling of gene regulatory networks is a valuable pursuit. Spatio-temporal
modelling has significant advantages over more traditional temporal approaches — not
only is it more faithful to the underlying biology but spatio-temporal simulations can
be more readily compared with experimental data. Furthermore, the approach allows
for more questions to be asked of the GRNs under study.
Results from previous mathematical models have reflected simplified experimental
findings but have not distinguished explicitly between spatial compartments within
the cell and have not considered (explicit) spatial movement of molecules. We have
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developed novel spatio-temporal models of two well characterised GRNs: the Hes1
GRN and the p53-Mdm2 GRN. The Hes1 GRN plays a role in somitogenesis and em-
bryonic stem cell differentiation, whereas the p53-Mdm2 GRN is critical for regulating
the cell-cycle. Both are implicated in human cancer and have been the subject of inten-
sive research over the past decade. This research has been conducted via two parallel
(complementary) streams: biological experimentation and mathematical modelling.
Building on directly from previous DDE models, we formulated equivalent PDE mod-
els on cell-like domains with separate nuclear and cytoplasmic compartments (with
reactions localised appropriately). In general, we solved the models numerically using
the finite element method as implemented in the software package COMSOL 3.5a, us-
ing triangular basis elements and Lagrange quadratic basis functions along with a back-
ward Euler time-stepping method of integration. We chose the finite element method
due to its ability to handle complicated geometries (the eukaryotic cell usually takes
an irregular shape) and boundaries with relative ease. The numerical simulation results
of our spatio-temporal reaction-diffusion models (presented in chapters 4 and 8) have
demonstrated the existence of oscillatory dynamics in negative feedback systems both
for relatively simple (Hes1) and more complex (p53-Mdm2) GRNs and have been able
to focus on reactions occurring both in the cell nucleus and in the cytoplasm. The use
of PDEs allows spatial effects to be examined explicitly and facilitates the study of
how protein localisation is regulated. In chapter 4 we investigated the effect of spatial
dimension on the Hes1 GRN, something that can only be done using a spatial model.
We found that for 1D, 2D, and 3D simulations our model yielded qualitatively similar
results and quantitatively similar results for 2D and 3D simulations.
In chapters 5 and 9 we extended our reaction-diffusion models by including a nuclear
membrane and active transport. We accounted for the permeability of the nuclear mem-
brane by considering its thickness and the fact that diffusion across it is slower than
in the nucleus or cytoplasm, and we assumed that proteins were convected from the
150
cytoplasm to the nucleus in order to model translocation along microtubules. The ex-
tended models were able to produce sustained oscillations with periods consistent with
experimental data (Hirata et al., 2002; Bar-Or et al., 2000; Geva-Zatorsky et al., 2006).
We found ranges of values for the model parameters such that sustained oscillatory dy-
namics occurred, noting that these ranges were consistent with available experimental
measurements. We also found that our model extensions acted to broaden the pa-
rameter ranges that yielded oscillations compared with the reaction-diffusion models.
Hence oscillatory behaviour is made more robust by the inclusion of both the nuclear
membrane and active transport.
Given that cell shape can influence intracellular signalling (Meyers et al., 2006; Neves
et al., 2008), we investigated the influence on the numerical simulations of varying
the cell domain, finding for our extended Hes1 model that oscillatory dynamics are
strongly robust to changes in the size and shape of the cell and its nucleus. In general
we found that qualitative dynamics were unaffected by varying the cell shape but quan-
titative dynamics were affected quite substantially. Hence, in the interests of making
accurate quantitative statements, we explored our extended p53-Mdm2 model on a do-
main that was imported from a high resolution microscopy image of an osteosarcoma
cell — the p53-Mdm2 pathway is known to be deregulated in osteosarcomas.
Motivated by experiments involving microtubule-disrupting chemotherapeutic drugs,
we considered the special case in our extended models where active transport rates
were set to zero. Strikingly, we found that this experiment had major implications
for the extended Hes1 GRN model. The numerical simulations displayed a qualita-
tive change — damped oscillations were now observed. Unfortunately, we can not
corroborate our findings with experimental data in this case, but instead leave this nu-
merical experiment as a prediction of the model. For our p53-Mdm2 extended model,
we found reductions in the levels of nuclear p53 and nuclear Mdm2, in qualitative
agreement with experimental data. We found that this narrowed the ranges of values
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for model parameters such that sustained oscillatory dynamics occurred.
We also investigated the influence of proteasome inhibitors on both the p53-Mdm2 and
Hes1 GRNs. We achieved this by decreasing the protein degradation parameters in our
models. In each case, interesting biological insights were gained. For the case of the
Hes1 GRN, both of our reaction-diffusion (chapter 4) and extended model (chapter 5)
were able to reflect temporal data regarding the how the concentration of Hes1 pro-
tein changed once the cell was treated with a proteasome inhibitor. Given the spatial
nature of our models, we were also able to make predictions about how proteasome
inhibition influenced the spatial distribution of Hes1 proteins. We left our spatial dis-
tribution plots as predictions of the model. Importantly, the reaction-diffusion model
with continuity of flux boundary conditions yields different spatial distributions to the
extended model. Hence, once corroborated with experimental evidence, we will be
able to find out which model is more accurate and gain an insight into how transport
of Hes1 protein is regulated. For the case of p53-Mdm2, experimental evidence of
how p53 and Mdm2 localise following proteasome inhibition is available. We found
that our reaction-diffusion model fell short of reproducing the experimental data but
that our extended model succeeded. Furthermore, for the Hes1 GRN we investigated
the influence of translation inhibitors. Here, we were able to reproduce temporal data
concerning the total concentrations of hes1 mRNA and Hes1 protein in the cell. In
this case, the spatial distributions for both the reaction-diffusion model and extended
model were consistent.
Encouraged by the results from our PDE approach, we formulated an equivalent stochas-
tic reaction-diffusion model of the Hes1 GRN in chapter 6. In our spatial stochastic
model, all reactions are modelled using elementary mass action kinetics. This is in
contrast to all previous modelling efforts where a Hill function approximation was
used for Hes1 binding to the promoter site. Since our model is explicitly spatial, such
an approach is neither appropriate nor necessary.
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We computed trajectories of the reaction-diffusion master equation using a spatially
extended Gillespie algorithm (the next subvolume method) as implemented in UR-
DME (Drawert et al., 2012). We estimated the period of our model trajectories using a
continuous time wavelet transform (as implemented in WAVOS, a MATLAB toolbox).
In the case of the Hes1 GRN, in contrast to our PDE models, our spatial stochastic
model is able to reproduce the variability in period and amplitude of Hes1 oscilla-
tions observed in experiments. As a result of this, we have stated that intrinsic noise
can explain heterogeneity in ES cell differentiation (see chapter 6 for details). We also
showed our model was robust to parameter changes through various parameter sweeps.
We were able to ask more questions of our model than recent stochastic DDE models,
as well as being able to directly compare our numerical simulations with biolumines-
cence movies of in vivo Hes1 expression.
As there is potential application for regenerative medicine, we have also proposed
methods of controlling differentiation responses via drug treatment. Our model has
predicted that applying proteasome inhibitors to an ES cell could yield a mesodermal
cell while applying translation inhibitors could yield a neuronal cell. Our model was
also able to reproduce experimental results in which hes1 transgenes were introduced
to hematopoietic progenitor cell which encoded a mutant Hes1 protein lacking the
DNA-binding domain (Yu et al., 2006).
Computational animations of our spatio-temporal simulations closely matched the ex-
perimental results of Geva-Zatorsky et al. (2010) and Kobayashi et al. (2009) where
concentration profiles of proteins in single cells were imaged utilising fluorescent fu-
sion proteins. With the continuing advance of imaging techniques in individual cells,
it will become increasingly important to model intracellular dynamics using a spatio-
temporal framework.
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10.2 Future directions
The work we have presented in this thesis has merely ‘scratched the surface’ of what
can be done with spatio-temporal modelling of GRNs. Future work will consider ex-
tending the models further in several ways, as well as performing detailed analysis of
the current models.
10.2.1 Partial differential equation models
We are currently undertaking a nonlinear analysis of the Hes1 reaction-diffusion model
which has led to the study of a nonlinear and nonlocal eigenvalue problem. Cells can
change shape on the same timescale as oscillatory nuclear-cytoplasmic translocation
of Hes1 or p53, and so we may develop a model with a moving boundary on an evolv-
ing domain. Based on cell imagery, we will consider more realistic support functions
for our translation and active transport terms. We may also study the interactions be-
tween different signalling pathways, i.e., “cross-talk”. For example, it is known that
the p53-Mdm2 GRN can co-operate with and antagonise the NF-κB GRN, which is
central to many stressful, inflammatory, and innate immune responses (Pommier et al.,
2004; Perkins, 2007). We are not aware of any spatio-temporal modelling studies of
interacting GRNs, though there have been temporal studies (Puszyn´ski et al., 2009).
Our p53-Mdm2 model is based on a reduced description of the GRN, and we may
explore the consequences of including more reactions and species in the model. We
may also explore the effect of different chemotherapeutic drugs on the Hes1 and p53-
Mdm2 GRNs. One aspect of intracellular dynamics which we have not included in our
current models, but which is of relevance to our studies, is that of molecular crowding,
i.e., volume exclusion events due to other molecules or organelles. Molecular crowding
generates an environment where diffusion is hindered by obstacles and traps, resulting
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in a form of molecular movement called “anomalous diffusion” (Mendez et al., 2010).
Anomalous diffusion refers to a form of molecular movement in which the mean-
square displacement of a molecule is not linear in time and this kind of movement
has been observed in many experimental studies (Weiss et al., 2004; Wachsmuth et al.,
2000; Caspi et al., 2000). In order to account for molecular crowding in mathemati-
cal models, numerous different approaches have been taken. In deterministic models,
fractional partial differential equations have been employed with success in simplified
settings but have proved challenging in more realistic settings (Yadav et al., 2008).
Many authors have taken a spatial stochastic approach to account for macromolecular
crowding, and numerical studies have proven more tractable than in the deterministic
case — for a recent example, see Marquez-Lago et al. (2012). Hence, in the future
we may explore the influence of anomalous diffusion on both our PDE and spatial
stochastic models of GRNs.
10.2.2 Spatial stochastic Hes1 gene regulatory network model
Future work will consider extending the Hes1 spatial stochastic model in various ways.
In particular, we will explicitly account for transport across the nuclear membrane and
dimerisation of Hes1 monomers. We aim to use our spatio-temporal modelling ap-
proach to shed light on the localisation of the Hes1 dimerisation reaction. This reac-
tion has been identified as a possible target for cancer treatment (Sang et al., 2010). As
mentioned in chapter 6, we will also conduct a global parameter sensitivity analysis
of our model using data clustering techniques. We may also consider cell-cell com-
munication in future work to see if this acts to stabilise and synchronise oscillatory
behaviour as was found experimentally in Masamizu et al. (2006) and in a mathemati-
cal model of Notch signalling in Terry et al. (2011).
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10.2.3 Spatial stochastic p53-Mdm2 gene regulatory network model
We are currently formulating and exploring a spatial stochastic model of the p53-
Mdm2 GRN. Preliminary results are encouraging and we present 4 trajectories in Fig-
ure 10.1 which display the total copy number of p53 (red) and Mdm2 (blue). This
Figure bears a striking resemblance to the corresponding experimental data, see Figure
2 in Geva-Zatorsky et al. (2010). Using a spatial stochastic approach makes it possi-
ble to replicate the noisy oscillatory dynamic displayed in the experimental data. In
addition, we also present a plot (Figure 10.2) showing how the spatio-temporal evo-
lution of a sample trajectory evolves. This plot also agrees well with the equivalent
experimental Figure (see Figure 1 of Geva-Zatorsky et al. (2010)).
Once we have thoroughly examined a spatial stochastic model of the p53-Mdm2 GRN,
we plan to extend it in various ways. Some examples include accounting for dimerisa-
tion and tetramerisation of p53, active transport of p53 along microtubules and mod-
elling transport across the nuclear membrane in greater detail. The spatial-stochastic
p53-Mdm2 model can be adapted to study possible mutations or potential drug treat-
ments by simply changing parameter sets. Using this approach, comparisons of mutant
and wild-type cells under a range of drug treatment combinations is also possible.
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Figure 10.1: Four trajectories from preliminary simulations of our spatial stochastic p53 GRN
model. Plots show how the copy number of p53 (red) and Mdm2 (blue) evolve over a 50 hour
time period.
Figure 10.2: Spatial snapshots of p53 protein distributions from preliminary simulations of
our spatial stochastic model. Time between sequential frames is 20 minutes.
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Chapter 11
Appendix
11.1 Protein translation and synthesis in the cytoplasm:
consideration of the location of the endoplasmic
reticulum
The endoplasmic reticulum (ER) is a network of flattened sacs and branching tubules
that extends throughout the cytoplasm in eukaryotic cells. These sacs and tubules are
all interconnected by a single continuous membrane so that the organelle has only one
large and intricately arranged lumen. The ER is divided into two distinct zones, the
rough ER and the smooth ER. The surface of the rough ER is embedded with many ri-
bosomes giving it a ‘rough’ appearance (hence its name). The rough ER is involved in
the synthesis of proteins and is also a membrane factory for the cell, while the smooth
ER is involved in the metabolising of carbohydrates, regulation of calcium concentra-
tion and the synthesis of lipids. The proteins made in the ER are either exported to the
exterior of the cell or are transported to other membrane structures such as the Golgi
apparatus, lysosomes and endosomes (Alberts et al., 2008). Thus proteins made in the
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endoplasmic reticulum are unlikely to translocate to the nucleus.
In our PDE models of the Hes1 and p53 GRNs, we have made allowance for the en-
doplasmic reticulum by assuming that proteins made in the cytoplasm are translated
a certain radial distance outside the nucleus. Beyond this radial distance, we have as-
sumed that free-floating ribosomes are found in sufficient abundance and distributed
homogeneously so that a step-function is suitable to account for their presence (see
equation 4.5). This is not unreasonable to assume as depending on the protein produc-
tion level of a particular cell, ribosomes may number in the millions (Alberts et al.,
2008). The Heaviside function H(x,y) states that in a region close to the nucleus (rep-
resenting the location of the ER), the function is zero, meaning there is no protein
synthesis in this region. In a region further away from the nucleus (outside the ER) the
function takes the value of one, representing the region of the cytoplasm where we al-
low the translation of protein to occur. The Heaviside function is illustrated graphically
in Figure 11.1.
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Figure 11.1: A schematic representation of equation 4.5. The grey region of the cytoplasm
depicts where we allow constant protein synthesis to occur, representing the region where the
Heaviside function H(x,y) = 1. The white regions represent the nucleus and ER, where the
Heaviside function H(x,y) = 0 (no protein synthesis takes place). The ER has a major axis of
length
√
2 units and minor axis of length 1 unit.
11.2 The Hes1 gene regulatory network
11.2.1 Dulac’s criterion
We state here Dulac’s criterion for proving the non-existence of periodic orbits in some
regions of the phase space. We begin by recalling that if ∂A is a simple closed curve
with outward normal n enclosing a region A and f : R2 → R2 is a continuously differ-
entiable vector field and g : R2 → R is a continuously differentiable function then the
divergence theorem of the plane states that
∮
∂A
g(f ·n)dr =
∫∫
A
∇ · (gf)dxdy,
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where gf is a vector, g(x,y)f(x,y), and is not to be confused with the composition of g
and f (i.e., g◦ f).
Theorem 1. If there exists a continuously differentiable function g : R2 → R such
that ∇ · (gf) is continuous and non-zero on some simply connected domain D, then no
periodic orbit can lie entirely in D.
Proof. Suppose a periodic orbit ∂A does lie entirely in D. Then
∫∫
A
∇ · (gf)dxdy 6= 0,
where A is the area bounded by ∂A, since ∇ · (gf) is either strictly greater than zero
or strictly less than zero throughout A. However, a periodic orbit is a trajectory, and
hence tangential to the vector field, f. So, f ·n = 0, where n is the outward normal to
the periodic orbit. Hence, ∮
∂A
g(f ·n)dr = 0,
producing a contradiction by the divergence theorem.
If g = 1 then this result is sometimes referred to as Bendixson’s criterion. Hence, in
section 3.3.2 it could be said that we applied Bendixson’s criterion to rule out periodic
solutions in the Hes1 ODE model.
11.2.2 Non-dimensionalisation of reaction-diffusion models
We summarise our non-dimensionalisation of the Hes1 reaction-diffusion models (de-
scribed in sections 4.2 and 5.2). To non-dimensionalise the extended Hes1 model given
by equations (4.1) – (4.4) and (5.5), subject to the conditions in equations (4.8) – (5.4),
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we first define re-scaled variables by dividing each variable by a reference value. Re-
scaled variables are given overlines to distinguish them from variables that are not
re-scaled. Thus we can write:
[mn] =
[mn]
[m0]
, [mc] =
[mc]
[m0]
, [pn] =
[pn]
[p0]
, [pc] =
[pc]
[p0]
, t =
t
τ
, x =
x
L
, y =
y
L
, (11.1)
where the right hand side of each equation is a dimensional variable divided by its
reference value. From equation (11.1), we can write variables in terms of re-scaled
variables and then substitute these expressions into equations (4.1) – (4.4) and (5.5),
and into the conditions in equations (4.8) – (5.4). This gives a model defined in terms
of re-scaled variables which has the same form as the dimensional model but now the
parameters are all non-dimensional. Denoting the non-dimensional parameters with an
asterisk, they are related to dimensional parameters as follows:
D∗i j =
τDi j
L2
, α∗m =
ταm
[m0]
, p∗ =
[p0]
pˆ
, µ∗m = τµm, α∗p =
τ[m0]αp
[p0]
,
µ∗p = τµp,D∗m =
τDm
L2
, D∗p =
τDp
L2
, d∗ = d
L
, a∗ =
τa
L
, l∗ = l
L
. (11.2)
We solve the non-dimensional model using the method described in section 4.3. We
simulate the model in COMSOL 3.5a, finding non-dimensional parameter values that
yield oscillatory dynamics. We chose the same values as in equation (25) in Sturrock
et al. (2011) except for those parameters which were new because of our extension to
the model. These latter values were chosen as follows: D∗m = D∗i j/5, D
∗
p = D∗i j/15,
d∗ = 0.01, a∗ = 0.03, l∗ = 0.63.
Finally, we calculated the dimensional parameter values. To do this, we needed to esti-
mate the reference values. Since Her1 in zebrafish and Hes1 in mice are both pathways
connected with somitogenesis, we used the reference concentrations for Her1 protein
and her1 mRNA in Terry et al. (2011) as our reference concentrations for Hes1 protein
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and hes1 mRNA. Thus, we chose [m0] = 1.5×10−9M and [p0] = 10−9M. We assumed
a cell to be of width 30µm. But from Figures 4.1 and 5.2, the cell width is equal to 3
non-dimensional spatial units or 3L dimensional units (using equation (11.1)). Hence
we set 3L = 30µm, so that L = 10µm. The experimentally observed period of os-
cillations of Hes1 is approximately 2 hours (Hirata et al., 2002). Our simulations of
the non-dimensionalised model gave oscillations with a period of approximately 300
non-dimensional time units or 300τ dimensional units (using equation (11.1)). Hence
we set 300τ = 2 hours = 7200 seconds, so that τ = 24 seconds. Using our references
values and non-dimensional parameter values, we found dimensional parameter values
from equation (11.2).
Note that we chose our reference time τ = 24 seconds based on simulations of the
extended Hes1 model since this was our most realistic Hes1 model. For the original
Hes1 model and for all special cases of the Hes1 model (for example, setting active
transport rates to zero), we retained the reference time τ = 24 seconds.
11.2.3 Parameter sweeps of spatial stochastic model
In this section we present parameters sweeps for the remaining parameters in the spatial
stochastic model which we did not discuss in section 6.4. The parameters αm (the
rate of transcription) and αp (the rate of translation) do not influence the mean period
distribution when varied (see Figures 11.2 and 11.4). Figure 11.3 reveals that provided
the scale of transcription repression (γ) is greater than or equal to 12, a broad range of
mean periods are found. The degradation parameters (µm and µp) permit broad mean
period distributions for a range of parameter values (shown in Figures 11.5 and 11.6).
If the degradation rates are too high or too low, the broad mean period distribution is
lost.
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Figure 11.2: Histogram plot showing the effect on the period of oscillations of changing the
parameter αm, the basal transcription rate of hes1 mRNA. 10 values of αm were chosen from
the range (0.01− 10)min−1 were chosen, and 100 trajectories for each different value were
recorded. All other parameters in the model (see column 4, Table 6.1) were held constant.
The mean periods were computed and divided into ‘bins’ varying from 150 mins to persistent
expression (PE) i.e. greater than 400 mins. It is clear that αm is robust to change, with no
significant changes in the mean periods observed when the parameter is varied.
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Figure 11.3: Histogram plot showing the effect on the period of oscillations of changing the
parameter γ , the scale of transcriptional repression. 10 values of γ were chosen from the range
(1− 100) were chosen, and 100 trajectories for each different value were recorded. All other
parameters in the model (see column 4, Table 6.1) were held constant. The mean periods
were computed and divided into ‘bins’ varying from 150 mins to persistent expression (PE)
i.e. greater than 400 mins. As may be expected, if γ is too small (corresponding to no or little
negative feedback) no oscillations are observed and almost all trajectories exhibit persistent
expression. Provided γ is greater than or equal to 12 we find that this parameter is robust to
change, with a broad range of periods found for each different value of γ .
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Figure 11.4: Histogram plot showing the effect on the period of oscillations of changing the
parameter αp, the basal translation rate of hes1 mRNA. 10 values of αp from the range (0.1−
10)min−1 were chosen, and 100 trajectories for each different value were recorded. All other
parameters in the model (see column 4, Table 6.1) were held constant. The mean periods
were computed and divided into ‘bins’ varying from 100 mins to persistent expression (PE) i.e.
greater than 400 mins. It is clear that αp is robust to change, with no significant changes in the
mean periods observed when the parameter is varied.
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Figure 11.5: Histogram plot showing the effect on the period of oscillations of changing the pa-
rameter µm, the degradation rate of hes1 mRNA. 10 values of µm from the range (0−1.0)min−1
were chosen, and 100 trajectories for each different value were recorded. All other parameters
in the model (see column 4, Table 6.1)) were held constant. The mean periods were computed
and divided into ‘bins’ varying from 100 mins to persistent expression (PE) i.e. greater than
400 mins. Low values of µm result in huge quantities of hes1 mRNA and subsequently Hes1
protein in the cell. Hence, it is not surprising that low values of µm result in persistent expres-
sion of Hes1. As µm is increased, we can see how the distribution of periods changes. We find
that for larger values of µm many mean periods are found in the short period bins (100 to 200
mins). Only for µm = 0.01 do we find a broad range of mean periods.
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Figure 11.6: Histogram plot showing the effect on the period of oscillations of changing the
parameter µp, the degradation rate of Hes1 protein. 10 values of µp from the range (0.00043−
1.0)min−1 were chosen, and 100 trajectories for each different value were recorded. All other
parameters in the model (see column 4, Table 6.1) were held constant. The mean periods
were computed and divided into ‘bins’ varying from 100 mins to persistent expression (PE) i.e.
greater than 400 mins. Low values of µp result in huge quantities of Hes1 protein present in the
cell. Hence, it is not surprising that low values results in most mean periods being placed in
the PE bin. As µp is increased, fewer mean periods are found to exhibit persistent expression.
We find that µp is relatively robust to change, with broad ranges of mean periods recorded,
provided it takes a value greater than or equal to 0.025min−1.
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11.3 The p53-Mdm2 gene regulatory network
11.3.1 Busenberg’s criterion
We present here an extension of Dulac’s criterion to systems inR3 as appears in Busen-
berg and Driessche (1990). This criterion is used for ruling out periodic solutions to
ordinary differential equation systems. We applied it to system of equations (7.1) –
(7.3), which models the p53-Mdm2 GRN.
Theorem 2. Let f : R3 → R3 be a Lipschitz continuous vector field and let γ(t) be a
closed, piecewise smooth, curve which is the boundary of an orientable smooth surface
S⊂R3. Suppose that g : R3 →R3 is defined and piecewise smooth in a neighbourhood
of S, and that it satisfies
g(γ(t)) · f(γ(t))≤ 0 (or ≥ 0) for all t, (11.3)
(∇×g) ·n≥ 0 (≤ 0) on S, and (∇×g) ·n> 0 (< 0) for some point on S, (11.4)
where n is the unit normal to S. Then γ(t) is not the finite union of solution trajectories
of
x′(t) = f(x(t)) (11.5)
which are traversed in the positive sense relative to the direction of n.
Proof. We first note that γ(t) is an orbit of solutions of (11.5) if, and only if, it is an
orbit of the system x′(t) =−f(x(t)), which is traversed in the opposite direction. Thus,
the two sets of inequalities in (11.3) and (11.4) are equivalent, and we give the proof
only for the first set. By (11.4) and using Stokes’ theorem we have:
0<
∫∫
S
(∇×g) ·ndA =
∫
γ
g(γ(t)) · γ ′(t)dt. (11.6)
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Now, if γ(t) is piecewise smooth with γ ′(t) = f(γ(t)), except for a finite number of
points, then from (11.3)
∫
γ
g(γ(t)) · γ ′(t)dt =
∫
γ
g(γ(t)) · f(γ(t))dt ≤ 0.
This contradicts (11.6) and the theorem is proved.
An immediate corollary of this theorem yields the criterion that we used in the proof
that the p53-Mdm2 system (given by equations (7.1) – (7.3)) can not produce periodic
solutions.
Corollary 1. Let S ⊂ R3 be a smooth, orientable surface such that any piecewise
smooth closed curve γ(t) ∈ S is the boundary of a surface S′ ⊂ S. If γ : R3 → R3 is
smooth, f : γ(t) → R3 is Lipschitz, and f and g satisfy
g(γ(t)) · f(γ(t))= 0, (11.7)
and
(∇×g) ·n> 0 on S (< 0 on S), (11.8)
where n is the unit normal to S, then γ(t) is not a phase polygon of the differential
equation x′(t) = f(x(t)).
Proof. If γ(t) was a phase polygon of x′(t) = f(x(t)), then {γ(t), t≥ 0}= ∂S′ for some
oriented smooth surface S′ ⊂ S when γ is a given positive orientation relative to the
normal n to S. Now, apply Theorem 2 to γ(t) and S′ to see that this is not possible.
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It is easy to see that this corollary generalises Dulac’s criterion (presented in sec-
tion 11.2.1). In fact, if
x′ = f1(x,y),
y′ = f2(x,y),
is a planar system, we extend it trivially to R3 by
x′ = f1(x,y),
y′ = f2(x,y),
z′ = 0,
and we choose g(x,y) = (- f2(x,y), f1(x,y),0). Then g(x,y) · ( f1(x,y), f2(x,y),0) = 0,
and letting S be the x, y plane, we have n = (0,0,1). Assuming f1(x,y) and f2(x,y) are
smooth, we have (∇× g) ·n = ∇ · ( f1(x,y), f2(x,y)) > 0 (<0), in this special case of
Corollary 1.
We note that both Theorem 1 and Corollary 1 do not require that the field f be smooth
or even differentiable. In fact, even the Lipschitz condition on f, which implies that f
is differentiable almost everywhere, can be replaced by requiring that f be continuous
and that the problem x′(t) = f(x(t)), x(0) = x0, has a unique solution.
11.3.2 Non-dimensionalisation of reaction-diffusion models
We non-dimensionalised the p53-Mdm2 model defined in section 8.2, and the extended
p53-Mdm2 model defined in section 9.2, using the technique described above for non-
dimensionalising the extended Hes1 model. We present here brief details of our non-
dimensionalisation of the extended p53-Mdm2 model.
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To non-dimensionalise the extended p53-Mdm2 model given by equations (8.1) – (8.8)
and (9.9) – (9.10) subject to conditions (8.9), (8.14) – (8.17) and (9.1) – (9.8), we define
re-scaled variables (denoted by overlines) by dividing each variable by a reference
value:
[p53mn] =
[p53mn]
[p53m0]
, [p53mc] =
[p53mc]
[p53m0]
, [p53n] =
[p53n]
[p530]
, [p53c] =
[p53c]
[p530]
,
[Mdm2mn] =
[Mdm2mn]
[Mdm2m0]
, [Mdm2mc] =
[Mdm2mc]
[Mdm2m0]
, (11.9)
[Mdm2n] =
[Mdm2n]
[Mdm20]
, [Mdm2c] =
[Mdm2c]
[Mdm20]
, t =
t
τ
, x =
x
L
, y =
y
L
.
Substituting the scaling in equation (11.9) into the extended p53-Mdm2 model gives a
non-dimensionalised model with non-dimensional parameters (which we denote with
asterisks) that are related to dimensional parameters as follows:
D∗i j =
τDi j
L2
, ζ ∗ = τζ
[p53m0]
, φ∗ = τφ , β ∗ = τβ [p53m0]
[p530]
, µ∗ = τµ, ν∗ = τν,
Mdm2∗ = M̂dm2
[Mdm20]
,α∗ =
τα
[Mdm2m0]
, η∗ = τη
[Mdm2m0]
, p53∗ = p̂53
[p530]
,
θ∗ = [p530]θ
[Mdm20]
,γ∗ = τγ[Mdm2m0]
[Mdm20]
, ρ∗ = τρ , D∗m =
τDm
L2
,D∗p =
τDp
L2
,
d∗ = d
L
, a∗ =
τa
L
, l∗ = l
L
.
We solve the non-dimensional model using COMSOL 3.5a, finding non-dimensional
parameter values that yield oscillatory dynamics. We chose the same values as in
equation (60) in Sturrock et al. (2011) except for those parameters which were new
because of our extension to the model. These latter values were chosen as follows:
θ∗ = 1, ζ ∗ = 0.35, D∗m = D∗i j/5, D∗p = D∗i j/15, d∗ = 0.01, a∗ = 0.03, l∗ = 0.63.
Finally, we calculated the dimensional parameter values. To do this, we had to estimate
172
the reference values. We found a reference concentration for [p530] of 0.5µM and
estimated reference concentrations for rest of the model species as follows: [p530] =
0.5µM, [Mdm2m0] = 0.05µM, [Mdm20] = 2µM, and [p53m0] = 0.025µM. As with
the Hes1 model, we assumed a cell to be of width 30µm, which again leads to the
reference length L = 10µm. Our simulations of the non-dimensionalised model gave
oscillations with a period of approximately 360 non-dimensional time units or 360τ
dimensional units (using equation (11.10)) and the experimentally observed period is
approximately 3 hours (Monk, 2003). Hence we set 360τ = 3 hours = 10800 seconds,
so that τ = 30s. The reference time τ = 30 seconds was based on simulations of
the extended p53-Mdm2 model since this was our most realistic p53-Mdm2 model.
For all variants of this model (for example, setting active transport rates to zero), we
retained the reference time τ = 30 seconds for ease of comparison of the numerical
results. Using our references values and non-dimensional parameter values, we found
dimensional parameter values from equation (11.10).
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